Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3004248	s-shbg	nmol/l (nmol/l)	12452	21083	0.00%
3004248	p-shbg	nmol/l (nmol/l)	465	788	0.00%
3004248	p-shbg	— (—)	379	704	100.00%	Distribution not available
3004248	shbg	nmol/l (nmol/l)	18	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Sleep apnoea, including avohilmo

2903

7932

2.45

307.65

2.0

1.7

34.40

42.60

nmol/l

63.43

2814

7753

Sleep disorders (combined)

2935

8293

2.39

307.65

2.0

1.6

35.14

42.55

nmol/l

50.28

2848

8110

Testicular dysfunction

762

849

19.62

307.65

3.2

1.7

30.26

37.51

nmol/l

14.99

752

825

Polycystic ovarian syndrome, consortium definition

887

919

5.93

307.65

1.2

1.1

50.41

61.69

nmol/l

6.93

881

909

Sleep apnoea

2818

7867

2.51

307.65

2.0

1.7

34.14

42.33

nmol/l

66.09

2732

7687

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1220

2676

4.86

307.65

2.9

1.6

34.79

41.85

nmol/l

15.32

1172

2604

Exclusions for E4_PCOS_BROAD

1139

1813

7.22

307.65

3.0

1.7

34.63

40.42

nmol/l

8.24

1096

1767

Disorders of other endocrine glands

2271

3846

6.36

307.65

2.7

1.5

35.18

42.96

nmol/l

26.44

2216

3758

Testicular hypofunction

679

759

19.82

307.65

3.2

1.7

30.03

37.43

nmol/l

13.66

672

737

Hypopituitarism

861

996

12.10

307.65

3.4

1.6

29.73

38.27

nmol/l

21.35

824

965

Other antidepressants

3093

7919

2.09

263.34

2.0

1.6

38.49

41.80

nmol/l

10.55

3003

7751

Endocrine, nutritional and metabolic diseases

2743

6831

2.09

233.88

2.1

1.5

36.71

42.73

nmol/l

22.97

2680

6710

Depression or dysthymia

2129

5324

2.30

233.04

1.9

1.6

38.55

41.99

nmol/l

8.35

2066

5203

Exclusions for E4_PCOS_CONSORTIUM

1453

3607

2.58

211.82

2.7

1.5

39.21

43.63

nmol/l

5.01

1399

3544

Selective serotonin reuptake inhibitors

2889

7936

1.96

208.05

1.9

1.6

38.81

41.78

nmol/l

8.01

2812

7767

Benign neoplasm: Pituitary gland, craniopharyngeal duct

303

495

7.06

182.37

2.9

1.7

41.55

39.51

nmol/l

0.47

298

477

Benign neoplasm: Pituitary gland, craniopharyngeal duct

303

507

6.89

178.10

2.9

1.8

41.55

40.54

nmol/l

0.19

298

484

Episodal and paroxysmal disorders

2805

8194

1.78

152.00

1.9

1.6

37.24

42.95

nmol/l

24.43

2733

8025

Medical observation and evaluation for suspected diseases and conditions

2063

5527

1.95

146.92

2.0

1.6

39.26

40.27

nmol/l

0.99

1958

5444

Recurrent or chronic depression

1196

3799

2.34

145.77

1.9

1.6

37.41

40.65

nmol/l

4.47

1165

3735

Depression medications

1306

2906

2.34

143.18

2.0

1.6

36.33

41.46

nmol/l

10.13

1272

2880

Mood disorders, excluding more controls

2413

8569

1.74

125.93

2.0

1.7

39.08

41.00

nmol/l

2.75

2345

8398

Mood [affective] disorders

2544

10195

1.67

115.00

2.0

1.7

39.10

40.91

nmol/l

2.67

2475

9979

Mood disorders

2545

10200

1.66

114.34

2.0

1.7

39.14

40.92

nmol/l

2.57

2476

9984

Benign neoplasm of other and unspecified endocrine glands

381

1086

3.71

113.78

2.6

1.7

41.70

41.77

nmol/l

0.01

374

1043

Hypothyroidism (congenital or acquired)

994

2536

2.32

112.24

2.1

1.6

38.99

42.84

nmol/l

3.65

973

2513

Benign neoplasm of other and unspecified endocrine glands

381

1111

3.63

109.92

2.6

1.8

41.70

41.91

nmol/l

0.04

374

1065

Neurological diseases

2292

6812

1.72

109.75

1.9

1.6

37.35

42.91

nmol/l

20.49

2226

6699

Used for control exclusion in common control thyroid runs

2852

9065

1.62

108.69

2.0

1.6

40.42

40.79

nmol/l

0.29

2777

8871

Hypothyroidism and >3 levothyroxin purchases

976

2512

2.30

108.33

2.1

1.6

39.28

42.97

nmol/l

3.33

955

2489

Hypothyroidism, levothyroxine purchases

976

2512

2.30

108.33

2.1

1.6

39.28

42.97

nmol/l

3.33

955

2489

Codeine

2408

8009

1.68

107.44

1.9

1.6

37.96

42.14

nmol/l

12.83

2351

7842

Depression

2363

9992

1.65

104.55

1.9

1.7

39.23

40.74

nmol/l

1.86

2304

9786

Codeine or tramadol medication

2712

9478

1.61

102.61

1.9

1.7

38.25

42.06

nmol/l

12.29

2647

9259

Coxibs

766

1654

2.53

102.19

1.9

1.5

37.91

44.67

nmol/l

10.09

747

1627

Genitourinary diseases

2252

6855

1.68

98.18

1.9

1.8

38.45

38.08

nmol/l

0.31

2188

6733

Anxiety disorders, excluding more controls

2036

8127

1.69

96.68

1.9

1.7

38.73

40.46

nmol/l

2.28

1981

7977

Diseases of male genital organs

2432

7704

1.65

95.69

1.9

1.8

36.98

37.88

nmol/l

1.30

2362

7547

Impotence

305

858

4.02

95.68

2.2

1.9

40.34

40.42

nmol/l

0.02

295

825

Obesity and other hyperalimentation

1316

7152

1.86

92.71

1.9

1.7

32.48

43.75

nmol/l

46.98

1271

6984

Obesity

1310

7125

1.85

92.28

1.9

1.7

32.48

43.74

nmol/l

46.50

1265

6958

Opioids

2478

8227

1.60

91.90

1.9

1.6

38.61

41.97

nmol/l

8.66

2413

8056

Medical treatment for female infertility

283

753

3.83

91.83

1.2

62.14

56.87

nmol/l

0.89

283

742

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1316

7175

1.83

88.80

1.9

1.7

37.83

40.69

nmol/l

4.38

1277

7010

Other nutritional deficiencies

1359

7464

1.81

88.47

1.9

1.7

33.42

43.82

nmol/l

38.73

1315

7288

Tramadol

1783

6857

1.70

86.13

2.0

1.7

38.63

41.78

nmol/l

6.50

1731

6703

Anxiety (asthma-related co-morbidities)

1571

7259

1.74

85.54

1.9

1.7

38.97

39.70

nmol/l

0.48

1528

7148

Neurotic, stress-related and somatoform disorders

2141

9677

1.60

82.81

1.9

1.7

38.83

40.28

nmol/l

1.76

2086

9490

Anxiety disorders

2152

9739

1.59

81.67

1.9

1.7

38.89

40.30

nmol/l

1.70

2097

9552

Neurological diseases, wide definition

973

2454

2.03

77.50

2.0

1.5

35.94

42.96

nmol/l

13.54

946

2426

Abnormalities of breathing

2129

8155

1.57

74.83

1.9

1.7

37.56

41.63

nmol/l

11.66

2089

7980

Other diseases of upper respiratory tract

2442

8428

1.53

73.95

1.8

1.7

41.04

41.65

nmol/l

0.55

2368

8244

General examination and investigation of persons without complaint and reported diagnosis

1700

5527

1.66

73.02

1.9

1.6

39.71

40.27

nmol/l

0.40

1644

5444

All anxiety disorders

1578

7784

1.66

72.91

1.9

1.7

39.04

39.76

nmol/l

0.48

1535

7661

Use of hypnotics and sedatives

2393

9196

1.52

72.83

1.9

1.7

39.96

41.04

nmol/l

1.31

2316

8992

Symptoms and signs involving the circulatory and respiratory systems

2485

8300

1.52

72.41

1.9

1.7

38.88

41.48

nmol/l

5.41

2427

8124

Oxicams

519

1190

2.53

71.62

2.0

1.6

40.44

45.40

nmol/l

4.12

506

1166

Other special examinations and investigations of persons without complaint or reported diagnosis

1752

5528

1.63

68.55

1.9

1.6

40.79

40.27

nmol/l

0.37

1707

5444

Mouth breathing

1111

6381

1.78

68.13

2.0

1.8

36.23

40.73

nmol/l

9.19

1095

6200

Other dorsopathies, not elsewhere classified

2416

8577

1.50

67.96

1.9

1.6

39.73

41.40

nmol/l

2.43

2353

8394

Deviated nasal septum

981

5465

1.84

66.96

1.9

1.8

37.99

40.56

nmol/l

3.57

944

5323

Hypertrophy of breast in women and men

290

970

3.06

66.00

2.0

1.6

46.99

44.36

nmol/l

0.81

275

947

Parasetamol

2285

7816

1.51

65.33

1.9

1.7

36.99

41.38

nmol/l

13.70

2219

7679

Obesity due to excess calories

941

5203

1.84

65.26

2.0

1.7

32.03

43.95

nmol/l

34.92

901

5070

Pain in throat and chest

1943

7762

1.55

64.68

1.9

1.7

39.42

41.07

nmol/l

2.09

1888

7587

Acetic acid derivatives and related substances

658

1618

2.16

62.23

1.9

1.5

39.09

44.91

nmol/l

6.54

640

1591

Behavioural syndromes associated with physiological disturbances and physical factors

755

3967

1.95

61.65

2.1

1.6

43.34

41.84

nmol/l

0.73

748

3875

Other anxiety disorders

1128

5930

1.72

60.33

1.9

1.7

40.09

40.59

nmol/l

0.22

1096

5838

Other joint disorders

2240

8155

1.48

58.63

1.9

1.6

39.40

41.30

nmol/l

3.08

2167

8001

Dorsalgia

2282

8504

1.47

57.82

1.9

1.6

39.94

41.43

nmol/l

2.03

2229

8321

Dorsopathies

2431

8623

1.45

57.72

1.9

1.6

40.04

41.32

nmol/l

1.57

2364

8440

Acute upper respiratory infections of multiple and unspecified sites

1634

7987

1.55

57.08

1.8

1.7

38.25

41.69

nmol/l

7.11

1603

7800

Obesity, other/unspecified

655

3374

1.98

56.70

1.8

1.7

34.39

43.89

nmol/l

13.28

634

3295

Obesity related asthma

705

3741

1.93

56.02

2.0

1.7

33.42

41.67

nmol/l

24.03

682

3634

Exposure to unspecified factor

2062

11024

1.47

55.45

1.8

1.7

40.20

41.09

nmol/l

0.93

2006

10784

Soft tissue disorders

2430

8849

1.44

55.31

1.9

1.7

39.70

41.17

nmol/l

1.95

2359

8676

Special screening examination for infectious and parasitic diseases

887

3743

1.82

55.29

1.7

1.6

40.11

38.33

nmol/l

1.23

853

3706

Injuries to the wrist and hand

2137

10729

1.46

55.27

1.8

1.7

40.66

41.14

nmol/l

0.37

2081

10490

Persons encountering health services for examination and investigation

1694

5528

1.56

55.21

1.9

1.6

40.27

nmol/l

0.00

1638

5444

Pain (limb, back, neck, head abdominally)

1873

6251

1.52

54.87

1.9

1.7

39.22

41.07

nmol/l

2.51

1824

6115

Chronic rhinitis, nasopharyngitis and pharyngitis

636

3297

1.97

54.09

1.9

1.7

39.09

41.30

nmol/l

1.58

628

3220

Other intervertebral disc disorders

1786

7344

1.51

52.45

2.0

1.7

38.66

41.20

nmol/l

4.94

1744

7176

Exposure to other specified factors

1703

10806

1.50

51.95

1.9

1.7

39.19

40.43

nmol/l

1.41

1649

10579

Psychiatric diseases

2413

8555

1.43

51.64

1.9

1.7

40.66

41.01

nmol/l

0.26

2334

8382

Oter anti-inflammatory and antirheumatic agents, non-steroids

391

891

2.48

51.62

1.9

1.6

41.60

46.80

nmol/l

3.82

374

871

Lumbar disc prolapse

1357

6923

1.58

51.60

2.0

1.7

38.79

41.08

nmol/l

3.30

1329

6760

Propionic acid derivatives

682

1764

1.97

50.93

1.8

1.5

39.16

44.19

nmol/l

5.15

661

1736

Any mental disorder

2418

8648

1.41

49.24

1.9

1.7

40.45

41.12

nmol/l

0.63

2337

8473

General symptoms and signs

2571

9306

1.40

49.11

1.9

1.7

39.93

40.80

nmol/l

0.93

2507

9100

Shoulder lesions

1585

6460

1.52

48.70

1.9

1.7

40.73

41.06

nmol/l

0.19

1523

6309

Disorders of skin appendages

1008

6219

1.65

47.02

1.7

42.57

40.68

nmol/l

0.91

989

6069

Nonorganic sleeping disorders, excluding more controls

435

2079

2.15

46.78

2.1

1.6

42.73

41.17

nmol/l

0.62

430

2043

Other headache syndromes

657

3615

1.84

46.25

1.9

1.6

40.49

44.70

nmol/l

3.94

639

3529

Benign neoplasms

2409

9758

1.39

45.94

1.9

1.7

40.98

40.79

nmol/l

0.12

2350

9547

Diseases of the musculoskeletal system and connective tissue

1462

4822

1.54

45.73

1.9

1.6

38.66

41.33

nmol/l

3.71

1424

4753

Inflammatory diseases of prostate (prostatitis)

451

2239

2.11

44.64

1.9

1.8

39.84

40.45

nmol/l

0.25

432

2160

Dislocation, sprain and strain of joints and ligaments of knee

1473

9334

1.49

43.29

1.8

1.7

38.81

40.08

nmol/l

1.37

1440

9132

Chronic sinusitis

792

4695

1.71

43.09

1.9

1.7

39.31

41.56

nmol/l

1.47

779

4583

Anti-inflammatory and antirheumatic products, non-steroids

645

1764

1.86

40.97

1.8

1.5

38.56

44.19

nmol/l

6.49

626

1736

Acute upper respiratory infections

1934

8665

1.41

40.91

1.8

1.7

39.08

42.43

nmol/l

8.00

1888

8441

Antihypertensive medication - note that there are other indications

1631

6168

1.46

40.86

1.9

1.6

35.98

42.54

nmol/l

22.22

1592

6081

Benign neoplasms

2103

8624

1.40

40.70

1.9

1.7

40.12

40.28

nmol/l

0.09

2060

8454

Rotator cuff syndrome

1150

5620

1.54

38.82

1.9

1.7

40.31

41.57

nmol/l

1.07

1101

5476

Arthropathies

2190

8168

1.38

38.62

1.9

1.6

39.32

41.27

nmol/l

2.99

2128

8014

Polyuria

418

2113

2.02

38.57

1.8

1.7

44.06

43.45

nmol/l

0.19

401

2028

Continuous positive airway pressure

484

2207

1.94

38.32

2.0

1.6

34.48

42.59

nmol/l

15.85

460

2164

Sleep disorders

495

2658

1.91

38.28

2.1

1.7

41.92

40.53

nmol/l

0.60

489

2592

Bronchitis

2076

9993

1.37

37.93

1.8

1.7

38.82

41.97

nmol/l

7.40

2032

9754

Transport accidents

1070

6239

1.54

37.39

1.9

1.7

40.64

41.19

nmol/l

0.29

1045

6130

Headache

1290

7376

1.48

36.67

1.9

1.7

39.32

41.34

nmol/l

2.06

1261

7213

Benzodiazepine use

1987

10393

1.37

36.56

2.0

1.7

40.18

41.29

nmol/l

1.18

1921

10169

Abdominal and pelvic pain

2412

9097

1.34

36.49

1.8

1.7

39.81

40.60

nmol/l

0.83

2348

8899

Chronic diseases of tonsils and adenoids

1716

7775

1.41

36.44

1.8

1.7

39.38

40.82

nmol/l

1.55

1679

7627

Non-selective monoamine reuptake inhibitors

516

2758

1.84

36.09

2.0

1.6

41.37

42.85

nmol/l

0.69

505

2663

Paracetamol of NSAID medication

476

1233

1.98

35.89

1.8

1.4

38.00

43.75

nmol/l

5.37

463

1214

Injuries to the shoulder and upper arm

1737

10566

1.39

35.65

1.9

1.7

39.24

40.00

nmol/l

0.75

1688

10326

Hyperkinetic disorders, excluding more controls

316

1448

2.20

35.59

2.1

1.6

36.84

39.47

nmol/l

0.99

305

1439

Sexual dysfunction

100

262

4.44

35.41

2.4

1.7

35.58

37.76

nmol/l

0.55

100

253

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1107

3641

1.54

35.27

1.9

1.6

36.47

40.18

nmol/l

6.50

1076

3585

Male infertility

300

1422

2.31

35.03

2.5

1.8

31.24

34.89

nmol/l

3.43

295

1400

Other diseases of intestines

2286

9998

1.34

34.87

1.8

1.7

40.19

40.85

nmol/l

0.65

2221

9800

Insomnia

365

1839

2.04

34.24

2.2

1.8

41.28

40.05

nmol/l

0.42

360

1789

Symptoms and signs involving the digestive system and abdomen

2399

9097

1.33

34.22

1.8

1.7

39.82

40.60

nmol/l

0.82

2333

8899

Irritable bowel syndrome

438

2339

1.90

34.20

2.0

1.6

40.84

42.61

nmol/l

0.84

429

2284

Intestinal infectious diseases

1888

10868

1.36

33.90

1.8

1.7

39.95

40.92

nmol/l

0.69

1856

10615

Nonorganic sleeping disorders

435

2336

1.91

33.74

2.1

1.7

42.73

40.19

nmol/l

1.28

430

2279

Persistent mood disorders

374

1908

2.00

33.66

2.0

1.7

40.14

41.17

nmol/l

0.30

358

1860

Acute sinusitis

1091

6882

1.50

33.50

1.9

1.7

38.97

41.03

nmol/l

1.94

1072

6725

Intracranial trauma

1176

6017

1.48

32.78

1.9

1.6

39.78

42.51

nmol/l

3.29

1149

5915

Hernia

1891

9530

1.36

32.34

1.8

40.32

39.63

nmol/l

0.56

1842

9315

Neoplasms

2127

8593

1.34

31.81

1.9

1.7

38.98

40.07

nmol/l

1.02

2085

8428

Diseases of the skin and subcutaneous tissue

2253

8574

1.33

31.53

1.8

1.7

40.86

40.59

nmol/l

0.16

2188

8388

Migraine

734

3911

1.61

31.45

1.8

1.5

41.68

45.09

nmol/l

2.23

726

3841

Spondylopathies

1466

6361

1.41

31.29

1.8

1.7

41.16

41.18

nmol/l

0.01

1422

6200

Low back pain

1443

7975

1.41

31.27

1.9

1.7

39.13

41.71

nmol/l

3.69

1412

7801

Abnormalities of heart beat

535

3089

1.74

31.17

1.8

1.6

43.10

43.54

nmol/l

0.15

515

2999

Personality disorders, excluding more controls

615

3734

1.68

31.05

1.9

1.7

39.36

40.29

nmol/l

0.38

601

3676

Pain in joint

1292

6005

1.44

31.02

2.0

1.7

39.55

41.25

nmol/l

1.72

1261

5875

Monoamine oxidase A inhibitors

222

959

2.37

30.75

2.0

1.7

40.54

42.51

nmol/l

0.62

216

929

Sciatica+with lumbago

883

5531

1.53

30.70

1.9

1.7

39.76

41.88

nmol/l

1.97

867

5394

Vasomotor and allergic rhinitis

753

4753

1.58

30.21

1.9

1.7

39.41

40.77

nmol/l

0.74

736

4667

Other specific joint derangements/joint disorders

1593

7824

1.38

29.89

1.9

1.6

39.64

41.51

nmol/l

2.33

1557

7674

Gastro-oesophageal reflux disease

1190

7412

1.44

29.59

1.8

1.7

42.09

41.42

nmol/l

0.39

1145

7230

Injuries to the knee and lower leg

2342

10360

1.30

29.46

1.8

1.7

40.03

41.36

nmol/l

1.83

2278

10130

Concussion

1002

5907

1.48

29.46

1.9

1.6

38.76

42.53

nmol/l

5.32

979

5806

Cervical disc disorders

633

3930

1.63

29.07

1.9

1.7

40.47

41.95

nmol/l

0.89

609

3815

Lower back pain or/and sciatica

1994

10572

1.32

28.19

1.9

1.7

39.58

41.49

nmol/l

3.02

1954

10321

GASTRO-related operations

1912

7233

1.34

28.11

1.8

1.7

40.25

40.24

nmol/l

0.01

1866

7106

Any gastric operation

1912

7233

1.34

28.11

1.8

1.7

40.25

40.24

nmol/l

0.01

1866

7106

Other pulmonary diagnosis

1767

6604

1.35

27.85

1.8

1.7

39.98

41.80

nmol/l

2.19

1717

6461

Arthrosis

1455

5815

1.39

27.60

2.0

1.7

39.25

41.12

nmol/l

2.42

1409

5676

Artrosis, including avohilmo

1778

7320

1.34

27.54

1.9

1.7

38.34

40.78

nmol/l

4.62

1724

7148

Persons encountering health services in other circumstances, wide

2508

10218

1.28

27.44

1.9

1.7

39.97

40.90

nmol/l

1.01

2458

9974

Generalized anxiety disorder

345

1840

1.92

27.43

2.0

1.6

39.79

42.18

nmol/l

0.96

331

1811

Hypothyroidism, other/unspecified

1389

6657

1.39

27.34

2.0

1.6

42.89

43.87

nmol/l

0.57

1353

6465

Factors influencing health status and contact with health services

968

3284

1.50

26.95

1.9

1.7

38.31

39.39

nmol/l

0.75

933

3235

Disorders of the thyroid gland

1588

7730

1.35

26.58

2.0

1.6

43.38

43.43

nmol/l

0.02

1550

7517

Diseases of the ear and mastoid process

2483

9890

1.28

26.52

1.8

1.7

41.30

40.65

nmol/l

0.49

2415

9695

Internal derangement of knee

791

5267

1.52

26.42

1.9

1.7

39.21

41.34

nmol/l

2.28

754

5147

Hypothyreosis and Thyroxine purchase for inclusion criteria

1398

6747

1.38

26.34

2.0

1.6

42.91

43.91

nmol/l

0.59

1362

6554

Osteoporosis

208

889

2.26

25.99

1.7

1.8

51.02

42.73

nmol/l

3.41

198

858

Injury of muscle and tendon at shoulder and upper arm level

750

4979

1.53

25.92

1.9

1.8

39.00

41.65

nmol/l

3.02

724

4824

Other disorders of penis

334

1811

1.92

25.85

1.9

1.8

39.47

38.79

nmol/l

0.22

322

1758

Viral hepatitis, IBD co-morbidity

186

809

2.40

25.82

2.2

1.6

49.68

39.30

nmol/l

5.26

174

796

Disturbance of activity and attention

303

1566

1.97

25.73

2.0

1.6

37.13

38.83

nmol/l

0.53

292

1552

Excluding asthma or asthma-COPD overlap

1745

6604

1.33

25.34

1.8

1.7

39.99

41.80

nmol/l

2.16

1694

6461

Use of pramipexole

292

1511

1.96

25.28

1.9

1.7

41.31

43.15

nmol/l

0.66

285

1450

Myalgia

355

1970

1.83

24.72

2.0

1.6

38.66

42.60

nmol/l

2.46

340

1924

Other disorders of adrenal gland

273

3.43

24.69

2.2

1.5

50.20

42.70

nmol/l

0.78

262

Other/unspecified dorsalgia

604

3839

1.58

24.61

1.9

1.6

39.92

42.02

nmol/l

1.41

590

3745

ILD differential diagnosis

1729

6563

1.33

24.59

1.8

1.7

39.88

41.85

nmol/l

2.48

1682

6421

Dentofacial anomalies [including malocclusion]

476

2840

1.68

24.58

1.9

1.7

41.01

41.67

nmol/l

0.20

470

2790

Panic disorder

336

1843

1.86

24.53

1.9

1.6

36.90

41.77

nmol/l

3.00

324

1815

Impingement syndrome of shoulder

440

2607

1.71

24.45

1.9

1.7

41.36

42.51

nmol/l

0.46

416

2529

COPD differential diagnosis

1728

6569

1.33

24.33

1.8

1.7

39.84

41.86

nmol/l

2.57

1681

6426

Examination and observation for other reasons

1235

5454

1.39

24.12

1.9

1.6

41.29

40.34

nmol/l

0.67

1206

5371

Spinal stenosis

694

3575

1.54

23.95

1.9

1.6

42.27

44.02

nmol/l

1.15

679

3448

Hyperkinetic disorders

316

1696

1.90

23.92

2.1

1.7

36.84

38.52

nmol/l

0.55

305

1679

Spondylosis

833

4899

1.47

23.74

1.9

1.7

41.51

42.32

nmol/l

0.49

805

4756

Pain, not elsewhere classified

464

2811

1.67

23.64

1.9

1.7

40.30

42.19

nmol/l

0.69

455

2737

Other disorders of male genital organs

172

760

2.43

23.62

2.0

1.8

35.20

36.73

nmol/l

0.43

162

740

Benign neoplasm of colon, rectum, anus and anal canal

828

5142

1.47

23.32

1.8

1.7

42.71

43.54

nmol/l

0.47

796

4966

Meniscus derangement

1112

5491

1.40

23.14

1.9

1.7

40.00

41.04

nmol/l

0.76

1082

5358

Postprocedural endocrine and metabolic disorders, not elsewhere classified

158

670

2.40

22.87

2.1

1.6

44.65

43.01

nmol/l

0.26

153

653

Tinnitus

393

2315

1.73

22.38

1.8

1.7

40.70

41.47

nmol/l

0.26

383

2244

Benign neoplasm: Colon

672

4397

1.51

22.25

1.8

1.7

42.72

44.04

nmol/l

0.75

644

4232

Cardiovascular diseases

1583

6587

1.32

21.86

1.9

1.7

37.51

40.82

nmol/l

5.83

1547

6486

Hyperplasia of prostate

1000

4075

1.42

21.72

1.8

1.7

41.97

42.09

nmol/l

0.06

960

3953

Other and unspecified tonsillitis

1036

6387

1.40

21.71

1.8

1.7

36.78

40.11

nmol/l

4.44

1019

6271

Bipolar affective disorders

418

2530

1.68

21.60

2.1

1.7

37.69

40.90

nmol/l

1.70

407

2482

Gonarthrosis

1158

4857

1.38

21.52

2.0

1.7

40.54

41.91

nmol/l

1.26

1111

4729

Diarrhoea and gastroenteritis of presumed infectious origin

1418

9825

1.32

21.43

1.8

1.7

39.16

40.42

nmol/l

1.16

1393

9610

Symptoms and signs involving the urinary system

1299

7541

1.34

21.33

1.8

1.7

42.58

41.32

nmol/l

1.10

1248

7349

Malaise and fatigue

736

4196

1.47

21.20

1.9

1.6

42.68

43.08

nmol/l

0.15

724

4064

Diseases of the eye and adnexa

2062

8178

1.27

21.15

1.8

1.7

41.02

39.90

nmol/l

1.12

2005

8026

Cough

564

3527

1.55

20.96

1.9

1.6

43.65

43.42

nmol/l

0.07

550

3420

Disorders of adult personality and behaviour

664

4498

1.50

20.93

1.9

1.7

39.15

40.16

nmol/l

0.45

650

4409

Diseases of the respiratory system

1214

4484

1.37

20.84

1.8

1.6

40.53

43.20

nmol/l

2.77

1176

4378

Visual disturbances

705

4835

1.47

20.64

1.9

1.7

41.58

42.37

nmol/l

0.35

682

4698

Other soft tissue disorders, not elsewhere classified

1756

8485

1.29

20.63

1.9

1.7

39.90

41.53

nmol/l

1.83

1710

8314

Other reaction to severe stress, and adjustment disorders

714

4927

1.47

20.34

1.8

1.7

41.67

40.60

nmol/l

0.39

696

4844

Symptoms and signs involving the skin and subcutaneous tissue

1045

7654

1.37

20.30

1.8

1.7

41.80

42.29

nmol/l

0.25

1011

7459

Adrenocortical insufficiency

221

3.44

20.19

2.3

1.5

55.56

41.52

nmol/l

1.51

211

Other disorders of patella

347

2042

1.73

19.94

1.8

1.7

37.86

41.06

nmol/l

2.14

332

1999

Other metabolic disorders

171

796

2.18

19.90

2.0

1.6

43.73

42.84

nmol/l

0.14

166

777

Diseases of oral cavity, salivary glands and jaws

1800

7248

1.28

19.89

1.8

1.7

41.00

40.90

nmol/l

0.06

1738

7110

Visual disturbances and blindness

736

5147

1.44

19.44

1.9

1.7

41.71

42.43

nmol/l

0.32

712

5002

Injuries to the head

2081

10914

1.25

19.31

1.8

1.7

40.04

41.21

nmol/l

1.42

2024

10676

Other arthrosis

906

4670

1.40

19.25

1.9

1.7

40.70

41.66

nmol/l

0.65

884

4547

Gastrointestinal diseases

1385

5285

1.32

19.22

1.8

1.7

39.26

40.59

nmol/l

1.18

1351

5196

Other extrapyramidal and movement disorders in other diseases

302

1726

1.77

19.19

2.0

1.7

41.87

42.76

nmol/l

0.27

290

1658

Diaphragmatic hernia

438

2771

1.60

18.76

1.8

1.7

43.39

42.37

nmol/l

0.30

426

2670

Personality disorders

615

4201

1.49

18.66

1.9

1.7

39.36

40.22

nmol/l

0.34

601

4117

Disturbances of skin sensation

460

2955

1.58

18.57

1.7

39.44

41.56

nmol/l

1.24

447

2887

Cervicalgia

297

1707

1.76

18.52

2.0

1.7

41.75

41.92

nmol/l

0.04

283

1659

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

516

3099

1.54

18.39

2.0

1.6

38.62

39.52

nmol/l

0.27

502

3061

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

797

5628

1.40

18.04

1.9

1.7

41.09

40.69

nmol/l

0.15

785

5520

Other enthesopathies

446

2867

1.57

17.90

2.0

1.6

39.94

41.63

nmol/l

0.78

435

2795

Allergic conjunctivitis

833

5941

1.39

17.90

1.9

1.7

40.83

40.86

nmol/l

0.01

819

5821

Endometriosis

129

313

2.46

17.89

1.2

60.94

55.36

nmol/l

0.73

129

308

Enthesopathies of lower limb, excluding foot

373

2306

1.64

17.74

1.9

1.7

39.56

40.92

nmol/l

0.52

361

2246

Phobic anxiety disorders

321

1916

1.71

17.66

2.0

1.6

36.39

39.79

nmol/l

1.62

312

1885

Asthma, excluding more controls

1530

6383

1.29

17.54

1.9

1.7

37.84

41.75

nmol/l

7.85

1498

6249

Haemorrhage from respiratory passages

501

3083

1.52

17.25

1.7

41.85

43.52

nmol/l

0.81

479

2980

Statin medication

1469

6439

1.29

17.23

1.9

1.8

35.49

40.75

nmol/l

11.72

1425

6318

Social phobias

228

1250

1.88

17.01

1.9

1.7

35.86

39.08

nmol/l

1.24

220

1239

Specific personality disorders

511

3430

1.51

16.98

1.9

1.7

39.34

40.75

nmol/l

0.59

502

3355

First line medication for Crohn's disease

2292

10296

1.22

16.76

1.9

1.7

39.77

41.00

nmol/l

1.42

2246

10067

Osteopathies and chondropathies

809

5598

1.38

16.66

1.8

1.7

42.21

40.76

nmol/l

0.94

780

5453

Disorders of thyroid, IBD co-morbidities

255

1044

1.80

16.31

1.7

1.4

49.22

48.89

nmol/l

0.04

249

1030

Menorrhagia

103

215

2.66

16.31

1.3

1.2

63.66

56.76

nmol/l

0.41

103

210

Mental and behavioural disorders due to opioids

150

730

2.17

16.24

2.6

1.9

46.39

35.36

nmol/l

5.03

138

723

Subjective visual disturbances

339

2093

1.64

16.23

1.9

1.7

41.54

42.34

nmol/l

0.21

325

2028

Autoimmune diseases

2389

10112

1.21

16.20

1.8

1.7

42.75

40.15

nmol/l

4.67

2334

9881

Asthma (mode)

1512

6563

1.27

16.16

1.8

1.7

38.13

41.85

nmol/l

6.91

1483

6421

Other functional intestinal disorders

551

3596

1.47

16.15

1.8

1.6

43.38

42.95

nmol/l

0.15

529

3498

Asthma

1535

6522

1.27

16.03

1.9

1.7

37.89

41.88

nmol/l

8.17

1503

6382

1959

8420

1.23

15.96

1.8

1.7

39.66

42.54

nmol/l

5.81

1910

8205

Type 2 diabetes

1822

8760

1.24

15.96

1.8

1.7

34.68

42.13

nmol/l

27.96

1757

8573

Disorders of lacrimal system

449

2967

1.53

15.89

2.0

1.7

43.06

42.78

nmol/l

0.07

432

2874

Artificial joint operation, meniscal resection

1606

8563

1.26

15.78

1.9

1.8

40.13

40.56

nmol/l

0.33

1554

8347

Haemorrhoids and perianal venous thrombosis

375

2385

1.59

15.77

1.7

43.09

43.15

nmol/l

0.02

361

2305

Temporomandibular joint disorders, including avohilmo

570

3952

1.45

15.76

1.8

1.6

45.15

43.69

nmol/l

0.53

554

3869

Fissure and fistula of anal and rectal regions

438

2900

1.53

15.53

1.8

1.7

40.64

41.04

nmol/l

0.13

420

2822

Certain infectious and parasitic diseases

1985

8123

1.23

15.48

1.8

1.7

41.63

40.92

nmol/l

0.48

1936

7946

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

467

3139

1.51

15.47

1.9

1.7

29.02

43.16

nmol/l

45.14

449

3045

Type 2 diabetes, definitions combined, including avohilmo

1705

8144

1.25

15.44

1.8

1.7

32.82

42.66

nmol/l

56.24

1645

7961

Other external causes of accidental injury

1625

6516

1.26

15.31

1.7

41.24

41.83

nmol/l

0.39

1574

6398

Hypertensive diseases (excluding secondary)

1241

5614

1.30

15.30

2.0

1.8

33.98

39.89

nmol/l

14.24

1211

5513

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

239

3570

0.58

15.26

1.7

45.05

43.50

nmol/l

0.32

232

3437

Tonsillectomy and adenotomy

1290

7066

1.28

15.12

1.7

1.8

39.29

39.35

nmol/l

0.02

1267

6943

Accidents

1622

6516

1.25

15.04

1.7

41.10

41.83

nmol/l

0.51

1569

6398

Diabetes mellitus

1948

9547

1.22

14.96

1.8

1.7

36.26

41.80

nmol/l

16.22

1885

9353

774

5676

1.36

14.87

1.9

1.7

35.26

40.72

nmol/l

10.60

760

5551

Allergic asthma (mode)

454

2998

1.50

14.85

1.8

1.6

37.72

41.71

nmol/l

3.02

447

2947

Hypertension, essential

1582

7254

1.25

14.85

1.9

1.7

35.77

41.10

nmol/l

14.38

1532

7099

Allergic asthma (mode), excluding more controls

454

2998

1.50

14.84

1.8

1.6

37.72

41.83

nmol/l

3.17

447

2948

Diabetes, varying definitions

1941

9534

1.22

14.77

1.8

1.7

36.04

41.81

nmol/l

19.71

1878

9340

Type 2 diabetes, strict (exclude DM1)

1681

8129

1.24

14.74

1.8

1.7

32.92

42.60

nmol/l

53.94

1619

7945

Type 2 diabetes, definitions combined

1678

8110

1.24

14.73

1.8

1.7

32.91

42.59

nmol/l

53.70

1616

7927

Other and unspecified polyneuropathies, also in other diseases

299

1841

1.65

14.61

1.7

1.8

43.22

42.65

nmol/l

0.16

292

1758

Redundant prepuce, phimosis and paraphimosis

734

5413

1.38

14.40

1.9

1.8

34.77

36.58

nmol/l

1.80

719

5303

Gingivitis and periodontal diseases

1727

7245

1.24

14.35

1.8

1.7

40.21

40.90

nmol/l

0.51

1665

7107

Cervicobrachial syndrome

313

1956

1.62

14.32

2.0

1.7

39.77

42.05

nmol/l

1.02

304

1905

Infections with a predominantly sexual mode of transmission

568

4016

1.43

14.32

1.8

1.7

41.54

40.55

nmol/l

0.35

543

3949

Dysphagia

308

1918

1.62

14.28

1.8

1.7

43.79

43.04

nmol/l

0.21

295

1844

Umbilical hernia

572

4071

1.42

14.08

2.0

1.8

37.08

41.05

nmol/l

4.18

551

3946

Anomalies of dental arch relationship, including avohilmo

354

2068

1.56

13.53

1.9

1.7

40.35

40.31

nmol/l

0.01

347

2021

Conjunctivitis

1209

8364

1.27

13.47

1.8

1.7

40.74

40.45

nmol/l

0.13

1178

8188

Triptan medication for migraine, min. 3 purchases

783

4625

1.34

13.43

1.8

1.6

42.69

42.85

nmol/l

0.05

775

4537

Allergic rhinitis

587

4186

1.40

13.40

1.9

1.7

39.31

40.33

nmol/l

0.41

575

4103

Polyneuropathies and other disorders of the peripheral nervous system

336

2174

1.57

13.35

1.8

42.57

42.54

nmol/l

0.01

328

2082

Hypothyroidism, strict autoimmune

1015

5203

1.30

13.26

1.8

1.5

44.44

44.22

nmol/l

0.07

992

5057

Extrapyramidal and movement disorders

432

2946

1.48

13.24

1.9

1.7

41.96

43.47

nmol/l

0.74

418

2827

Fenamates

190

700

1.85

13.20

1.6

1.5

42.53

49.00

nmol/l

2.30

180

687

Diseases of oesophagus, stomach and duodenum

1936

9781

1.21

13.17

1.8

1.7

41.72

40.67

nmol/l

1.01

1875

9568

Other disorders of lacrimal gland

364

2404

1.53

13.05

2.0

1.7

43.11

43.03

nmol/l

0.02

348

2331

Chronic laryngitis and laryngotracheitis

181

1003

1.83

12.97

1.8

1.7

40.52

43.32

nmol/l

0.90

170

971

Atherosclerosis, excluding cerebral and coronary sclerosis

214

2871

0.59

12.97

1.6

1.7

44.85

45.71

nmol/l

0.18

201

2733

Other diseases of hard tissues of teeth

1194

7081

1.27

12.88

1.8

1.7

43.24

40.72

nmol/l

2.61

1159

6947

Nerve, nerve root and plexus disorders

1856

9698

1.21

12.70

1.9

1.7

39.42

41.58

nmol/l

3.41

1784

9489

Malignant neoplasm

1080

8094

0.79

12.60

1.8

41.79

40.87

nmol/l

0.49

1056

7893

Diseases of appendix

1435

10671

1.23

12.60

1.8

1.7

40.08

40.67

nmol/l

0.31

1411

10419

Deforming dorsopathies

395

2681

1.49

12.47

2.1

1.7

40.45

41.76

nmol/l

0.52

382

2616

Appendicitis, broad definition

1428

10663

1.23

12.46

1.8

1.7

40.06

40.67

nmol/l

0.33

1404

10411

Dental operations

1214

4948

1.27

12.46

1.8

1.7

40.56

41.34

nmol/l

0.51

1171

4844

Orchitis and epididymitis

257

1596

1.65

12.45

1.9

1.8

38.83

38.96

nmol/l

0.03

250

1543

Fall on same level

2264

10711

1.19

12.44

1.8

1.7

40.60

40.96

nmol/l

0.26

2190

10494

Other hypertrichosis

30.19

12.39

1.4

1.3

42.50

30.33

nmol/l

—

Cardiovascular diseases (excluding rheumatic etc)

1518

7166

1.23

12.33

1.9

1.7

36.50

40.57

nmol/l

8.32

1483

7047

Other (not insulin) diabetes medications

1674

8335

1.22

12.28

1.8

1.7

32.95

42.48

nmol/l

53.28

1608

8149

Gonarthrosis [arthrosis of knee](FG)

1279

6046

1.25

12.22

1.9

1.7

40.97

41.97

nmol/l

0.84

1227

5883

Diabetes medication

1900

9659

1.20

12.21

1.8

1.7

36.55

41.73

nmol/l

13.75

1832

9462

Substance abuse, excluding more controls

1177

8261

1.26

12.16

1.9

1.7

40.35

40.52

nmol/l

0.09

1132

8088

ILD medications

2253

10493

1.18

12.09

1.8

1.7

39.91

41.08

nmol/l

1.34

2208

10257

Symptoms and signs involving speech and voice

356

2384

1.51

12.00

1.7

45.94

43.87

nmol/l

0.70

348

2292

Blepharochalasis

225

1363

1.66

11.70

1.5

1.7

46.11

45.65

nmol/l

0.11

220

1299

Hallux rigidus

149

804

1.87

11.66

1.8

1.6

46.39

43.71

nmol/l

0.65

142

777

Erosion of teeth, including avohilmo

379

2503

1.48

11.61

1.9

1.7

42.69

40.28

nmol/l

0.90

365

2459

COPD, early/later onset

296

3790

0.65

11.60

1.8

1.7

42.99

44.93

nmol/l

0.64

279

3626

Asthma-related infections

914

7047

1.28

11.60

1.9

1.7

35.79

41.12

nmol/l

11.65

898

6874

Asthma, hospital admission 2, infections

914

7047

1.28

11.60

1.9

1.7

35.79

41.12

nmol/l

11.65

898

6874

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

301

3552

0.66

11.59

1.6

1.7

45.24

43.53

nmol/l

0.40

284

3420

Asthma (only as main-diagnosis), excluding more controls

1321

6383

1.24

11.59

1.9

1.7

38.11

41.75

nmol/l

5.99

1292

6249

Any event in cancer register

1151

8478

0.80

11.56

1.8

1.7

41.95

41.65

nmol/l

0.13

1124

8274

Biguanides

1628

8320

1.21

11.53

1.8

1.7

32.88

43.02

nmol/l

58.52

1566

8133

Peripheral artery disease

266

3315

0.64

11.46

1.6

1.7

44.93

44.94

nmol/l

0.00

250

3168

Symptoms and signs involving the nervous and musculoskeletal systems

799

6166

1.30

11.44

1.9

1.7

41.50

42.67

nmol/l

0.64

787

5974

Other diseases of blood and blood-forming organs

125

645

1.99

11.36

2.3

1.9

34.94

39.45

nmol/l

1.43

120

621

Diverticular disease of intestine

994

5206

1.27

11.36

1.8

1.7

41.56

42.35

nmol/l

0.50

951

5067

Endometriosis of pelvic peritoneum

200

2.78

11.34

1.1

1.2

63.20

57.21

nmol/l

0.44

195

Stroke, including SAH

508

5162

0.72

11.30

1.7

42.93

43.13

nmol/l

0.07

486

4985

Colonic or urogenital fistula

447

3170

1.43

11.28

1.8

40.76

40.82

nmol/l

0.02

429

3076

Acute appendicitis

1354

10502

1.22

11.19

1.8

1.7

39.88

40.56

nmol/l

0.36

1333

10253

Nasal polyp

350

2377

1.49

11.18

1.7

39.92

41.26

nmol/l

0.62

340

2305

COPD, hospital admissions

295

3758

0.66

11.16

1.8

1.7

42.91

44.95

nmol/l

0.68

278

3596

Dental operations, only avohilmo

1277

5297

1.24

11.11

1.8

1.7

40.33

41.25

nmol/l

0.69

1232

5184

1480

7659

1.22

10.99

1.8

1.7

39.99

42.47

nmol/l

3.24

1441

7472

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1480

7659

1.22

10.99

1.8

1.7

39.99

42.47

nmol/l

3.24

1441

7472

Disorders of ocular muscles, binocular movement, accommodation and refraction

769

5893

1.30

10.99

1.7

40.90

41.30

nmol/l

0.15

752

5744

Other disorders of eyelid

387

2588

1.45

10.98

1.7

43.76

45.35

nmol/l

0.67

376

2472

Asthma (only as main-diagnosis)

1324

6522

1.23

10.97

1.9

1.7

38.17

41.88

nmol/l

6.24

1295

6382

All-cause Heart Failure

416

4231

0.70

10.96

1.6

1.7

44.06

44.21

nmol/l

0.04

396

4058

Stroke, excluding SAH

460

4739

0.72

10.91

1.7

43.14

43.44

nmol/l

0.09

440

4568

Lateral epicondylitis

223

1381

1.64

10.80

2.2

1.7

38.58

40.98

nmol/l

0.78

218

1343

Pain in limb

1292

7647

1.23

10.76

1.8

1.6

40.74

42.07

nmol/l

1.02

1262

7483

Heart failure, strict

432

4346

0.71

10.75

1.6

1.7

43.62

44.09

nmol/l

0.15

412

4173

External causes of morbidity and mortality

1264

5141

1.24

10.70

1.8

1.6

41.06

41.95

nmol/l

0.57

1222

5055

Abnormal findings on examination of blood, without diagnosis

768

5570

1.30

10.69

1.8

1.7

42.27

43.30

nmol/l

0.62

753

5369

Other symptoms and signs involving cognitive functions and awareness

552

3829

1.36

10.64

1.8

1.7

42.42

42.64

nmol/l

0.07

531

3701

Mental and behavioural disorders due to sedatives or hypnotics

180

1064

1.74

10.64

2.3

1.9

40.67

36.92

nmol/l

1.19

169

1039

Spondylolisthesis/Spondylolysis

241

1528

1.59

10.55

2.1

1.7

37.71

41.50

nmol/l

2.36

229

1484

Heart failure and coronary heart disease

150

1947

0.57

10.55

1.6

1.7

46.36

46.58

nmol/l

0.04

143

1847

Infections of the skin and subcutaneous tissue

1195

9736

1.23

10.51

1.9

1.7

38.39

39.82

nmol/l

1.25

1158

9522

Malignant neoplasm, wide definition for exclusion

1162

8428

0.81

10.47

1.8

41.47

40.65

nmol/l

0.44

1140

8228

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1162

8427

0.81

10.46

1.8

41.47

40.65

nmol/l

0.45

1140

8227

Hypertension

1583

7474

1.20

10.45

1.9

1.8

35.50

40.97

nmol/l

15.33

1538

7319

Hypertensive diseases

1583

7477

1.20

10.43

1.9

1.8

35.50

40.96

nmol/l

15.30

1538

7322

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1163

8425

0.81

10.35

1.8

41.47

40.64

nmol/l

0.46

1141

8225

Sleep disorders, other/unspecified

344

2.32

10.32

2.1

1.6

44.30

39.96

nmol/l

0.66

336

Functional dyspepsia

324

2200

1.49

10.30

1.6

1.7

39.97

42.39

nmol/l

1.31

315

2132

Metabolic disorders

1677

8761

1.19

10.29

2.0

1.7

39.19

40.83

nmol/l

1.72

1624

8564

Migraine, single triptan purchase ok & required. ICD-code if available is included

1400

7851

1.21

10.28

1.8

1.7

39.79

39.78

nmol/l

0.00

1377

7698

Triptan medication for migraine, single purchase ok

1400

7851

1.21

10.28

1.8

1.7

39.79

39.78

nmol/l

0.00

1377

7698

Complications of medical and surgical care

975

7418

1.25

10.25

1.9

1.7

42.49

43.03

nmol/l

0.19

941

7214

COPD, hospital admissions 1, only main diagnosis

185

2575

0.61

10.24

1.9

1.7

45.03

45.33

nmol/l

0.05

175

2454

Excessive attrition of teeth

725

3013

1.32

10.20

1.8

1.7

43.03

40.43

nmol/l

1.63

701

2965

Benign neoplasm: Sigmoid colon

230

1457

1.60

10.14

1.7

41.84

43.01

nmol/l

0.31

221

1393

Hernia of abdominal wall, postoperative

283

1885

1.52

9.97

1.9

1.7

39.71

41.45

nmol/l

0.58

272

1825

Mixed and other personality disorders

189

1151

1.68

9.96

2.1

1.8

36.88

38.23

nmol/l

0.32

181

1127

COPD, hospital admission 2, with asthma infections

177

2472

0.61

9.90

1.8

1.7

40.86

44.69

nmol/l

1.22

169

2360

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

786

6151

1.28

9.89

1.9

1.7

41.93

43.13

nmol/l

0.62

762

5965

Benign neoplasm: Colon

660

3871

1.31

9.84

1.9

1.7

42.54

43.03

nmol/l

0.20

634

3746

Malignant neoplasm of prostate

432

3755

0.72

9.80

1.6

1.7

45.88

45.52

nmol/l

0.12

419

3583

Any reimbursement code in KELA

1453

6058

1.21

9.74

1.9

1.6

38.43

41.42

nmol/l

4.18

1417

5973

Heart failure,strict

421

4177

0.72

9.55

1.6

1.7

42.60

44.00

nmol/l

0.60

401

4017

Other chronic obstructive pulmonary disease, including avohilmo

410

4696

0.72

9.50

1.8

1.7

43.61

44.22

nmol/l

0.18

389

4520

Sequelae of injuries, of poisoning and of other consequences of external causes

483

3581

1.36

9.46

1.9

1.8

39.69

39.14

nmol/l

0.20

469

3492

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

618

4747

1.32

9.45

1.9

1.8

37.27

38.85

nmol/l

1.14

606

4636

Diseases of external ear

502

3739

1.35

9.44

1.9

1.7

43.40

41.56

nmol/l

0.41

467

3635

Disorders of vestibular function (Vertigo)

477

3497

1.36

9.43

1.8

1.7

43.36

nmol/l

0.00

459

3375

Falls/tendency to fall

2198

9509

1.16

9.38

1.7

41.48

40.91

nmol/l

0.46

2132

9315

Other chronic obstructive pulmonary disease

296

3572

0.68

9.35

1.8

1.7

42.99

44.63

nmol/l

0.51

279

3421

Carpal tunnel syndrome

776

5526

1.27

9.35

1.9

1.7

38.80

42.50

nmol/l

4.51

747

5387

Cardiac arrhythmias

1185

6445

1.22

9.35

2.0

1.7

39.30

41.16

nmol/l

1.85

1151

6332

Disorders of conjunctiva

1309

9131

1.21

9.35

1.8

1.7

41.56

40.78

nmol/l

0.44

1275

8935

Benign neoplasm of colon, rectum, anus and anal canal

793

4468

1.28

9.30

1.9

1.7

42.33

42.37

nmol/l

0.02

764

4338

Spermatocele

177

1084

1.67

9.18

1.8

43.01

41.56

nmol/l

0.41

172

1039

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

418

3430

0.72

9.17

1.6

1.7

44.22

44.07

nmol/l

0.05

404

3302

Complications of procedures, not elsewhere classified

1211

8677

1.21

9.13

1.8

1.7

41.45

42.13

nmol/l

0.40

1164

8465

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2063

10153

1.16

9.12

1.9

1.7

40.57

40.94

nmol/l

0.23

2024

9910

Soft tissue disorders related to use, overuse and pressure

369

2631

1.41

9.11

1.9

1.7

40.66

41.36

nmol/l

0.22

357

2561

Hernia of abdominal wall

750

5932

1.27

9.06

1.9

1.7

38.50

42.19

nmol/l

4.23

721

5752

Dermatitis

851

6824

1.25

9.05

1.8

1.7

41.92

42.41

nmol/l

0.21

827

6644

Disorders of synovium and tendon

800

5735

1.26

8.98

1.9

1.6

40.96

41.96

nmol/l

0.55

777

5605

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

719

5656

1.28

8.97

1.9

1.7

41.70

43.33

nmol/l

0.90

698

5471

Asthma and allergy

239

1554

1.54

8.95

1.8

1.6

36.64

41.49

nmol/l

2.69

234

1525

Benign neoplasm: Sigmoid colon

230

1503

1.55

8.92

1.7

1.8

41.84

43.52

nmol/l

0.49

221

1432

Asthma, hospital admissions , main diagnosis only

1345

10113

1.20

8.91

1.9

1.7

38.04

41.57

nmol/l

6.17

1316

9878

Other and unspecified disorders of skin and subcutaneous tissue

425

2.06

8.88

1.8

1.7

47.91

41.20

nmol/l

1.08

407

Hypothyroidism, strict autoimmune, 3 medication purchases required

1009

5600

1.23

8.87

1.7

1.6

44.85

44.72

nmol/l

0.04

986

5434

Asthma and allergy, excluding more controls

239

1561

1.53

8.77

1.8

1.6

36.64

41.44

nmol/l

2.64

234

1533

Emotionally unstable personality disorder

227

1487

1.55

8.76

2.0

1.7

42.89

41.30

nmol/l

0.38

222

1461

Myocardial infarction

511

4829

0.75

8.68

1.7

41.61

43.10

nmol/l

0.87

485

4673

Substance use, excluding alcohol

471

3531

1.35

8.66

2.1

1.8

40.99

37.69

nmol/l

2.11

448

3461

ILD medications: prednisolone, methylprednisolone, prednisone

2078

10182

1.16

8.66

1.8

1.7

40.06

41.12

nmol/l

1.08

2034

9950

Other and unspecified dermatitis

678

5326

1.28

8.63

1.8

1.7

42.04

42.41

nmol/l

0.13

657

5180

Myocardial infarction, strict

471

4569

0.75

8.62

1.7

41.67

43.45

nmol/l

1.04

451

4415

Obsessive-compulsive disorder

147

875

1.72

8.51

2.0

1.6

36.92

39.55

nmol/l

0.67

147

866

Benign paroxysmal vertigo

267

1816

1.48

8.50

1.9

1.7

43.23

43.40

nmol/l

0.03

256

1747

Abnormal serum enzyme levels

534

4031

1.32

8.46

1.7

43.01

44.07

nmol/l

0.52

527

3858

COPD, hospital admissions 3, with asthma pneumonia sepsis

125

1821

0.58

8.46

1.8

1.7

42.16

45.64

nmol/l

0.72

118

1736

Gonarthrosis,primary

1233

6466

1.20

8.43

1.9

1.7

41.45

42.59

nmol/l

1.03

1181

6288

Diseases of middle ear and mastoid

1146

7814

1.21

8.36

1.7

39.28

40.19

nmol/l

0.56

1122

7650

Influenza and pneumonia

1913

10891

1.16

8.35

1.8

1.7

39.09

41.00

nmol/l

2.86

1868

10652

Skin changes due to chronic exposure to nonionizing radiation

274

1777

1.47

8.30

1.6

1.7

50.11

48.19

nmol/l

0.64

264

1677

Vocal cord dysfunction

190

1121

1.59

8.28

1.8

1.6

44.09

44.04

nmol/l

0.01

184

1090

Any event in hilmo or specialist outpatient

3.37

8.28

1.7

1.3

35.64

42.43

nmol/l

1.19

COPD

325

3738

0.71

8.22

1.8

1.7

44.51

44.54

nmol/l

0.01

307

3587

Diseases of salivary glands

260

1775

1.48

8.19

1.8

1.7

42.78

40.97

nmol/l

0.54

249

1732

Conjunctivitis (acute, non atopic)

442

3296

1.35

8.16

1.7

40.46

40.93

nmol/l

0.12

426

3219

Ischaemic Stroke, excluding all haemorrhages

424

4291

0.74

8.16

1.7

43.17

43.82

nmol/l

0.22

404

4127

Actinic keratosis

266

1728

1.47

8.15

1.6

1.7

50.09

48.38

nmol/l

0.54

256

1630

Any dementia

1165

0.53

8.14

1.4

1.6

52.48

48.46

nmol/l

0.66

1096

Malignant neoplasm of digestive organs

212

3131

0.66

8.13

1.5

1.7

44.38

45.05

nmol/l

0.10

198

2988

Adhesive capsulitis of shoulder

205

1336

1.55

8.08

1.8

1.7

43.56

42.47

nmol/l

0.28

197

1293

Presence of other devices

202

1310

1.55

8.07

1.6

1.7

43.37

46.67

nmol/l

1.59

191

1265

Hypothyroidism, drug reimbursement

201

921

1.57

8.07

1.7

1.5

41.62

45.79

nmol/l

1.69

190

906

Pain associated with micturition

135

795

1.72

8.05

1.8

1.7

39.89

42.21

nmol/l

0.55

125

773

Other and unspecified disorders of vitreous body

341

2438

1.40

8.03

1.8

1.7

44.83

44.85

nmol/l

0.00

323

2325

Pollen allergy

350

2506

1.40

8.03

1.9

1.7

39.27

39.42

nmol/l

0.03

342

2457

Anaemias

437

2158

1.36

8.00

2.0

1.5

44.83

42.96

nmol/l

0.53

427

2136

Infections, IBD-co-morbidities

234

1135

1.51

7.95

1.7

1.5

40.98

43.60

nmol/l

0.79

228

1119

Disorders of refraction and accommodation

422

3139

1.35

7.91

1.7

39.57

41.09

nmol/l

0.55

415

3065

Acute appendicitis, no complications

1103

9199

1.20

7.89

1.8

1.7

40.26

40.18

nmol/l

0.03

1088

8990

Injuries to the ankle and foot

1317

10196

1.18

7.72

1.8

1.7

40.48

40.23

nmol/l

0.12

1285

9982

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

170

1082

1.60

7.57

2.0

1.7

37.33

38.18

nmol/l

0.21

165

1059

Dental caries 1 and operation codes

1558

6848

1.17

7.56

1.8

1.7

40.13

41.61

nmol/l

1.64

1497

6705

Other disorders of bone

356

2612

1.38

7.55

1.8

38.72

39.45

nmol/l

0.26

344

2547

Other benign neoplasms of skin

411

3080

1.34

7.50

1.8

1.7

42.19

42.96

nmol/l

0.26

387

2976

Persons with potential health hazards related to communicable diseases

722

5783

1.25

7.37

1.7

41.12

40.67

nmol/l

0.13

713

5667

COPD related to multimorbidity

244

2947

0.69

7.36

1.9

1.7

41.74

45.94

nmol/l

1.73

228

2807

Urticaria and erythema

483

3719

1.31

7.29

1.8

1.7

41.54

42.26

nmol/l

0.17

467

3627

Finngen Rheumatological endpoints

1891

9412

1.15

7.28

1.9

1.7

39.58

41.07

nmol/l

1.79

1834

9211

Organic, including symptomatic, mental disorders

276

2799

0.71

7.26

1.7

48.85

44.71

nmol/l

1.41

260

2668

Viral hepatitis

194

1288

1.54

7.25

2.1

1.8

49.11

36.28

nmol/l

8.20

182

1258

Major coronary heart disease event excluding revascularizations

690

5906

0.80

7.21

1.7

41.78

42.34

nmol/l

0.27

661

5727

Other disorders of ear

1414

8070

1.17

7.21

1.8

1.7

42.71

41.38

nmol/l

1.29

1355

7884

Cerebrovascular diseases

698

6183

0.81

7.11

1.7

42.73

42.60

nmol/l

0.05

666

5991

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

222

1524

1.49

7.10

2.2

1.8

42.22

35.93

nmol/l

3.18

214

1498

Other follicular disorders

139

859

1.65

7.04

1.8

38.03

39.22

nmol/l

0.26

132

838

Injuries to the abdomen, lower back, lumbar spine and pelvis

585

4610

1.27

6.99

1.7

42.43

40.61

nmol/l

1.00

569

4493

Diseases of inner ear

603

4698

1.26

6.97

1.8

1.7

43.15

42.85

nmol/l

0.11

581

4541

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

456

3512

1.31

6.92

1.8

1.6

42.78

41.69

nmol/l

0.30

435

3460

COPD/asthma/ILD related infections

1760

7672

1.15

6.91

1.8

1.7

39.80

42.50

nmol/l

4.64

1714

7485

COPD/asthma related infections

1760

7672

1.15

6.91

1.8

1.7

39.80

42.50

nmol/l

4.64

1714

7485

Other and unspecified nerve root and plexus disorders, also in other diseases

315

2304

1.38

6.86

2.0

1.7

39.35

40.35

nmol/l

0.36

305

2246

Dyspnoea

1296

8493

1.17

6.86

1.9

1.7

39.01

42.68

nmol/l

7.65

1263

8266

Nontoxic goitre/thyroid nodule

162

1040

1.56

6.85

1.7

42.33

45.56

nmol/l

0.88

157

1000

Heart failure and bmi 25plus

280

2674

0.72

6.82

1.7

1.8

39.90

40.19

nmol/l

0.08

262

2564

Persons encountering health services in circumstances related to reproduction

1349

7852

1.17

6.80

1.8

37.59

37.30

nmol/l

0.17

1333

7704

Seborrhoeic dermatitis

167

1088

1.56

6.75

2.0

1.8

39.65

40.81

nmol/l

0.27

161

1049

Other viral hepatitis

179

1190

1.54

6.72

2.2

1.9

48.85

36.03

nmol/l

8.41

167

1165

Any dementia, excluding more controls

1072

0.56

6.71

1.4

1.6

52.27

48.78

nmol/l

0.54

1011

Hydrocele

246

1735

1.44

6.70

1.6

1.7

42.16

40.34

nmol/l

0.65

237

1671

Disorders of lipoprotein metabolism and other lipidaemias

1385

7490

1.17

6.69

1.9

1.7

37.97

40.87

nmol/l

4.35

1339

7306

Calculus of kidney and ureter

481

3753

1.29

6.66

1.7

1.8

40.20

42.20

nmol/l

1.14

466

3613

Urolithiasis

513

4036

1.28

6.64

1.6

1.8

41.21

42.27

nmol/l

0.46

497

3885

Heartburn

147

933

1.59

6.63

1.7

1.8

38.54

41.77

nmol/l

0.93

140

899

Any prescribed medicine buy

5.83

6.58

1.9

1.2

37.60

38.47

nmol/l

0.06

Asthma, including avohilmo

2130

10968

1.13

6.58

1.8

1.7

38.19

41.50

nmol/l

8.06

2088

10713

Other symptoms and signs involving the nervous and musculoskeletal systems

551

4374

1.27

6.57

2.0

1.7

39.90

42.43

nmol/l

1.60

544

4244

Benign neoplasm: Colon, unspecified

267

1914

1.41

6.54

1.8

1.7

43.32

44.29

nmol/l

0.27

252

1827

Other spirochaetal diseases

306

2244

1.37

6.54

1.7

1.8

46.02

41.58

nmol/l

2.41

293

2164

Dementia, including avohilmo

154

1631

0.65

6.52

1.5

1.7

52.76

47.77

nmol/l

1.35

144

1537

Care involving use of rehabilitation procedures

968

7731

1.19

6.50

1.8

1.7

39.78

41.59

nmol/l

1.35

954

7531

Dental caries 3 and operation codes

1619

7231

1.15

6.45

1.8

1.7

40.79

41.66

nmol/l

0.71

1554

7083

Later onset COPD

1173

0.57

6.41

1.7

1.5

51.52

51.80

nmol/l

0.03

1087

Lyme disease

300

2201

1.37

6.40

1.7

1.8

45.88

41.60

nmol/l

2.23

288

2122

Poisoning by drugs, medicaments and biological substances

461

3600

1.29

6.39

2.0

1.7

40.99

39.60

nmol/l

0.55

439

3527

Other disorders of veins

367

2772

1.33

6.38

1.8

1.7

43.99

42.93

nmol/l

0.33

349

2678

Heart failure, not strict

788

6558

0.82

6.36

1.8

1.7

41.47

42.06

nmol/l

0.29

755

6368

Chromosomal abnormalities, not elsewhere classified

237

2.22

6.35

2.4

1.8

34.49

36.59

nmol/l

0.34

231

Ovarian dysfunction: androgen excess

+∞

6.35

1.3

0.0

31.67

—

nmol/l

—

Benign lipomatous neoplasm

386

2945

1.32

6.33

1.8

41.13

41.38

nmol/l

0.06

378

2848

Contact with and exposure to communicable diseases

585

4688

1.25

6.28

1.7

41.30

40.99

nmol/l

0.07

579

4597

Other benign neoplasms of skin

411

3104

1.31

6.27

1.8

1.7

42.19

43.09

nmol/l

0.31

387

2996

Other diseases of lip and oral mucosa

203

1398

1.47

6.25

1.8

1.7

42.16

40.92

nmol/l

0.30

198

1358

Recurrent dislocation and subluxation of joint

151

981

1.57

6.24

2.1

1.8

36.21

37.63

nmol/l

0.41

146

962

Other sexually transmitted chlamydial diseases

171

1143

1.53

6.24

1.7

41.68

38.89

nmol/l

0.58

163

1127

Anogenital herpesviral [herpes simplex] infection

109

654

1.70

6.23

1.9

1.7

43.53

41.76

nmol/l

0.26

103

638

Disorders of vitreous body and globe

467

3566

1.28

6.23

1.8

1.7

45.82

43.95

nmol/l

0.94

445

3416

Other disorders of skin and subcutaneous tissue

820

6248

1.21

6.22

1.8

1.7

43.52

42.65

nmol/l

0.43

796

6056

Dental caries 2 and operation codes

1339

9206

1.16

6.22

1.8

1.7

40.99

40.22

nmol/l

0.38

1289

9023

Thyrotoxicosis

207

1431

1.45

6.20

1.7

50.02

44.03

nmol/l

1.38

202

1387

Other diseases of liver

258

1859

1.40

6.20

1.9

1.8

37.64

40.34

nmol/l

0.87

248

1797

Dental caries 2, only avohilmo

1344

9178

1.16

6.19

1.8

1.7

40.97

40.13

nmol/l

0.43

1294

8994

Other disorders of skin and subcutaneous tissue, not elsewhere classified

175

1175

1.50

6.13

1.8

1.7

44.21

42.02

nmol/l

0.47

163

1129

Thyrotoxicosis, other and/or unspecified

176

1182

1.50

6.12

1.7

51.63

43.40

nmol/l

1.86

171

1145

Ganglion

262

1895

1.39

6.12

1.8

1.6

41.68

41.89

nmol/l

0.05

256

1853

Dementia

137

1464

0.64

6.06

1.5

1.6

53.43

48.42

nmol/l

1.18

127

1376

Disorders of vitreous body

449

3438

1.28

6.05

1.8

1.7

45.90

44.08

nmol/l

0.88

427

3291

Dental caries 2

1369

9350

1.15

6.00

1.8

1.7

41.05

40.21

nmol/l

0.45

1319

9163

Undetermined asthma

159

1054

1.52

5.91

2.1

1.7

35.66

43.36

nmol/l

4.71

153

1022

Chronic viral hepatitis

160

1071

1.53

5.90

2.2

1.8

50.30

35.98

nmol/l

8.87

148

1050

292

2031

1.36

5.87

1.6

1.7

49.26

47.28

nmol/l

0.68

281

1918

Fever of other and unknown origin

833

6481

1.20

5.79

1.9

1.7

40.68

41.86

nmol/l

0.68

819

6311

Injury, poisoning and certain other consequences of external causes

966

4084

1.19

5.77

1.8

1.6

41.24

42.48

nmol/l

0.77

934

4019

Other heart diseases

1029

5792

1.18

5.77

1.9

1.7

38.41

39.87

nmol/l

1.24

1001

5687

Appendectomy

1126

9344

1.17

5.73

1.8

1.7

39.76

40.24

nmol/l

0.27

1109

9132

Undetermined asthma, excluding more controls

159

1062

1.51

5.72

2.1

1.7

35.66

43.46

nmol/l

4.82

153

1030

Vasomotor rhinitis (mode)

555

1.72

5.71

1.9

1.7

40.82

40.23

nmol/l

0.10

537

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

778

6022

1.20

5.70

1.8

1.7

43.87

42.73

nmol/l

0.57

755

5829

Otitis externa

324

2454

1.33

5.68

1.9

1.7

44.33

40.78

nmol/l

0.62

306

2389

Benign neoplasm: Rectum, anus and anal canal

222

1584

1.41

5.67

1.9

1.8

42.33

43.44

nmol/l

0.32

215

1518

Asthma (diagnoses ohter than nonallergic)

1319

9827

1.15

5.66

1.9

1.7

37.80

42.22

nmol/l

9.71

1291

9589

Superficial injury of abdomen, lower back and pelvis

248

1807

1.39

5.63

1.6

1.7

40.67

40.16

nmol/l

0.11

239

1761

Malignant neoplasm of stomach

334

0.27

5.60

1.3

1.8

65.78

42.55

nmol/l

—

315

Oedema, not elsewhere classified

344

2619

1.31

5.55

1.8

1.7

41.81

43.13

nmol/l

0.46

335

2525

Other heart diseases, wide

1728

9496

1.13

5.54

1.9

1.7

39.44

39.97

nmol/l

0.40

1678

9305

Other diseases of blood and blood-forming organs, wide

274

2034

1.36

5.51

2.1

1.8

39.76

41.62

nmol/l

0.55

262

1968

Mycoses

359

2770

1.31

5.50

1.8

1.7

45.32

41.63

nmol/l

1.30

350

2684

Other inflammation of eyelid

149

992

1.52

5.49

1.6

1.8

41.80

42.01

nmol/l

0.03

141

960

malignant neoplasm of male genital organs

526

4130

0.80

5.48

1.8

1.7

43.04

44.60

nmol/l

0.86

512

3950

COPD (mode)

231

2517

0.72

5.47

1.9

1.7

43.16

45.22

nmol/l

0.63

218

2422

Benign neoplasm: Rectum

203

1439

1.42

5.41

1.9

1.8

41.32

43.30

nmol/l

0.65

197

1376

Disorders of sclera, cornea, iris and ciliary body

875

7433

1.18

5.40

1.9

1.8

41.69

40.47

nmol/l

0.63

853

7244

Other medical care

274

3565

0.75

5.40

1.9

1.7

42.05

44.01

nmol/l

0.80

264

3430

Other predominantly sexually transmitted diseases, not elsewhere classified

281

2103

1.35

5.38

1.8

1.7

39.85

40.53

nmol/l

0.16

270

2065

Hypertrophic scar

438

1.79

5.37

1.9

1.6

41.78

40.93

nmol/l

0.10

425

Hypertrophic disorders of skin

475

1.75

5.37

1.8

1.6

43.50

40.78

nmol/l

0.37

462

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

541

4400

1.24

5.36

1.7

40.11

39.44

nmol/l

0.24

530

4303

Ovarian dysfunction: estrogen excess

+∞

5.29

1.2

0.0

39.40

—

nmol/l

—

Other diseases of anus and rectum

333

2554

1.31

5.29

1.8

1.7

40.76

42.38

nmol/l

0.67

318

2476

Benign neoplasm: Ascending colon

135

888

1.54

5.28

2.0

1.8

42.74

43.48

nmol/l

0.16

129

846

Symptoms and signs involving cognition, perception, emotional state and behaviour

1518

9388

1.14

5.28

1.8

1.7

42.58

41.57

nmol/l

0.76

1462

9169

Primary gonarthrosis, bilateral

470

3290

1.25

5.25

2.0

1.7

42.62

44.93

nmol/l

1.46

450

3160

Major coronary heart disease event

800

6314

0.84

5.23

1.7

1.8

41.50

41.93

nmol/l

0.22

768

6127

Benign lipomatous neoplasm

386

3027

1.28

5.23

1.8

41.13

41.71

nmol/l

0.15

378

2920

Other disorders of the musculoskeletal system and connective tissue

189

1334

1.43

5.20

2.0

1.8

40.30

41.29

nmol/l

0.25

184

1285

Constipation

1123

6963

1.16

5.18

1.9

1.7

43.88

42.48

nmol/l

1.00

1075

6770

Acute bronchitis

572

4598

1.22

5.16

1.7

36.90

41.21

nmol/l

4.67

557

4474

Other disorders of prostate

357

1.86

5.15

2.0

1.8

42.35

42.43

nmol/l

0.01

342

Benign neoplasm: Colon, unspecified

267

1987

1.35

5.13

1.8

1.7

43.32

45.03

nmol/l

0.55

252

1896

Hard cardiovascular diseases

984

7334

0.86

5.09

1.7

1.8

41.03

40.79

nmol/l

0.12

948

7142

Atopic dermatitis

920

6731

1.17

4.98

1.7

40.20

40.57

nmol/l

0.16

900

6610

Congenital malformations, deformations and chromosomal abnormalities

1069

8895

1.16

4.95

1.8

1.7

39.59

40.16

nmol/l

0.30

1049

8711

Algoneurodystrophy

255

2.00

4.94

2.2

1.6

42.46

40.50

nmol/l

0.23

249

Disorders of continuity of bone

140

944

1.50

4.93

1.9

1.8

41.57

38.92

nmol/l

0.66

135

917

Early syphilis

232

2.10

4.86

1.7

1.9

40.41

36.37

nmol/l

0.51

227

Viral infections characterized by skin and mucous membrane lesions

685

5756

1.20

4.83

1.9

1.7

40.08

40.60

nmol/l

0.20

676

5623

Other and unspecified follicular disorders

477

1.72

4.83

1.9

1.8

39.14

39.33

nmol/l

0.02

462

Poisoning by medicine

402

3211

1.26

4.76

2.0

1.7

41.07

39.66

nmol/l

0.53

384

3147

Injuries to the neck

401

3202

1.26

4.76

1.9

1.7

42.16

40.24

nmol/l

0.77

393

3123

Testicular hyperfunction

16.63

4.73

3.1

1.3

22.00

37.73

nmol/l

—

Dizziness and giddiness

946

6625

1.16

4.70

1.8

1.7

42.90

42.99

nmol/l

0.03

907

6449

Sacrococcygeal disorders, not elsewhere classified

178

2.17

4.69

2.5

1.7

39.82

41.56

nmol/l

0.19

171

Pure hypercholesterolaemia

1110

6493

1.15

4.67

1.9

1.7

38.36

41.70

nmol/l

4.66

1062

6324

Inflammatory bowel disease treatment related agents

2094

10759

1.11

4.65

1.8

1.7

40.25

41.02

nmol/l

0.68

2052

10514

Keratitis

567

4705

1.21

4.65

1.9

1.7

40.65

40.15

nmol/l

0.19

552

4585

Other viral diseases

557

4604

1.21

4.64

1.9

1.7

38.18

40.09

nmol/l

0.82

545

4513

Sulfonylureas

223

2390

0.74

4.64

1.9

1.7

40.58

48.71

nmol/l

6.32

208

2272

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

518

3841

0.82

4.62

1.8

41.32

43.01

nmol/l

0.98

503

3703

Persons encountering health services in other circumstances

574

4767

1.21

4.61

1.8

1.7

40.74

41.90

nmol/l

0.45

562

4631

Mental and behavioural disorders due to use of other stimulants, including caffeine

101

650

1.61

4.61

2.4

1.9

43.30

34.63

nmol/l

2.63

644

Chronic gastritis

240

1797

1.34

4.60

2.0

1.7

44.44

44.42

nmol/l

0.00

227

1718

Hypoparathyroidism

122

2.41

4.58

2.4

1.5

41.90

42.66

nmol/l

0.06

116

Sensorineural hearing loss

954

5770

1.16

4.57

1.7

43.12

42.43

nmol/l

0.42

906

5615

Polyarthrosis

109

678

1.55

4.54

1.8

1.6

45.05

45.13

nmol/l

0.01

104

650

Myocardial infarction, unclassifiable

108

1457

0.66

4.52

1.6

1.7

43.86

45.51

nmol/l

0.34

102

1385

Urticaria

381

3042

1.26

4.51

1.9

1.7

41.37

42.22

nmol/l

0.19

367

2968

Cutaneous abscess, furuncle and carbuncle

470

3844

1.23

4.50

1.9

1.7

39.95

39.72

nmol/l

0.07

456

3753

Hypermetropia

617

1.59

4.49

1.8

1.7

40.08

39.42

nmol/l

0.06

598

Emergency coronary revascularization (for ACS)

530

4599

0.82

4.48

1.7

42.46

44.40

nmol/l

1.16

507

4424

Benign neoplasm: Rectum, anus and anal canal

222

1653

1.35

4.47

1.9

1.8

42.33

43.94

nmol/l

0.51

215

1578

Unspecific neurodegenerative disorder

117

1204

0.67

4.46

1.5

1.6

55.68

49.72

nmol/l

1.44

109

1131

Congenital malformations of genital organs

585

1.59

4.38

1.9

1.5

39.48

44.63

nmol/l

1.16

575

Benign neoplasm: Rectum

203

1497

1.37

4.37

1.9

1.8

41.32

43.61

nmol/l

0.80

197

1430

Otitis externa, unspecified

160

1135

1.42

4.37

2.1

1.8

42.16

40.14

nmol/l

0.24

154

1101

Benign neoplasm: Ascending colon

135

930

1.46

4.30

2.0

1.8

42.74

43.55

nmol/l

0.18

129

886

Coronary revascularization (ANGIO or CABG)

486

4108

0.82

4.28

1.7

41.78

44.18

nmol/l

1.48

464

3962

Acute alcohol intoxication, ICD10

283

3615

0.78

4.25

1.7

1.8

39.14

39.50

nmol/l

0.11

276

3525

Superficial injury of lower leg

348

2773

1.26

4.23

1.9

1.7

39.22

40.68

nmol/l

0.51

337

2713

Conductive and sensorineural hearing loss

1047

6346

1.15

4.23

1.7

43.32

42.10

nmol/l

0.95

996

6181

Other arrhythmias

939

6253

1.15

4.22

1.9

1.7

42.45

41.91

nmol/l

0.27

904

6100

Retinal detachments and breaks

389

3141

1.24

4.19

1.7

45.85

43.44

nmol/l

1.10

373

3012

Dental caries 1, only avohilmo

1355

6153

1.13

4.18

1.8

1.7

40.31

41.86

nmol/l

1.58

1306

6026

Implicit viral Sepsis

235

1784

1.33

4.18

1.9

1.7

42.21

nmol/l

0.00

228

1725

Radiculopathy

169

1219

1.40

4.17

1.9

1.7

38.17

42.99

nmol/l

2.30

162

1179

Covid-19 confirmed case

399

3234

1.24

4.17

1.6

1.7

39.61

41.71

nmol/l

1.00

391

3136

Peripheral artery operations in Hilmo

1039

0.59

4.17

1.9

1.8

42.73

43.93

nmol/l

0.18

992

Sequelae of external causes of morbidity and mortality

296

2320

1.28

4.14

2.0

1.7

42.53

41.87

nmol/l

0.18

285

2238

Asthma, unspecified (mode), excluding more controls

717

4809

1.17

4.11

1.9

1.7

37.92

42.97

nmol/l

6.75

698

4694

Asthma, unspecified (mode)

718

4863

1.17

4.11

1.9

1.7

37.96

43.09

nmol/l

6.95

699

4743

Other gastritis (incl. Duodenitis)

267

2067

1.30

4.11

1.8

1.7

42.48

42.86

nmol/l

0.10

261

1989

Viral Sepsis

235

1789

1.32

4.10

1.9

1.7

42.21

42.18

nmol/l

0.01

228

1730

Chronic lower respiratory diseases

2193

10827

1.10

4.07

1.8

1.7

38.61

41.32

nmol/l

5.58

2139

10586

Disorders of eyelid, lacrimal system and orbit

1064

7341

1.14

4.07

1.8

1.7

43.66

42.84

nmol/l

0.44

1031

7141

Diastasis of muscle

2.94

4.04

2.0

1.4

37.89

39.89

nmol/l

0.14

Assault

354

2852

1.26

4.03

1.9

1.8

37.81

36.44

nmol/l

0.60

341

2796

Early onset COPD

211

2780

0.75

4.01

1.9

1.7

39.62

42.44

nmol/l

1.00

200

2676

Trigger finger

155

1111

1.41

4.00

1.9

1.6

41.94

42.73

nmol/l

0.20

150

1074

Provisional assignment of new diseases of uncertain etiology

678

5797

1.17

3.99

1.6

1.7

39.93

41.50

nmol/l

0.96

668

5650

Other otitis externa (chronic)

557

1.58

3.98

1.9

1.7

50.96

40.34

nmol/l

0.63

541

Codes for special purposes

678

5800

1.17

3.97

1.6

1.7

39.93

41.50

nmol/l

0.96

668

5653

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

306

2427

1.27

3.94

1.9

1.8

40.30

39.17

nmol/l

0.34

289

2381

Myocardial infarction, with ST-elevation

123

1758

0.69

3.93

1.6

1.8

41.30

43.41

nmol/l

0.50

114

1678

Cramp and spasm

481

1.63

3.93

2.1

1.8

44.10

38.63

nmol/l

1.10

464

Ill-defined and unknown causes of mortality

472

0.42

3.90

1.6

1.8

40.70

41.94

nmol/l

0.09

451

Acute alcohol intoxication

350

4313

0.81

3.85

1.7

1.8

40.61

40.16

nmol/l

0.14

342

4194

Fracture at wrist and hand level

729

6292

1.16

3.84

1.9

1.8

39.74

38.19

nmol/l

1.12

716

6156

Nausea and vomiting

283

2190

1.28

3.84

1.6

45.17

42.62

nmol/l

0.60

278

2132

Mixed disorders of conduct and emotions, excluding more controls

280

1.83

3.82

1.7

1.5

36.16

39.14

nmol/l

0.31

280

Striking against or struck by other objects

718

6194

1.17

3.82

1.9

1.8

38.70

38.51

nmol/l

0.08

695

6056

Other acute lower respiratory infections

855

7124

1.15

3.80

1.8

1.7

37.49

40.61

nmol/l

3.48

835

6946

Examination and encounter for administrative purposes

416

1.66

3.78

1.9

1.7

43.57

39.80

nmol/l

0.58

406

Diseases of pulp and periapical tissues

585

4976

1.18

3.73

1.9

1.7

41.19

40.73

nmol/l

0.14

554

4871

Oral lichen ruber planus wide, hypothyreosis or thyroxin

141

2.15

3.71

1.6

49.83

43.50

nmol/l

0.44

133

Injury of muscle and tendon at hip and thigh level

157

1146

1.39

3.71

1.8

39.14

40.11

nmol/l

0.21

147

1108

Coronary artery bypass grafting

235

2304

0.77

3.71

1.6

1.7

44.92

46.39

nmol/l

0.38

224

2181

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

490

1.59

3.66

2.4

1.6

37.73

40.23

nmol/l

0.50

479

Adverse effects, not elsewhere classified

237

1838

1.30

3.66

1.8

1.7

37.48

42.06

nmol/l

2.24

231

1787

Assault by bodily force

201

1531

1.33

3.64

2.0

1.9

37.12

36.72

nmol/l

0.10

194

1496

Gluteal tendinitis

149

2.11

3.64

1.3

1.6

44.65

42.88

nmol/l

0.12

141

Benign neoplasm: Pancreas

143

2.14

3.63

1.6

1.8

52.47

43.41

nmol/l

0.29

134

Peritonsillar abscess

389

3202

1.22

3.59

1.6

1.7

38.01

40.38

nmol/l

1.24

383

3141

Diseases of arteries, arterioles and capillaries

666

5762

0.86

3.58

1.8

1.7

43.00

42.99

nmol/l

0.01

638

5575

Poisoning by narcotics and psychodysleptics [hallucinogens]

303

1.78

3.57

2.0

1.8

40.74

35.96

nmol/l

0.55

296

Asthma-related pneumonia

397

3269

1.22

3.56

1.8

1.7

36.05

41.92

nmol/l

6.57

391

3168

Localized swelling, mass and lump of skin and subcutaneous tissue

387

3187

1.22

3.54

1.7

43.78

41.52

nmol/l

0.76

369

3092

Heterophoria

104

711

1.48

3.54

1.5

1.7

41.78

40.30

nmol/l

0.26

694

Other viral diseases, not elsewhere classified

305

2446

1.25

3.52

1.9

1.7

38.09

39.60

nmol/l

0.38

298

2392

Car occupant injured in other and unspecified transport accidents

324

2625

1.24

3.50

1.9

1.8

40.28

39.86

nmol/l

0.10

315

2563

Abnormal findings on diagnostic imaging of central nervous system

394

1.65

3.49

2.0

1.7

42.14

40.17

nmol/l

0.23

377

Candidiasis

141

1022

1.39

3.46

1.8

1.7

49.18

42.16

nmol/l

1.56

134

986

Asthma-related pneumonia or sepsis

397

3281

1.21

3.45

1.8

1.7

36.05

41.96

nmol/l

6.64

391

3180

Asthma, hospital admissions 3, pneumonia

397

3281

1.21

3.45

1.8

1.7

36.05

41.96

nmol/l

6.64

391

3180

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

355

2875

1.23

3.43

1.7

1.6

42.46

44.17

nmol/l

0.41

349

2814

Localized hypertrichosis

10.38

3.43

1.3

2.3

42.33

37.71

nmol/l

—

Artificial joint re-operation

327

1.70

3.41

2.5

1.8

42.02

44.34

nmol/l

0.32

307

Coxarthrosis, primary, with hip surgery

405

3185

1.21

3.40

1.8

1.7

41.56

45.16

nmol/l

3.28

394

3040

Benign neoplasm: Pancreas

147

2.08

3.40

1.6

1.8

52.47

43.75

nmol/l

0.28

137

Non-ischemic cardiomyopathy

210

2222

0.77

3.39

1.6

1.7

42.22

44.17

nmol/l

0.55

200

2124

Noninfective enteritis and colitis

741

6462

1.15

3.37

1.8

1.7

40.66

40.29

nmol/l

0.14

723

6303

Inguinal hernia

1432

8753

1.11

3.32

1.7

1.8

42.29

38.71

nmol/l

6.95

1394

8549

Cholecystectomy

676

5191

1.15

3.25

1.7

41.10

44.72

nmol/l

3.06

654

5017

Diabetic nephropathy, excluding more controls

136

1539

0.73

3.23

1.7

1.8

49.37

35.24

nmol/l

3.00

131

1491

Schizophrenia, schizotypal and delusional disorders

478

5615

0.85

3.20

1.8

39.23

38.28

nmol/l

0.31

465

5503

Dental caries 2 and operation codes, only avohilmo

1207

6739

1.11

3.19

1.8

1.7

40.49

40.44

nmol/l

0.02

1159

6598

Other and unspecified erythematous conditions

215

1.84

3.17

1.7

41.31

39.45

nmol/l

0.17

205

Gonarthrosis, primary, with knee surgery

491

3404

1.18

3.17

1.9

1.7

40.18

45.72

nmol/l

8.51

465

3268

Schizophrenia or delusion

478

5609

0.85

3.17

1.8

39.23

38.21

nmol/l

0.34

465

5498

Other and unspecified effects of external causes

420

3529

1.20

3.16

1.9

1.7

36.45

40.48

nmol/l

3.17

411

3451

Peripheral arterial reconstruction

1158

0.67

3.14

1.5

1.7

42.68

45.78

nmol/l

0.85

1097

Other strabismus

311

2534

1.23

3.14

1.7

42.50

40.52

nmol/l

0.71

302

2472

Dental caries 3, only avohilmo

1421

6589

1.11

3.13

1.8

1.7

40.42

41.92

nmol/l

1.53

1369

6457

Correction of physiology of bite - demanding therapy visit

517

1.52

3.13

2.0

1.6

44.21

41.92

nmol/l

0.33

503

Failure and rejection of transplanted organs and tissues

175

1.95

3.09

1.7

1.8

44.85

38.06

nmol/l

0.58

166

Disorders of gallbladder, biliary tract and pancreas

1163

8314

0.90

3.09

1.7

41.43

42.39

nmol/l

0.69

1119

8101

Coxarthrosis

612

3587

1.16

3.09

1.8

1.6

41.56

43.52

nmol/l

1.50

594

3481

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

427

0.46

3.08

1.8

1.7

51.35

43.37

nmol/l

0.35

402

Other neurological diseases

880

6277

1.13

3.07

1.8

1.7

41.24

42.78

nmol/l

1.17

855

6078

Olecranon bursitis

125

912

1.39

3.06

2.0

1.7

37.09

41.14

nmol/l

1.38

119

881

Unspecified dementia

285

0.38

3.06

1.3

1.6

60.58

49.71

nmol/l

0.47

268

Glucosamine medication

334

2191

1.22

3.06

1.9

1.7

44.58

45.68

nmol/l

0.39

313

2090

Fasciculation

127

2.12

3.04

1.6

48.50

40.06

nmol/l

0.55

122

Other benign neoplasms of connective and other soft tissue

120

869

1.39

3.03

1.7

1.8

42.17

40.69

nmol/l

0.20

120

837

Other bacterial diseases

1330

10114

0.91

3.02

1.9

1.7

41.15

40.23

nmol/l

0.62

1294

9869

Superficial injury of wrist and hand

336

2782

1.22

3.00

1.7

38.73

39.34

nmol/l

0.20

328

2723

Specific development disorders of scholastic skills

648

1.46

2.98

2.0

1.7

34.85

37.44

nmol/l

0.42

639

Secondary malignant neoplasm of respiratory and digestive organs

0.00

2.97

0.0

1.8

—

44.04

—

Phlebitis and thrombophlebitis (not including DVT)

257

2071

1.25

2.97

1.9

1.8

40.71

41.59

nmol/l

0.26

246

2004

Cellulitis

353

2942

1.21

2.95

2.1

1.7

39.29

39.92

nmol/l

0.18

338

2861

Complications of internal orthopaedic prosthetic devices, implants and grafts

185

1436

1.29

2.91

2.1

1.7

43.14

43.89

nmol/l

0.21

176

1375

Carbimazole or st.post thyroidectomy, condition for graves disease

169

1296

1.31

2.91

1.6

1.7

43.33

43.74

nmol/l

0.07

161

1254

Melanocytic naevi of trunk

153

1161

1.33

2.88

1.7

42.18

41.64

nmol/l

0.10

153

1124

Fibroblastic disorders

255

2061

1.24

2.87

1.8

1.7

42.99

44.30

nmol/l

0.42

249

1984

Childhood asthma (age<16), excluding more controls

317

2075

1.22

2.87

1.7

1.6

36.22

40.23

nmol/l

1.49

311

2054

Strabismus

365

3054

1.20

2.86

1.7

42.58

40.99

nmol/l

0.56

355

2977

Childhood asthma (age<16)

317

2077

1.22

2.86

1.7

1.6

36.22

40.24

nmol/l

1.49

311

2057

Sudden idiopathic hearing loss

116

845

1.38

2.85

2.0

1.8

42.19

41.27

nmol/l

0.17

109

812

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

110

1506

0.73

2.84

1.6

1.8

41.64

44.78

nmol/l

0.88

104

1428

Cyst of kidney

497

1.50

2.83

1.7

1.8

40.59

42.98

nmol/l

0.44

471

Undefined dementia

292

0.41

2.82

1.4

1.6

58.69

50.30

nmol/l

0.37

273

Dental caries 1

1300

6035

1.10

2.81

1.8

1.7

40.45

41.84

nmol/l

1.27

1251

5911

All pneumoniae

1716

10913

1.09

2.81

1.8

1.7

39.14

40.80

nmol/l

2.07

1671

10670

Dental pulpitis 4

1907

9152

1.08

2.81

1.7

40.30

41.48

nmol/l

1.17

1833

8983

Dental pulpitis 1

1907

9154

1.08

2.80

1.7

40.38

41.49

nmol/l

1.05

1833

8985

Open wound of lower leg

215

1712

1.26

2.80

1.7

1.8

42.60

40.00

nmol/l

0.81

206

1665

Other ill-defined and unspecified causes of mortality

411

0.48

2.80

1.6

1.8

40.70

42.03

nmol/l

0.09

391

Colorectal cancer, excluding all cancers (controls excluding all cancers)

185

2276

0.78

2.79

1.5

1.7

40.57

44.74

nmol/l

2.17

174

2172

Opening and dilatation of root channel of tooth

106

765

1.40

2.79

1.9

1.8

40.21

39.10

nmol/l

0.16

744

Lesion of ulnar nerve

224

1794

1.26

2.79

2.0

1.7

38.19

40.70

nmol/l

0.85

215

1743

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

668

5871

1.14

2.78

1.8

1.7

38.49

39.77

nmol/l

0.58

652

5762

Dental pulpitis 4, only avohilmo

1938

9360

1.08

2.77

1.7

40.45

41.49

nmol/l

0.98

1863

9184

Diseases of pulp and periapical tissues, including avohilmo

1903

9139

1.08

2.76

1.7

40.28

41.49

nmol/l

1.22

1829

8970

Superficial injury of thorax

230

1851

1.25

2.74

1.8

39.83

40.05

nmol/l

0.05

222

1799

Complications of surgical and medical care, not elsewhere classified

1471

9679

1.09

2.70

1.9

1.7

42.14

41.63

nmol/l

0.26

1417

9456

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

377

0.47

2.70

1.8

47.67

41.03

nmol/l

0.25

357

Dental caries, including avohilmo

1296

6031

1.10

2.70

1.8

1.7

40.46

41.85

nmol/l

1.26

1247

5907

Meningitis, viral

3.27

2.69

1.3

1.7

45.70

40.98

nmol/l

—

Spontaneous rupture of synovium and tendon

635

1.43

2.68

1.7

37.95

42.45

nmol/l

1.09

616

Left bundle-branch block

446

1.51

2.68

1.7

45.64

42.82

nmol/l

0.25

433

Subacute thyroiditis

161

1.88

2.68

1.9

1.6

49.17

43.20

nmol/l

0.45

155

Benign neoplasm: Testis

2.50

2.65

1.4

2.1

30.12

38.01

nmol/l

1.01

Other congenital malformations

111

814

1.37

2.64

1.8

1.7

42.29

40.06

nmol/l

0.29

111

797

Melanocytic naevi of trunk

153

1178

1.31

2.63

1.7

42.18

41.94

nmol/l

0.04

153

1139

Chondropathies

248

2024

1.23

2.62

1.8

38.52

39.67

nmol/l

0.35

237

1974

Other erythematous conditions

237

1.71

2.60

1.8

1.7

41.08

40.32

nmol/l

0.06

227

Acquired clawhand, clubhand, clawfoot and clubfoot

2.85

2.60

1.6

1.8

34.67

38.41

nmol/l

0.25

Herpesviral keratitis and keratoconjunctivitis

354

1.57

2.59

2.1

1.7

37.87

39.87

nmol/l

0.24

338

Other maltreatment syndromes

635

1.43

2.59

1.7

1.9

36.85

36.26

nmol/l

0.11

623

Mental retardation, wide definition

513

0.56

2.58

1.8

36.10

37.92

nmol/l

0.14

498

Misadventures to patients during surgical and medical care

144

1103

1.31

2.57

2.2

1.8

41.65

42.40

nmol/l

0.14

138

1060

Other bursopathies

154

1191

1.30

2.56

1.9

1.7

41.25

42.10

nmol/l

0.14

148

1151

Hypersomnia

143

1.94

2.56

2.4

1.8

43.00

36.92

nmol/l

0.50

138

Injuries to the thorax

721

6417

1.13

2.55

1.8

41.86

40.41

nmol/l

0.78

686

6244

Other benign neoplasms of connective and other soft tissue

120

897

1.35

2.55

1.6

1.8

42.17

41.15

nmol/l

0.13

120

865

Budesonide

190

1512

1.26

2.53

1.6

1.8

40.09

40.11

nmol/l

0.00

185

1467

Pedal cyclist injured in collision with motor vehicle

365

1.56

2.52

1.5

1.7

44.37

38.20

nmol/l

1.02

355

Benign neoplasm of male genital organs

303

1.62

2.51

1.9

1.8

37.97

39.73

nmol/l

0.20

290

Atopic dermatitis, strict definition with reimbursement

478

4019

1.16

2.51

1.7

1.6

39.90

41.45

nmol/l

0.63

466

3943

Dental pulpitis 2, only avohilmo

1178

5486

1.10

2.50

1.8

1.7

40.64

41.98

nmol/l

1.09

1134

5385

Dental pulpitis 1, only avohilmo

1935

9391

1.08

2.49

1.7

40.41

41.50

nmol/l

1.04

1860

9215

Lactose intolerance, other/unspecified

233

1.70

2.48

1.6

36.95

40.06

nmol/l

0.59

227

Benign neoplasm of male genital organs

304

1.62

2.48

1.9

37.97

38.75

nmol/l

0.08

292

Pneumonias (Asthma/COPD co-morbidities)

1695

10880

1.08

2.48

1.8

1.7

39.19

40.77

nmol/l

1.90

1651

10636

Benign neoplasm: Skin of eyelid, including canthus

123

927

1.33

2.46

1.7

1.8

42.46

43.06

nmol/l

0.11

110

891

Other hearing loss

217

1727

1.24

2.45

1.8

1.7

43.97

44.18

nmol/l

0.05

207

1661

Unspecified haematuria

551

4141

1.14

2.42

1.7

43.53

43.12

nmol/l

0.14

536

3991

Other noninfective gastroenteritis and colitis

297

2485

1.20

2.42

1.8

1.7

41.90

40.38

nmol/l

0.43

284

2416

Later onset COPD, excluding more controls

885

0.71

2.41

1.8

1.5

50.21

52.59

nmol/l

0.33

826

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1082

0.71

2.40

1.5

1.8

41.27

43.36

nmol/l

0.48

1031

N06DA Anticholinesterases

927

0.71

2.40

1.5

1.6

56.87

50.22

nmol/l

1.16

870

Use of anticholinesterases

927

0.71

2.40

1.5

1.6

56.87

50.22

nmol/l

1.16

870

Panniculitis affecting regions of neck and back

298

1.60

2.38

2.2

1.7

38.40

39.18

nmol/l

0.10

288

Intracranial injury

897

7839

1.11

2.38

1.9

1.7

40.36

40.81

nmol/l

0.22

879

7643

Dermatitis and eczema

1839

11223

1.08

2.38

1.8

1.7

41.29

40.82

nmol/l

0.33

1794

10973

Autoimmune diseases related-to ILD

1377

11168

1.09

2.36

1.7

41.56

40.71

nmol/l

0.55

1344

10909

Immunodeficiencies

395

1.51

2.35

2.1

1.7

43.17

40.38

nmol/l

0.30

380

Viral meningitis

437

1.49

2.34

2.2

1.7

38.03

39.04

nmol/l

0.13

427

Other and unspecified urticaria

226

1851

1.23

2.33

1.9

1.7

42.19

41.68

nmol/l

0.07

217

1800

Colorectal adenocarcinoma

110

1456

0.75

2.33

1.6

1.7

41.64

44.59

nmol/l

0.80

104

1384

Other and unspecified mental retardation

186

0.37

2.32

1.1

1.8

33.43

35.19

nmol/l

—

179

Malignant neoplasm of oesophagus

202

0.39

2.31

1.8

41.13

42.42

nmol/l

—

192

Fall on same level involving ice and snow

753

6762

1.12

2.31

1.7

40.79

40.89

nmol/l

0.04

734

6588

Other specified/unspecified arthritis

310

2620

1.19

2.29

1.7

1.6

41.09

42.09

nmol/l

0.32

301

2546

Mental retardation

494

0.58

2.28

1.8

36.10

37.38

nmol/l

0.09

481

Primary coxarthrosis, bilateral

225

1846

1.22

2.28

1.9

1.7

39.45

44.72

nmol/l

3.83

219

1758

Thoracic aortic aneurysm

204

1661

1.24

2.26

1.7

1.8

42.76

42.69

nmol/l

0.01

193

1585

Hidradenitis suppurativa

383

1.51

2.26

1.7

36.18

39.72

nmol/l

0.67

375

Separation of retinal layers (serosa)

600

1.41

2.26

1.9

37.13

37.89

nmol/l

0.16

580

Dental caries 3

1375

6476

1.09

2.25

1.8

1.7

40.45

41.93

nmol/l

1.45

1324

6347

Fracture of lumbar spine and pelvis

201

1631

1.24

2.25

1.7

1.8

46.66

41.84

nmol/l

1.89

195

1574

Coxarthrosis, primary

562

4313

1.13

2.21

1.8

1.7

41.68

44.55

nmol/l

2.68

544

4142

Bell's palsy

148

1165

1.28

2.20

1.7

1.8

42.59

41.44

nmol/l

0.19

141

1131

Hypertrophy of bone

3.17

2.20

1.4

1.6

34.33

37.30

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

321

1.55

2.20

2.1

1.7

37.55

37.17

nmol/l

0.04

312

Lactose intolerance

266

1.60

2.17

1.7

1.6

36.29

39.61

nmol/l

0.70

259

Coronary angioplasty

375

3334

0.86

2.17

1.7

42.55

44.98

nmol/l

1.17

356

3197

Other disorders of teeth and supporting structures

283

2388

1.19

2.16

1.8

1.7

42.19

40.92

nmol/l

0.32

275

2325

Adenocarcinoma and papillary adenocarcinoma of stomach

183

0.38

2.16

1.4

1.8

66.00

43.83

nmol/l

—

173

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

183

0.38

2.16

1.4

1.9

66.00

42.82

nmol/l

—

173

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

3.04

2.16

1.1

1.2

60.22

47.32

nmol/l

—

Mandibular retrognathia AND surgery (BSSRO)

267

1.60

2.15

1.6

1.7

35.79

39.32

nmol/l

0.47

262

Fitting and adjustment of other devices

301

2374

1.18

2.14

1.7

42.64

45.89

nmol/l

1.67

278

2264

Other and unspecified coagulation defects

388

1.48

2.13

1.8

1.7

41.33

40.88

nmol/l

0.05

377

Psoas tendinitis

3.31

2.12

2.3

1.5

54.75

30.32

nmol/l

—

Disorders of iron metabolism

168

1.77

2.12

2.0

1.7

33.45

39.76

nmol/l

1.55

163

Dental pulpitis 2

1147

5388

1.09

2.11

1.8

1.7

40.80

41.92

nmol/l

0.80

1103

5290

Other congenital malformations of circulatory system

229

1.64

2.11

2.4

1.8

43.16

37.98

nmol/l

0.40

219

Helminthiases

146

1.81

2.09

1.4

1.8

38.69

40.66

nmol/l

0.23

141

Noninfectious colitis NAS

166

1335

1.25

2.08

1.8

40.54

39.29

nmol/l

0.23

158

1296

Collagenous colitis

616

1.37

2.08

1.8

1.7

41.96

40.69

nmol/l

0.19

593

Amblyopia ex anopsia

374

1.49

2.07

1.9

1.6

41.91

40.51

nmol/l

0.14

363

Abnormal findings on diagnostic imaging of lung

504

4343

1.13

2.03

1.7

43.47

43.46

nmol/l

0.00

491

4172

Valvular heart disease excluding rheumatic fever

501

4135

0.88

2.02

1.8

1.7

45.60

42.27

nmol/l

2.34

481

4008

Other infective otitis externa

535

1.40

2.01

1.8

1.7

46.24

39.97

nmol/l

1.11

518

Other bacterial intestinal infections

184

1503

1.23

2.00

1.8

42.08

42.35

nmol/l

0.04

179

1450

Colorectal cancer

139

1746

0.79

2.00

1.6

1.7

39.79

44.42

nmol/l

1.99

131

1661

Suggestive for eosinophilic asthma

120

934

1.29

1.99

1.9

1.8

40.39

41.82

nmol/l

0.30

114

901

Oxycodone

371

3115

1.15

1.99

2.1

1.6

40.79

44.49

nmol/l

2.23

353

3010

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

350

0.54

1.98

1.5

1.7

44.79

46.02

nmol/l

0.10

329

Other peripheral vertigo

553

1.38

1.98

1.6

1.8

46.79

42.35

nmol/l

0.64

525

Other specified disorders of external ear

404

1.46

1.97

1.6

1.8

42.17

39.88

nmol/l

0.29

389

Syncope and collapse

563

4451

1.12

1.97

1.7

1.6

42.25

43.02

nmol/l

0.31

543

4311

Mild mental retardation

321

0.52

1.96

2.1

1.7

38.06

37.97

nmol/l

0.00

312

Alcohol dependence

435

4933

0.88

1.96

1.9

1.8

41.55

39.73

nmol/l

0.94

423

4799

Papulosquamous disorders

513

4560

1.13

1.95

1.7

1.8

43.66

40.97

nmol/l

1.10

496

4419

All influenza

402

3519

1.15

1.95

1.7

1.8

39.70

39.69

nmol/l

0.00

392

3430

Diseases of liver

459

4053

1.14

1.95

1.8

41.68

41.16

nmol/l

0.15

444

3921

Atopic dermatitis, strict definition

448

3871

1.14

1.95

1.7

39.36

41.18

nmol/l

0.78

438

3801

Other and unspecified iron deficiency

267

2264

1.18

1.94

1.8

1.7

45.46

44.69

nmol/l

0.13

258

2178

Dengue fever [classical dengue]

3.43

1.94

3.0

1.2

39.00

39.23

nmol/l

—

Open bite

472

1.41

1.93

2.1

1.6

45.42

40.98

nmol/l

0.34

462

Other disorders of white blood cells

447

1.42

1.92

2.3

1.8

35.89

39.64

nmol/l

0.60

431

Disorder of lipoprotein metabolism, unspecified

150

1206

1.25

1.91

1.9

1.7

39.34

44.24

nmol/l

1.72

142

1154

Other systemic involvement of connective tissue (FG)

169

1366

1.23

1.91

1.7

1.6

39.52

45.52

nmol/l

2.39

162

1320

Bilateral sagittal split ramus osteotomy operation

357

1.48

1.90

1.8

1.7

36.21

39.29

nmol/l

0.49

350

Non-rheumatic valve diseases

498

4089

0.89

1.90

1.8

1.7

45.75

42.31

nmol/l

2.45

478

3962

Impacted maxillary molar

740

1.32

1.90

1.4

1.5

47.21

40.85

nmol/l

0.61

734

Labour and delivery complicated by fetal stress [distress]

167

901

1.24

1.90

1.2

62.23

54.33

nmol/l

1.07

167

895

Heart failure and antihypertensive medication

279

2158

0.85

1.89

1.8

1.7

39.93

44.79

nmol/l

2.82

267

2111

Non-small cell lung cancer, adenocarcinoma

343

0.55

1.87

1.5

1.7

44.79

45.68

nmol/l

0.07

323

Non-small cell lung cancer, adenocarcinoma, helper endpoint

343

0.55

1.87

1.5

1.7

44.79

45.68

nmol/l

0.07

323

Erythema nodosum

167

1.69

1.85

1.7

1.5

50.39

42.96

nmol/l

0.29

161

Viral and other specified intestinal infections

431

3718

1.14

1.85

1.7

41.22

38.07

nmol/l

0.75

426

3651

Pedestrian injured in collision with pedal cycle

343

1.48

1.85

2.0

1.8

44.24

38.39

nmol/l

1.06

330

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

776

4476

1.10

1.84

1.7

41.36

41.69

nmol/l

0.13

757

4386

Benign neoplasm: Descending colon

468

1.40

1.84

1.8

43.92

43.00

nmol/l

0.10

442

Chronic periapical parodontitis

296

2549

1.17

1.83

1.9

1.7

42.68

41.03

nmol/l

0.36

280

2484

Impacted teeth

365

2970

1.15

1.83

1.4

1.6

40.69

40.46

nmol/l

0.05

359

2921

Conotruncal defects

165

0.42

1.82

1.7

39.43

36.28

nmol/l

—

159

Other specified and unspecified disorders of eyelid

116

1.85

1.81

2.0

1.6

37.43

41.66

nmol/l

0.40

111

Other diseases of urinary system

1246

7542

0.93

1.79

1.7

46.35

43.72

nmol/l

2.66

1210

7340

Embedded and impacted teeth

508

3858

1.12

1.79

1.5

1.7

40.90

40.35

nmol/l

0.14

500

3795

Benign neoplasm: Skin of eyelid, including canthus

123

975

1.27

1.79

1.7

1.8

42.46

43.03

nmol/l

0.10

110

933

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

456

4055

1.13

1.77

1.8

1.7

42.78

41.48

nmol/l

0.38

435

3974

Exposure to other specified electric current

250

1.56

1.77

2.6

1.7

32.50

37.94

nmol/l

0.86

244

Open wound of ankle and foot

172

1419

1.22

1.77

1.8

41.09

38.74

nmol/l

0.49

167

1378

Open wound of wrist and hand

943

8617

1.09

1.74

1.7

1.8

39.65

39.09

nmol/l

0.32

917

8428

Vestibular neuronitis

741

1.30

1.74

2.0

1.9

43.30

39.66

nmol/l

0.72

711

Adult-onset Still disease

0.00

1.74

0.0

1.5

—

39.78

—

Bacterial infection, other or unspecified

520

5225

0.90

1.74

1.8

1.7

42.83

42.75

nmol/l

0.02

500

5052

Lesion of plantar nerve

233

1.55

1.73

1.7

1.6

40.89

41.72

nmol/l

0.09

225

Other disorders of binocular movement

202

1.61

1.73

1.9

1.6

37.03

39.85

nmol/l

0.28

196

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

104

812

1.29

1.73

2.0

1.8

42.38

41.28

nmol/l

0.15

779

Abscess of anal and rectal regions

164

1351

1.22

1.72

1.7

1.8

37.85

38.56

nmol/l

0.15

157

1314

Perichondritis of external ear

118

1.81

1.72

1.5

1.7

43.71

42.24

nmol/l

0.07

113

Dentinal caries

377

3305

1.14

1.71

2.0

1.7

40.44

39.95

nmol/l

0.15

365

3230

Other congenital malformations of skin

366

1.44

1.70

1.6

1.7

41.65

39.94

nmol/l

0.16

354

Sequelae with surgical and medical care as external cause

196

1643

1.20

1.69

2.0

1.7

42.02

42.29

nmol/l

0.05

187

1580

Diseases of the myoneural junction and muscle

145

1181

1.23

1.69

1.8

38.66

40.59

nmol/l

0.40

139

1140

Conduction disorders

318

2300

1.15

1.69

1.7

44.52

43.52

nmol/l

0.26

298

2209

Fracture of rib(s), sternum and thoracic spine

425

3777

1.13

1.68

1.8

43.03

41.06

nmol/l

0.75

402

3663

Mixed disorders of conduct and emotions

351

1.45

1.68

1.7

1.6

36.16

38.32

nmol/l

0.21

346

Other and unspecified acne

181

1.64

1.67

2.4

1.7

48.00

38.95

nmol/l

0.83

176

Other disorders of Eustachian tube

220

1.56

1.67

2.3

1.6

36.00

41.77

nmol/l

0.36

210

Bacterial intestinal infections, IBD co-morbidities

182

1518

1.20

1.66

1.8

41.47

42.23

nmol/l

0.14

177

1463

Presence of cardiac and vascular implants and grafts

464

3928

0.89

1.66

1.6

1.8

44.64

43.65

nmol/l

0.35

424

3803

Benign neoplasm: Connective and other soft tissue of head, face and neck

150

1.69

1.65

1.5

1.7

47.20

40.81

nmol/l

0.26

143

Mental and behavioural disorders due to cannabinoids

724

1.31

1.65

2.1

1.9

40.62

34.88

nmol/l

1.45

717

Hypotension

118

941

1.26

1.65

1.9

1.7

46.41

44.20

nmol/l

0.48

112

895

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.28

1.65

1.8

1.7

57.00

51.32

nmol/l

0.26

Early onset COPD, excluding more controls

211

2483

0.85

1.64

1.9

1.7

39.61

43.78

nmol/l

1.78

200

2402

Diabetic nephropathy

137

1655

0.81

1.63

1.7

1.8

49.48

37.11

nmol/l

2.45

132

1591

Degeneration of the brain due to alcohol

263

0.52

1.63

1.1

1.8

63.04

40.72

nmol/l

1.04

249

Senile cataract

603

4125

0.90

1.62

1.7

46.58

43.78

nmol/l

1.48

566

3983

Urethritis and urethral syndrome

190

1.60

1.62

1.8

1.7

45.70

40.24

nmol/l

0.71

184

Immunodeficiency with predominantly antibody defects

222

1.55

1.61

2.3

1.7

43.15

38.30

nmol/l

0.58

217

Fracture of lower leg, including ankle

788

7214

1.09

1.61

1.8

38.78

39.91

nmol/l

0.76

771

7043

Nonsuppurative otitis media

413

3174

1.13

1.61

1.7

1.6

38.61

40.58

nmol/l

0.69

403

3115

Renal tubulo-interstitial diseases

953

7888

0.92

1.61

1.7

42.60

43.56

nmol/l

0.48

923

7673

Degeneration of nervous system due to alcohol

261

0.53

1.60

1.1

1.8

63.04

40.48

nmol/l

1.06

248

Mental and behavioural disorders due to psychoactive substance use

1215

10720

1.07

1.60

1.9

1.8

40.32

39.76

nmol/l

0.35

1169

10482

Venous thromboembolism

569

5003

1.11

1.59

1.9

1.7

40.33

43.11

nmol/l

2.42

558

4828

Epilepsy

395

3498

1.13

1.59

1.8

1.6

47.31

42.88

nmol/l

1.66

384

3408

Other systemic involvement of connective tissue

179

1498

1.20

1.58

1.7

39.42

45.04

nmol/l

2.33

172

1444

Other osteochondropathies

126

1021

1.24

1.58

1.7

1.8

38.01

38.68

nmol/l

0.12

121

991

Gout

327

2616

1.14

1.58

1.9

1.6

36.62

44.60

nmol/l

8.86

312

2520

Other diseases of pleura

402

3997

0.89

1.56

1.8

1.7

44.63

43.86

nmol/l

0.29

389

3830

Autoimmune polyglandular failure

3.57

1.56

4.0

1.3

52.80

33.13

nmol/l

—

Use of bromocriptine

3.54

1.55

2.6

1.7

38.00

44.53

nmol/l

—

Other specific arthropathies

3.50

1.55

2.0

1.2

28.40

37.33

nmol/l

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

1.55

0.0

1.5

—

37.64

—

AV-block

163

1231

1.21

1.54

1.7

44.40

44.74

nmol/l

0.06

149

1173

Insulin medication

852

7876

0.92

1.54

1.7

43.17

41.79

nmol/l

0.69

824

7693

Suppurative and unspecified otitis media

702

5705

1.09

1.54

1.6

1.7

38.56

39.53

nmol/l

0.48

690

5599

Retrobulbar neuritis in diseases classified elsewhere

2.68

1.53

1.1

1.6

70.29

33.56

nmol/l

—

Other and unspecified myopathies

104

827

1.27

1.53

1.8

38.14

39.94

nmol/l

0.31

797

Myeloproliferative diseases

606

1.31

1.53

2.1

1.8

40.41

42.07

nmol/l

0.28

576

Other arthritis (FG)

368

3264

1.13

1.53

1.7

41.56

42.11

nmol/l

0.17

358

3170

Carrier of infectious disease

185

1.59

1.53

1.8

1.7

34.55

39.28

nmol/l

0.78

179

Septicaemia

375

4054

0.89

1.53

1.9

1.7

43.05

43.02

nmol/l

0.01

364

3905

Disorders of lens

750

5147

0.92

1.52

1.7

45.57

42.62

nmol/l

2.04

711

4992

Sequelae of cerebrovascular disease

259

2619

0.87

1.52

1.7

45.52

44.56

nmol/l

0.22

243

2502

Other specified/unspecified spondylopathies

123

1.72

1.51

1.8

1.5

45.24

41.41

nmol/l

0.36

117

Benign neoplasm of bone and articular cartilage

112

900

1.25

1.51

1.7

1.8

39.69

38.89

nmol/l

0.13

107

874

L02BB Anti-androgens

678

0.72

1.51

1.7

53.88

47.76

nmol/l

0.73

635

Melanocytic naevi of scalp and neck

234

1.52

1.51

2.3

1.7

47.51

39.59

nmol/l

0.73

223

Diabetic retinopathy, excluding more controls

276

1787

0.87

1.51

1.8

44.23

34.89

nmol/l

6.66

264

1734

Benign neoplasm: Stomach

503

1.34

1.51

1.6

1.7

39.96

43.42

nmol/l

0.79

478

Suicide or other Intentional self-harm

411

3676

1.12

1.50

1.9

1.8

41.11

39.80

nmol/l

0.44

390

3598

Alcohol abuse, main dg

237

2739

0.86

1.50

1.7

1.8

39.14

39.31

nmol/l

0.04

232

2665

Other CVD

145

1198

1.21

1.49

1.8

1.7

47.07

44.00

nmol/l

0.75

138

1145

Cytomegalovirus infection, IBD co-morbidity

227

1.52

1.49

1.4

1.8

37.00

39.38

nmol/l

0.19

217

Other disorders of conjunctiva

128

1046

1.23

1.48

1.8

49.14

42.41

nmol/l

1.86

122

1005

Benign neoplasm of bone and articular cartilage

112

903

1.25

1.48

1.7

1.8

39.69

39.68

nmol/l

0.00

107

873

Corneal ulcer

279

2440

1.15

1.47

2.0

1.8

39.61

39.42

nmol/l

0.05

270

2377

Human immunodeficiency virus [HIV] disease resulting in other conditions

423

1.38

1.46

1.8

1.9

49.47

36.68

nmol/l

2.26

416

Insulin, combination of fast acting with intermediate-acting or long-acting

852

8465

0.93

1.45

1.7

1.8

43.17

40.91

nmol/l

1.44

824

8238

Diseases of the digestive system

536

4861

1.10

1.44

1.7

42.70

42.51

nmol/l

0.06

515

4697

Cardiodefibrillation

429

3851

1.12

1.43

1.7

44.89

43.67

nmol/l

0.53

419

3686

Disorders of orbit

295

1.43

1.42

2.0

1.7

41.14

40.69

nmol/l

0.03

285

5-aminosalicylic acid

379

3388

1.12

1.42

1.8

39.02

39.27

nmol/l

0.07

374

3308

L02BX Other hormone antagonists and related agents

482

0.68

1.41

1.7

44.88

47.23

nmol/l

0.26

450

Benign neoplasm: Descending colon

492

1.33

1.41

1.8

43.92

43.65

nmol/l

0.03

465

Other/unspecified cytomegaloviral diseases

198

1.54

1.40

1.5

1.7

37.73

39.18

nmol/l

0.10

189

Benign neoplasm: Connective and other soft tissue of head, face and neck

158

1.61

1.39

1.5

1.8

47.20

41.16

nmol/l

0.24

151

Impacted cerumen

713

1.27

1.39

2.0

1.7

39.81

41.82

nmol/l

0.33

684

Melanocytic naevi of scalp and neck

239

1.48

1.39

2.3

1.7

47.51

39.72

nmol/l

0.72

229

Unspecified jaundice

409

0.66

1.39

1.5

1.8

48.50

40.95

nmol/l

0.76

388

Iron deficiency anaemia

343

3021

1.13

1.38

1.9

1.7

44.63

44.33

nmol/l

0.06

331

2908

Acute suppurative otitis media

541

4606

1.10

1.38

1.6

1.7

37.39

38.74

nmol/l

0.69

529

4524

Coxarthrosis [arthrosis of hip](FG)

614

4065

1.09

1.38

1.8

1.7

41.59

43.93

nmol/l

2.02

595

3932

Wide developmental disorders

469

1.34

1.38

1.7

1.8

33.53

36.30

nmol/l

0.47

463

Chronic hepatitis, not elsewhere classified

264

1.45

1.38

1.5

1.7

53.80

38.80

nmol/l

1.24

252

Cytomegaloviral disease

248

1.47

1.37

1.4

1.7

35.86

38.95

nmol/l

0.27

238

Flatulence and related conditions

1.86

1.37

1.6

1.5

40.20

37.95

nmol/l

0.17

298

1.43

1.37

2.0

1.8

35.40

38.14

nmol/l

0.36

292

Family history of other conditions

112

1.72

1.37

1.8

1.7

42.53

36.28

nmol/l

0.48

112

Calcific aortic valvular stenosis, including rheumatic fever

174

1999

0.85

1.36

1.6

1.7

44.84

45.50

nmol/l

0.15

164

1900

Pneumonia due to Haemophilus influenzae

0.00

1.36

0.0

1.7

—

38.46

—

Evidence of alcohol involvement determined by blood alcohol level

221

0.53

1.36

2.3

1.7

35.83

38.54

nmol/l

0.28

213

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1582

9146

1.06

1.36

1.8

36.10

41.29

nmol/l

12.76

1520

8955

Toxic effect of other and unspecified substances

200

1.53

1.36

1.6

1.8

35.00

35.98

nmol/l

0.10

193

Sequelae of injuries of head

782

1.25

1.33

2.0

1.8

42.10

37.61

nmol/l

0.86

761

Polyglandular dysfunction

2.61

1.33

3.5

1.3

52.67

32.92

nmol/l

—

Lipomatosis, not elsewhere classified

2.59

1.32

1.5

1.8

27.17

42.92

nmol/l

—

Acanthosis nigricans

2.44

1.32

1.5

1.7

39.50

39.91

nmol/l

—

Diabetic retinopathy, strict definition

179

1835

0.85

1.32

1.8

51.38

35.57

nmol/l

5.20

170

1772

Polypectomy (DHB20)

115

945

1.23

1.32

1.9

1.8

39.40

39.65

nmol/l

0.05

115

911

Open wound of forearm

149

1255

1.19

1.31

1.8

41.10

38.64

nmol/l

0.60

142

1219

Other leukaemias of specified cell type

2.88

1.30

3.2

1.4

59.40

36.89

nmol/l

—

Open wound of hip and thigh

518

1.31

1.30

2.1

1.8

36.09

37.63

nmol/l

0.23

504

Malignant neoplasm of rectum

704

0.75

1.30

1.4

1.8

41.60

43.36

nmol/l

0.28

669

Operations 2 for CAVS

174

1990

0.85

1.29

1.6

1.7

44.84

45.55

nmol/l

0.16

164

1891

Calcific aortic valvular stenosis, diagnosis (helper)

174

1990

0.85

1.29

1.6

1.7

44.84

45.55

nmol/l

0.16

164

1891

Brain meningioma

193

1.51

1.29

1.8

47.69

42.44

nmol/l

0.56

183

Coagulation defects, purpura and other haemorrhagic conditions

210

1821

1.16

1.28

1.8

42.70

41.76

nmol/l

0.22

205

1760

Gastric ulcer

157

1330

1.18

1.28

1.9

1.7

46.47

43.52

nmol/l

0.65

152

1273

Fracture of skull and facial bones

414

3747

1.11

1.28

1.8

39.89

38.04

nmol/l

0.84

399

3662

Paroxysmal tachycardia

315

2370

1.13

1.27

2.0

1.7

42.35

43.55

nmol/l

0.38

302

2311

Melanocytic naevi of upper limb, including shoulder

162

1.56

1.27

1.6

33.96

40.65

nmol/l

1.13

155

Bacterial pneumoniae

458

4456

0.91

1.27

1.8

1.7

39.95

41.76

nmol/l

0.89

451

4310

Non-Hodgkin lymphoma, all

242

0.57

1.26

1.6

1.8

43.57

43.27

nmol/l

0.01

228

Bacterial Sepsis

440

4308

0.91

1.26

1.8

1.7

42.28

42.96

nmol/l

0.24

426

4154

Acute pancreatitis

272

2406

1.13

1.25

1.7

1.8

39.73

41.02

nmol/l

0.46

265

2327

Tic and related disorders

131

1.63

1.25

1.3

1.6

35.00

38.03

nmol/l

0.28

131

Degeneration of macula and posterior pole

312

2290

1.13

1.25

1.8

1.6

47.86

46.35

nmol/l

0.33

301

2172

Use of donepezil

564

0.73

1.25

1.6

1.5

59.05

49.89

nmol/l

1.25

531

Acute and transient psychotic disorders

146

1721

0.84

1.24

1.9

40.48

37.49

nmol/l

0.56

141

1679

Sequelae of inflammatory diseases of the central nervous system

2.25

1.24

1.8

39.62

33.41

nmol/l

—

Calcific aortic valvular stenosis

175

1992

0.86

1.24

1.7

44.84

45.57

nmol/l

0.17

165

1893

Calcific aortic valvular stenosis, operated

175

1992

0.86

1.24

1.7

44.84

45.57

nmol/l

0.17

165

1893

Brain meningioma, excluding all cancers (controls excluding all cancers)

220

1.46

1.23

1.8

48.53

43.94

nmol/l

0.50

209

Palmar fascial fibromatosis [Dupuytren]

168

1438

1.17

1.23

1.7

45.24

44.40

nmol/l

0.20

163

1384

Myositis ossificans

2.71

1.23

1.6

1.4

43.80

41.21

nmol/l

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

188

0.52

1.22

1.2

1.9

44.10

38.35

nmol/l

—

181

Orthopaedic devices associated with adverse incidents

1.82

1.22

1.5

1.7

44.33

44.72

nmol/l

—

Other specified disorders of muscle

314

1.38

1.22

1.8

31.58

38.12

nmol/l

2.31

309

Autism

384

1.35

1.21

1.8

1.7

33.69

36.09

nmol/l

0.33

378

Inflammatory bowel disease

528

4849

1.09

1.21

1.7

1.8

39.93

39.52

nmol/l

0.14

518

4731

Mental retardation, excluding more controls

411

0.69

1.20

1.8

1.7

36.10

38.02

nmol/l

0.15

404

Traumatic subdural haemorrhage

109

884

1.22

1.20

1.5

1.6

43.22

46.38

nmol/l

0.66

109

857

Other specified and unspecified disorders of eye and adnexa

289

1.39

1.20

1.5

1.8

45.25

40.05

nmol/l

0.68

276

Unspecified fall

656

6030

1.08

1.20

1.7

41.46

40.60

nmol/l

0.38

635

5867

Transient ischemic attack

504

3824

1.09

1.19

1.8

1.7

41.56

44.27

nmol/l

2.08

487

3672

Dental caries

421

3791

1.10

1.19

2.0

1.7

40.51

40.15

nmol/l

0.12

409

3706

Cholelithiasis, broad definition with cholecystitis

840

6160

0.93

1.19

1.7

40.94

44.31

nmol/l

3.85

807

5977

Morphin

1.89

1.18

1.9

1.4

46.92

45.20

nmol/l

0.08

Substance abuse

1177

10633

1.06

1.18

1.9

1.8

40.35

39.76

nmol/l

0.37

1132

10395

Traumatic cerebral oedema

0.00

1.18

0.0

1.6

—

34.09

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

129

1085

1.19

1.18

2.2

1.7

35.62

45.55

nmol/l

6.37

117

1039

Primary open-angle glaucoma

192

1624

1.15

1.17

1.6

1.7

48.44

45.27

nmol/l

1.06

187

1539

Other leukaemias of specified cell type

2.59

1.16

3.2

1.4

59.40

37.75

nmol/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1616

10816

1.05

1.16

1.8

1.7

39.45

40.69

nmol/l

1.25

1573

10574

Hyperlipidaemia, other/unspecified

439

3790

1.10

1.16

1.8

1.7

40.39

44.28

nmol/l

3.16

414

3657

Brain glioblastoma and astrocytoma

184

0.54

1.15

1.2

1.9

44.10

38.70

nmol/l

—

177

Inflammatory disease of uterus

465

1.29

1.14

1.2

52.12

54.89

nmol/l

0.25

459

Other demyelinating diseases of the central nervous system

366

0.68

1.13

1.2

1.7

36.32

39.14

nmol/l

0.38

356

Conductive hearing loss, unspecified

752

1.23

1.13

1.7

1.8

45.17

39.52

nmol/l

1.22

729

Disorder of external ear, unspecified

293

1.38

1.13

2.3

1.7

40.03

39.71

nmol/l

0.02

283

Dermatitis due to ingested food

315

1.36

1.12

1.3

1.5

39.77

36.96

nmol/l

0.33

310

Gonococcal infection

345

1.35

1.12

1.9

32.96

37.55

nmol/l

1.07

338

STROKE

750

5572

0.93

1.11

1.8

1.7

40.58

41.24

nmol/l

0.35

725

5427

Autism spe

381

1.33

1.11

1.9

1.8

33.56

36.26

nmol/l

0.38

375

Lesion of lateral popliteal nerve

548

1.27

1.11

1.9

1.8

43.71

39.93

nmol/l

0.53

530

Assault by hanging, strangulation and suffocation

2.28

1.11

2.4

1.7

36.14

33.70

nmol/l

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

117

1389

0.84

1.10

1.6

1.8

40.03

44.60

nmol/l

1.65

111

1321

Traumatic spondylopathy

2.46

1.10

1.2

1.3

47.80

42.05

nmol/l

—

Other disorders of urethra and urinary system

504

4102

0.92

1.09

1.6

47.21

46.40

nmol/l

0.23

488

3964

Benign neoplasm: Stomach

531

1.27

1.09

1.6

1.8

39.96

43.69

nmol/l

0.89

504

Melanocytic naevi of upper limb, including shoulder

169

1.49

1.08

1.6

33.96

40.19

nmol/l

1.05

159

Benign neoplasm: Skin of other and unspecified parts of face

711

1.23

1.08

1.9

1.7

39.98

42.69

nmol/l

0.44

685

Parodontitis and operation codes

1289

9518

1.05

1.08

1.8

40.88

40.81

nmol/l

0.03

1232

9300

Fracture of foot, except ankle

369

3358

1.10

1.07

1.7

42.87

39.15

nmol/l

1.76

364

3281

Mental and behavioural disorders due to alcohol, excluding acute intoxication

831

8829

0.94

1.06

1.9

1.8

41.05

39.85

nmol/l

0.79

803

8610

Nonspecific lymphadenitis

623

1.24

1.06

1.6

1.8

43.27

38.76

nmol/l

0.68

610

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

392

1.31

1.06

1.6

1.8

41.94

38.11

nmol/l

0.48

379

Diabetic retinopathy

323

2257

0.90

1.05

1.8

44.49

35.57

nmol/l

7.41

307

2182

DVT of lower extremities and pulmonary embolism

409

3730

1.09

1.04

1.9

1.7

40.06

42.96

nmol/l

1.95

403

3587

Otorrhoea

2.34

1.04

2.0

1.5

41.80

38.18

nmol/l

—

Bacterial pneumonia, not elsewhere classified

421

4063

0.92

1.04

1.8

1.7

40.08

41.86

nmol/l

0.79

414

3930

Effects of foreign body entering through natural orifice

497

4591

1.09

1.04

1.8

39.35

38.69

nmol/l

0.29

482

4475

Pedal cyclist injured in transport accident

354

3220

1.10

1.04

1.9

1.8

42.59

39.33

nmol/l

1.77

345

3143

Contact with blunt object, undetermined intent

1.73

1.04

2.1

1.7

42.14

38.06

nmol/l

0.30

Diseases of arteries, arterioles and capillaries (FINNGEN)

347

2669

0.91

1.03

1.7

40.08

42.24

nmol/l

1.16

334

2602

Primary_lymphoid and hematopoietic malignant neoplasms

245

2185

1.12

1.03

1.8

43.45

42.82

nmol/l

0.16

238

2094

Outcome of delivery

540

0.80

1.03

1.2

59.60

50.63

nmol/l

0.72

533

Normal-pressure hydrocephalus

203

0.59

1.03

1.9

1.7

48.00

47.08

nmol/l

0.03

189

Retained (old) intraocular foreign body

0.00

1.03

0.0

1.9

—

40.54

—

Toxic effect of ethanol

642

0.77

1.03

1.6

1.8

41.26

38.61

nmol/l

0.30

627

Valvular operations

145

1678

0.86

1.02

1.7

43.94

42.36

nmol/l

0.37

140

1615

Benign neoplasm: Spinal meninges

1.91

1.02

1.9

2.0

46.80

41.92

nmol/l

—

Alopecia areata

188

1.45

1.02

1.5

1.7

48.44

41.04

nmol/l

0.74

181

Renal failure

409

4075

0.92

1.01

1.7

42.72

43.35

nmol/l

0.20

392

3911

Accidental poisoning by and exposure to alcohol

273

0.65

1.01

1.6

1.7

35.56

40.07

nmol/l

0.46

262

Explicit Sepsis

395

4132

0.91

1.01

1.9

1.7

44.00

43.63

nmol/l

0.08

384

3987

Chlamydial lymphogranuloma (venereum)

2.49

0.99

1.7

1.8

34.00

37.18

nmol/l

—

Allergic contact dermatitis due to drugs in contact with skin

132

0.53

0.99

1.9

1.7

42.14

40.99

nmol/l

—

124

Post-traumatic hydrocephalus, unspecified

0.00

0.99

0.0

1.8

—

43.33

—

Unstable angina pectoris

354

3216

0.91

0.99

1.7

42.87

44.86

nmol/l

0.79

340

3078

Cholelithiasis

788

5876

0.94

0.98

1.7

40.94

44.55

nmol/l

4.10

756

5698

Malignant neoplasm of corpus uteri

2.18

0.98

1.0

1.3

41.80

65.91

nmol/l

—

Polymyalgia rheumatica

566

1.24

0.98

1.5

1.7

36.57

45.72

nmol/l

3.65

539

Cerebrovascular diseases (FINNGEN)

442

3431

0.92

0.97

1.8

1.7

40.48

41.49

nmol/l

0.41

426

3354

Other septicaemia

324

3492

0.91

0.97

1.9

1.7

43.72

43.15

nmol/l

0.10

315

3359

Lesion of radial nerve

372

1.30

0.96

2.7

1.8

40.83

38.70

nmol/l

0.19

358

Charcot foot

185

0.59

0.95

1.3

1.8

30.27

40.34

nmol/l

1.94

175

Maternal care for known or suspected malpresentation of fetus

111

700

1.18

0.95

1.2

64.24

56.55

nmol/l

1.10

111

695

Effects of other deprivation

2.30

0.95

2.7

1.8

41.67

36.22

nmol/l

—

Infection of intervertebral disc (pyogenic)

117

1.56

0.95

1.9

1.7

44.22

39.68

nmol/l

0.41

112

Other diseases caused by chlamydiae

1.78

0.95

1.9

1.5

35.78

41.27

nmol/l

—

Fatigue fracture of vertebra

2.27

0.94

1.2

55.33

39.07

nmol/l

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

494

3640

0.93

0.94

1.5

1.7

46.66

44.01

nmol/l

1.72

476

3507

Other blood glucose lowering drugs, excl. Insulins

161

1409

1.15

0.94

1.9

1.7

34.54

45.25

nmol/l

10.31

155

1355

Acidosis

184

0.59

0.94

2.4

1.7

36.64

42.36

nmol/l

0.50

177

Other and unspecified vaccines and biological substances

1.76

0.93

1.2

1.4

26.56

36.50

nmol/l

—

Lichen simplex chronicus

295

1.33

0.93

1.9

1.7

39.69

38.84

nmol/l

0.08

283

Glaucoma secondary to other eye disorders

304

0.69

0.93

1.7

48.00

39.35

nmol/l

0.75

292

Hallux valgus (acquired)

186

1187

1.14

0.93

1.7

1.6

44.46

45.07

nmol/l

0.12

180

1142

In situ neoplasms

200

1777

1.13

0.92

1.5

1.6

49.27

48.14

nmol/l

0.24

192

1708

Cardiomyopathy

191

2150

0.89

0.92

1.6

1.7

39.31

41.97

nmol/l

0.95

186

2071

Benign neoplasm: Larynx

314

1.32

0.91

2.3

1.8

32.20

40.06

nmol/l

2.65

301

Nutritional anaemias

397

3557

1.09

0.90

1.9

1.7

45.88

44.69

nmol/l

0.30

384

3421

Acute pancreatitis (for exclusion)

272

2465

1.11

0.90

1.7

1.8

39.73

40.69

nmol/l

0.32

265

2383

Postprocedural disorders of digestive system, not elsewhere classified

211

1.38

0.88

1.5

1.7

43.86

40.84

nmol/l

0.28

198

Abrasion of teeth

341

2295

1.09

0.88

1.7

1.8

44.91

41.30

nmol/l

1.72

333

2248

Recurring oral aphthae

333

1.30

0.88

1.8

1.7

39.37

40.04

nmol/l

0.06

319

Anisometropia and aniseikonia

220

1.37

0.88

1.5

1.7

44.17

40.03

nmol/l

0.47

209

Cholera

111

1.54

0.87

1.8

44.00

42.99

nmol/l

0.07

105

Endocarditis

380

0.73

0.87

1.9

1.7

41.11

40.46

nmol/l

0.06

366

Insulin, fast-acting (human)

221

2456

0.90

0.87

1.8

52.93

37.81

nmol/l

11.82

216

2402

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

405

1.27

0.87

1.6

1.8

41.94

38.98

nmol/l

0.34

392

Atrial fibrillation and flutter

605

3699

1.07

0.86

1.8

1.7

39.35

40.64

nmol/l

0.74

585

3619

Type 2 diabetes, wide definition

1153

7167

1.05

0.86

1.9

1.7

35.09

42.45

nmol/l

18.18

1095

6995

Autoimmune hepatitis

1.84

0.86

2.1

1.4

45.25

37.44

nmol/l

—

Myeloproliferative diseases (CML excluded)

540

1.23

0.86

1.8

41.69

42.05

nmol/l

0.05

511

Diseases caused by chlamydiae

1.83

0.86

1.4

1.5

37.75

42.34

nmol/l

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

413

0.75

0.86

1.3

1.8

41.87

41.91

nmol/l

0.00

391

Injuries to the elbow and forearm

945

8115

1.05

0.86

1.8

1.7

40.22

40.50

nmol/l

0.13

924

7925

Chronic periodontitis, including avohilmo

1363

9661

1.04

0.86

1.8

40.89

40.70

nmol/l

0.10

1301

9445

Sub-endpoint used in defining T1D endpoints

434

4597

0.93

0.86

1.7

1.8

50.33

38.67

nmol/l

10.49

427

4480

Psoriasis

388

3584

1.09

0.86

1.7

1.8

42.87

40.46

nmol/l

0.74

374

3479

Defect, injury or illness of lumbar spine

1.98

0.85

1.0

1.3

32.83

33.58

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of head

442

1.25

0.85

1.5

1.7

43.36

38.89

nmol/l

0.83

431

Rheumatoid arthritis, including avohilmo

256

2822

0.91

0.85

1.6

1.7

44.73

43.09

nmol/l

0.44

250

2727

Other and unspecified paralytic syndromes

137

1.48

0.85

1.5

1.9

33.45

36.23

nmol/l

0.25

130

Bacterial pneumonia (organism specified)

484

4729

0.93

0.85

1.8

1.7

40.31

42.02

nmol/l

0.83

477

4569

Alcohol use disorder, ICD-based

764

8072

0.94

0.84

1.9

1.8

40.99

39.73

nmol/l

0.79

736

7870

Open wound of thorax

261

0.68

0.84

1.6

1.8

32.33

37.87

nmol/l

0.43

254

L01XE Protein kinase inhibitors

366

0.73

0.84

2.1

1.7

44.26

41.69

nmol/l

0.20

346

Clear cell adenocarcinoma of kidney

411

0.75

0.84

1.3

1.8

41.87

41.07

nmol/l

0.06

389

Chronic periodontitis, complicated

1123

0.85

0.83

2.0

1.9

43.53

41.16

nmol/l

0.38

1080

Circumscribed brain atrophy

115

0.52

0.83

1.7

1.8

38.50

42.90

nmol/l

—

107

Disseminated intravascular coagulation [defibrination syndrome]

1.92

0.83

2.0

1.7

47.17

40.91

nmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

311

1.30

0.83

2.1

1.8

38.35

37.38

nmol/l

0.13

298

Hypoglycaemia, other or unspecified

726

1.19

0.83

2.0

1.8

52.77

38.45

nmol/l

3.15

701

Neovascular glaucoma

296

0.71

0.83

1.7

48.00

39.98

nmol/l

0.67

284

Systemic connective tissue disorders

245

2220

1.11

0.82

1.7

41.13

44.38

nmol/l

1.26

235

2142

Myocardial infarction, without ST-elevation

353

3530

0.92

0.82

1.7

42.61

44.75

nmol/l

1.04

335

3374

Other disorders of glucose regulation and pancreatic internal secretion

106

912

1.17

0.82

1.9

1.8

50.88

38.66

nmol/l

3.31

101

884

Benign neoplasm: Skin of other and unspecified parts of face

736

1.19

0.81

1.9

1.7

39.98

42.92

nmol/l

0.49

707

Corneal scars and opacities

215

1.36

0.81

1.6

1.8

42.48

39.19

nmol/l

0.48

206

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

442

0.76

0.81

1.9

1.8

41.09

40.66

nmol/l

0.05

419

Thyrotoxicosis with toxic multinodular goitre

172

1.40

0.81

1.4

1.6

45.46

43.75

nmol/l

0.10

162

Other and unspecified epidermal thickening

224

1.35

0.80

1.3

1.7

46.57

40.09

nmol/l

0.69

213

Herpesviral [herpes simplex] infections

112

969

1.16

0.80

1.9

1.7

36.95

41.42

nmol/l

0.95

112

938

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

392

1.26

0.80

1.6

1.8

43.20

37.93

nmol/l

0.48

381

Other degenerative disorders of eyelid and periocular area

0.00

0.80

0.0

1.6

—

46.67

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.80

0.0

1.5

—

36.24

—

Monoarthritis, not elsewhere classified

383

1.26

0.80

1.6

1.7

44.75

39.71

nmol/l

0.63

370

Calcific tendinitis

1.69

0.79

2.4

1.4

37.27

43.56

nmol/l

0.46

Ulcerative colitis

395

3667

1.08

0.79

1.7

1.8

39.05

39.15

nmol/l

0.03

387

3580

Special screening examination for neoplasms

286

1.30

0.79

1.6

1.7

51.88

43.03

nmol/l

0.63

278

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1307

8865

0.96

0.78

1.7

42.45

41.45

nmol/l

0.75

1263

8639

Erythema intertrigo

182

1.39

0.78

1.9

1.6

37.56

38.01

nmol/l

0.05

171

Purpura and other haemorrhagic conditions

145

1281

1.14

0.78

1.6

1.8

44.04

40.94

nmol/l

0.77

140

1237

Other specified congenital malformation syndromes affecting multiple systems

191

1.38

0.78

2.0

1.6

37.65

37.31

nmol/l

0.02

186

Psoriasis vulgaris

269

2461

1.10

0.77

1.7

1.8

43.86

39.93

nmol/l

0.99

257

2385

Congenital malformations of the respiratory system

132

1.45

0.76

2.7

1.8

42.00

36.69

nmol/l

0.52

127

Sulfasalazine

372

3451

1.08

0.76

1.7

43.94

41.19

nmol/l

1.00

367

3358

Suppurative and necrotic conditions of lower respiratory tract

582

0.80

0.76

1.5

1.8

44.26

39.07

nmol/l

0.66

558

Autoimmune diseases excluding thyroid diseases

1876

10061

1.04

0.76

1.7

43.30

40.13

nmol/l

5.17

1836

9830

Diagnoses used for exclusion with ILD

288

2644

1.09

0.76

1.9

1.8

40.09

40.92

nmol/l

0.26

277

2552

Acute renal failure

176

1962

0.89

0.76

1.7

1.8

41.50

42.62

nmol/l

0.27

166

1881

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

161

0.62

0.76

1.5

1.8

40.70

43.67

nmol/l

—

151

Oral corticosteroids

1736

10139

1.04

0.76

1.8

1.7

40.28

41.13

nmol/l

0.68

1699

9899

Mental and behavioural disorders due to alcohol

963

9806

0.95

0.75

1.9

1.8

40.62

39.84

nmol/l

0.49

932

9580

Aortic aneurysm

276

2490

1.09

0.74

1.7

43.65

44.51

nmol/l

0.23

262

2375

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

242

0.70

0.74

1.3

1.8

53.76

40.51

nmol/l

0.82

229

Adhesive middle ear disease

176

1.38

0.73

1.7

31.38

38.98

nmol/l

1.79

169

Assault by other and unspecified firearm discharge

1.80

0.73

1.4

2.2

34.14

35.34

nmol/l

—

Benign neoplasm: Nasopharynx

1.60

0.72

1.3

1.7

43.17

39.97

nmol/l

0.13

Oral lichen ruber planus, hypothyreosis or thyroxin

1.81

0.72

1.3

1.8

62.14

43.67

nmol/l

—

Other coagulation defects

534

1.20

0.72

2.0

1.7

40.67

40.88

nmol/l

0.02

516

Other specified and unspecified disorders of iris and ciliary body

1.79

0.72

2.0

1.3

44.86

33.25

nmol/l

—

Other abnormal findings of blood chemistry

362

1.25

0.72

1.9

1.7

39.98

40.09

nmol/l

0.01

347

Noninfective disorders of pinna

1.98

0.72

3.0

1.8

24.80

41.08

nmol/l

—

Retention of urine

377

2965

1.08

0.72

1.8

1.7

45.89

44.76

nmol/l

0.36

357

2837

Malignant neoplasm of oral cavity

287

0.73

0.72

1.5

1.8

40.38

40.07

nmol/l

0.02

272

Other diseases of gallbladder

229

1.32

0.71

1.9

1.7

37.63

42.19

nmol/l

0.64

218

Fracture of femur

159

1620

0.89

0.71

1.6

1.7

47.33

42.27

nmol/l

1.44

153

1562

Other diseases of the digestive system

345

3205

1.08

0.70

1.7

42.67

42.78

nmol/l

0.03

329

3089

Pedal cyclist injured in noncollision transport accidents

170

1530

1.12

0.70

2.0

1.8

42.02

38.88

nmol/l

0.97

165

1488

Exclusion endpoint for clefts

230

1.32

0.70

1.8

1.6

40.57

37.79

nmol/l

0.19

224

Rheumatic valve diseases

142

0.63

0.70

1.2

1.9

42.89

41.10

nmol/l

—

134

Parodontitis or operation codes

1361

9659

1.04

0.69

1.8

40.98

40.71

nmol/l

0.15

1299

9443

Loose body in joint

257

1.29

0.69

1.6

1.7

38.24

38.33

nmol/l

0.01

248

Erysipelas

747

7153

0.95

0.68

1.9

1.8

40.28

40.87

nmol/l

0.29

724

6952

Chalazion

138

1229

1.13

0.68

1.7

1.8

43.20

40.59

nmol/l

0.59

131

1191

Malignant neoplasm of eye, brain and central nervous system

463

0.79

0.68

1.8

39.54

38.72

nmol/l

0.10

445

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

306

0.74

0.68

1.3

1.9

49.26

39.99

nmol/l

0.71

293

Varicose veins

443

3567

0.94

0.67

1.6

1.7

44.75

44.34

nmol/l

0.14

430

3429

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

121

0.57

0.67

1.3

1.8

37.71

41.76

nmol/l

—

113

Upper arm

1.84

0.67

1.2

1.9

38.00

38.39

nmol/l

—

Benign neoplasm: Larynx

330

1.25

0.67

2.3

1.8

32.20

39.49

nmol/l

2.44

316

Parodontitis

1358

9655

1.04

0.67

1.8

40.95

40.72

nmol/l

0.12

1296

9439

Injury of eye and orbit

292

2705

1.08

0.66

1.8

38.43

38.16

nmol/l

0.08

283

2644

Dyshidrosis [pompholyx]

145

1.39

0.66

2.6

1.5

31.90

40.76

nmol/l

1.39

138

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

237

0.71

0.66

1.8

38.35

44.46

nmol/l

0.76

226

Other, unspecified and serous retinal detachments

259

0.73

0.65

1.4

1.8

46.95

40.17

nmol/l

0.78

250

Paralytic ileus and intestinal obstruction

228

2090

1.09

0.65

2.0

1.7

43.07

42.67

nmol/l

0.09

221

2019

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

178

0.67

0.65

2.2

1.8

38.25

44.10

nmol/l

0.53

167

Third [oculomotor] nerve palsy

120

1.43

0.65

2.1

1.8

33.59

41.04

nmol/l

1.01

114

Family history of certain disabilities and chronic diseases leading to disablement

477

1.20

0.65

1.9

1.6

38.54

40.95

nmol/l

0.34

469

Macular cyst

137

1.40

0.65

1.7

41.84

41.40

nmol/l

0.03

131

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.77

0.65

2.2

1.7

42.20

39.93

nmol/l

—

1.76

0.64

1.2

1.4

22.00

34.03

nmol/l

—

Ventral hernia

221

2025

1.09

0.64

1.9

1.7

40.83

42.51

nmol/l

0.45

210

1947

Dialysis

503

0.81

0.64

1.4

1.8

42.49

38.00

nmol/l

0.74

486

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

384

2823

0.93

0.64

1.6

1.7

47.57

45.17

nmol/l

1.19

366

2707

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

405

2962

0.94

0.64

1.6

1.7

47.78

45.01

nmol/l

1.49

387

2838

Papilloedema, unspecified

207

1.31

0.64

1.6

1.7

36.52

41.74

nmol/l

0.72

199

Complications following infusion, transfusion and therapeutic injection

112

1.44

0.64

1.9

1.8

47.19

38.78

nmol/l

0.41

107

Combinations of oral blood glucose lowering drugs

387

3629

1.07

0.63

1.8

1.7

32.57

44.65

nmol/l

29.66

371

3505

Behavioural disorders

369

0.78

0.63

2.3

1.7

43.03

36.90

nmol/l

0.54

362

Chondrocostal junction syndrome [Tietze]

234

1.29

0.63

2.2

1.7

38.53

41.88

nmol/l

0.44

226

Open wound of head

828

8513

0.96

0.63

1.8

39.71

39.40

nmol/l

0.15

798

8310

Superficial injury of ankle and foot

175

1590

1.10

0.62

1.8

39.13

38.40

nmol/l

0.15

170

1556

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

729

0.85

0.62

1.8

40.26

40.34

nmol/l

0.01

699

Discharge of firework

0.00

0.62

0.0

1.7

—

32.95

—

Contact with machinery

229

2109

1.09

0.62

1.6

1.8

43.77

38.92

nmol/l

2.37

223

2037

Tuberculosis of other organs, strict

102

0.59

0.62

1.3

1.6

34.83

43.67

nmol/l

—

Lordosis

1.70

0.62

1.2

1.1

26.00

39.13

nmol/l

—

Pemphigus vulgaris

0.00

0.61

0.0

1.5

—

44.15

—

Coronary atherosclerosis

884

5943

0.96

0.61

1.8

1.7

40.56

41.68

nmol/l

0.79

853

5769

Parodontitis or/and operation codes

947

5862

0.96

0.61

1.8

40.14

39.89

nmol/l

0.10

907

5734

Benign neoplasm: Extrahepatic bile ducts

0.00

0.61

0.0

1.4

—

33.86

—

Injury of muscle and tendon at ankle and foot level

299

1.25

0.60

2.4

1.8

36.57

36.90

nmol/l

0.04

288

Secondary right heart disease

221

0.72

0.60

1.6

1.8

61.00

41.48

nmol/l

1.50

204

Other surgical follow-up care

308

1.24

0.60

1.7

43.92

38.97

nmol/l

0.59

299

Malignant neoplasm, without specification of site

151

0.66

0.60

1.4

1.8

31.30

42.90

nmol/l

—

143

Benign neoplasm: Skin of lower limb, including hip

192

1.31

0.59

1.6

1.7

45.12

40.46

nmol/l

0.51

185

Whooping cough

1.59

0.59

1.3

1.5

33.70

33.84

nmol/l

—

Enduring personality changes

1.54

0.59

2.3

1.8

39.88

36.43

nmol/l

—

Epiphora

1.45

0.59

1.8

1.6

43.36

42.22

nmol/l

0.08

Need for immunization against other single viral diseases

273

1.26

0.59

1.6

1.8

49.47

36.44

nmol/l

1.23

266

Other sideroblastic anaemias

0.00

0.59

0.0

1.4

—

39.48

—

Fall on and from stairs and steps

287

2673

1.08

0.59

1.8

1.7

41.09

40.85

nmol/l

0.06

278

2594

Other and unspecified mononeuropathies of lower limb

175

1.32

0.58

1.8

1.6

46.26

41.04

nmol/l

0.39

167

Anoxic brain damage

116

0.60

0.58

1.9

1.6

46.71

41.61

nmol/l

—

109

Use of disulfiram, acamprosate or naltrexone

195

1791

1.09

0.58

1.8

1.9

37.69

37.39

nmol/l

0.08

185

1747

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

1.70

0.57

4.5

1.6

36.17

37.14

nmol/l

—

Benign neoplasm: Floor of mouth

1.70

0.57

1.7

1.8

37.33

40.89

nmol/l

—

Benign neoplasm: Floor of mouth

1.70

0.57

1.7

1.6

37.33

41.11

nmol/l

—

Left hemicolectomy

161

0.68

0.57

1.8

1.7

40.00

41.05

nmol/l

0.09

152

Other specified/unspecified systemic involvement of connective tissue

283

1.24

0.56

2.0

1.7

53.26

42.48

nmol/l

0.87

274

Leisure time condition

223

2061

1.08

0.56

1.6

1.8

44.80

39.97

nmol/l

1.39

218

2008

Dental caries 3 and operation codes, only avohilmo

460

2444

0.94

0.56

1.8

1.7

40.29

42.16

nmol/l

0.83

445

2394

Other retinal disorders

661

5555

0.95

0.56

1.8

1.7

46.36

41.94

nmol/l

3.38

642

5373

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.53

0.56

1.0

1.8

52.11

40.79

nmol/l

—

Carcinoma in situ of prostate

1.49

0.56

1.8

46.08

45.33

nmol/l

0.05

Bus occupant injured in other and unspecified transport accidents

1.52

0.55

2.0

1.7

27.89

37.02

nmol/l

—

Asthma/COPD (KELA code 203)

1476

10714

0.97

0.55

1.8

1.7

38.36

41.38

nmol/l

5.34

1441

10474

Other and unspecified disorders of orbit

1.60

0.55

1.5

1.6

53.33

39.53

nmol/l

—

Direct fill therapy

184

1690

1.09

0.54

1.9

1.8

41.78

39.84

nmol/l

0.50

178

1640

Benign neoplasm of thyroid gland

142

1.34

0.54

1.6

1.7

41.63

43.77

nmol/l

0.15

136

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

1.58

0.54

1.0

1.2

43.00

70.05

nmol/l

—

Pericarditis

395

1.20

0.54

1.6

1.7

38.07

39.62

nmol/l

0.25

380

Pulmonary heart disease, diseases of pulmonary circulation

277

2586

1.07

0.54

1.9

1.7

40.58

43.00

nmol/l

1.12

272

2481

Superficial injury of ankle and foot, unspecified

1.47

0.54

1.7

2.0

31.33

35.94

nmol/l

—

Endometriosis ASRM stages 1,2

487

1.17

0.53

1.1

1.2

64.07

55.02

nmol/l

0.89

482

Effects of air pressure and water pressure

100

1.43

0.53

2.1

1.9

37.07

34.42

nmol/l

0.30

100

Infective bursitis

359

1.21

0.53

2.0

1.8

39.23

38.87

nmol/l

0.02

350

Enteropathic arthropathies

214

1.27

0.53

1.6

33.22

36.94

nmol/l

0.67

209

Iridocyclitis

282

2639

1.07

0.53

1.9

1.8

43.55

40.05

nmol/l

0.96

277

2563

Toxic effect of alcohol

315

0.79

0.53

1.7

1.8

35.64

36.70

nmol/l

0.09

304

Respiratory conditions due to other external agents

0.61

0.52

1.5

2.0

31.67

44.14

nmol/l

—

Diabetes, insulin treatment (Kela reimbursement)

1618

9624

1.03

0.52

1.8

36.09

41.09

nmol/l

12.30

1556

9422

Primary_lymphoid and hematopoietic malignant neoplasms

245

2281

1.08

0.52

1.8

43.45

43.09

nmol/l

0.09

238

2181

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

224

1.26

0.52

1.6

1.7

38.07

37.14

nmol/l

0.11

216

Other fall from one level to another

355

3349

1.06

0.51

1.6

1.7

41.44

40.09

nmol/l

0.44

350

3263

Chronic periodontitis

187

1725

1.09

0.51

2.1

1.7

41.85

41.05

nmol/l

0.16

177

1674

Other specified and unspecified retinal disorders

251

1.24

0.51

1.7

1.8

37.13

38.66

nmol/l

0.21

241

Secondary and unspecified malignant neoplasm of lymph nodes

753

1.13

0.51

1.6

1.8

46.08

40.78

nmol/l

1.29

722

Persons encountering health services for specific procedures and health care

1776

10717

1.03

0.51

1.8

1.7

40.76

40.78

nmol/l

0.01

1731

10475

Hypertensive heart and/or renal disease

232

1930

0.93

0.50

1.6

1.7

41.01

47.55

nmol/l

4.19

221

1857

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

201

0.74

0.50

1.2

1.8

54.80

40.96

nmol/l

0.75

191

Basal cell carcinoma

408

3081

1.06

0.49

1.5

1.7

48.19

45.84

nmol/l

1.17

389

2936

Pustulosis palmaris et plantaris

243

1.24

0.49

1.6

1.7

48.90

40.20

nmol/l

0.57

233

Pneumonia, organism unspecified

1448

10185

1.03

0.49

1.8

1.7

39.42

40.58

nmol/l

1.05

1404

9954

Exposure to other and unspecified man-made environmental factors

190

1.27

0.48

1.5

1.7

34.96

37.59

nmol/l

0.34

185

Other bursitis of hip

1.41

0.48

1.5

45.92

44.11

nmol/l

0.11

Benign neoplasm: Skin of lower limb, including hip

199

1.26

0.48

1.6

1.8

45.12

41.67

nmol/l

0.34

192

Gastroduodenal ulcer

234

2180

1.07

0.48

1.9

1.7

46.55

44.10

nmol/l

0.71

227

2086

653

1.13

0.47

1.6

52.97

49.68

nmol/l

0.50

613

Type of accident

396

3761

1.05

0.47

1.7

41.73

39.94

nmol/l

0.64

385

3672

Other CVD (FINNGEN)

111

789

1.11

0.47

1.9

1.6

45.50

46.60

nmol/l

0.19

105

759

Use of memantine

618

0.87

0.47

1.4

1.5

64.02

50.66

nmol/l

2.57

583

Use of other anti-dementia drugs

618

0.87

0.47

1.4

1.5

64.02

50.66

nmol/l

2.57

583

GI-bleeding

343

3244

1.06

0.47

1.7

42.97

42.71

nmol/l

0.06

327

3127

Lagophthalmos

1.48

0.47

1.1

1.9

44.70

43.70

nmol/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

182

1.27

0.47

2.0

1.8

36.35

39.65

nmol/l

0.43

174

Other juvenile arthritis

402

1.17

0.46

1.7

1.6

46.19

40.73

nmol/l

0.33

396

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

0.61

0.46

2.0

1.7

43.60

41.26

nmol/l

—

Alcohol induced polyneuropathy

121

0.65

0.46

1.3

1.6

36.75

42.45

nmol/l

—

115

Respiratory tuberculosis, clinically confirmed

0.61

0.46

1.6

1.7

53.80

43.64

nmol/l

—

Rheumatoid arthritis

221

2150

0.93

0.46

1.6

44.91

44.12

nmol/l

0.16

216

2075

Injuries to the hip and thigh

529

4635

1.05

0.45

1.9

1.7

41.96

41.48

nmol/l

0.16

509

4493

Diabetic neuropathy

124

1125

1.10

0.45

1.8

1.7

44.17

37.20

nmol/l

2.26

118

1075

Chronic tubulo-interstitial nephritis

198

0.75

0.45

1.5

1.8

46.87

41.48

nmol/l

0.33

189

Carcinoma in situ of skin of scalp and neck

103

1.37

0.45

1.4

1.8

60.64

49.24

nmol/l

0.63

Malignant melanoma of skin

833

0.89

0.45

1.5

1.8

44.03

43.53

nmol/l

0.06

798

Non-allergic asthma

741

1.12

0.45

1.5

1.7

40.02

40.41

nmol/l

0.06

718

Other and unspecified nonorganic psychotic disorders

338

3565

0.95

0.45

1.8

38.83

37.37

nmol/l

0.40

331

3495

Benign neoplasm: Skin of scalp and neck

201

1.25

0.45

2.2

1.8

49.00

41.80

nmol/l

0.36

192

Other noninfective disorders of lymphatic vessels and lymph nodes

242

0.78

0.45

2.6

1.7

36.00

40.46

nmol/l

0.41

236

Hereditary retinal dystrophy

152

0.72

0.44

1.5

1.8

34.36

36.49

nmol/l

0.20

147

Psoriatic arthropathies, strict definition

0.00

0.44

0.0

1.3

—

43.19

—

Unspecified mental disorder

701

6760

1.04

0.44

1.9

1.8

37.86

39.28

nmol/l

0.81

681

6621

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

184

1.26

0.43

2.0

1.9

36.35

39.60

nmol/l

0.43

176

Respiratory tuberculosis, confirmed

127

0.71

0.43

1.3

1.8

55.11

43.58

nmol/l

—

120

Other infective (teno)synovitis

1.63

0.43

2.0

1.6

32.60

37.97

nmol/l

—

Malignant neoplasm of larynx

131

0.68

0.43

1.4

1.7

42.78

43.35

nmol/l

—

123

Pyothorax

436

0.84

0.43

1.6

1.8

45.14

39.01

nmol/l

0.62

413

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

275

2596

1.06

0.43

1.7

1.8

38.27

38.91

nmol/l

0.18

270

2529

Other malignant neoplasms of skin (=non-melanoma skin cancer)

401

3015

1.05

0.43

1.5

1.7

48.19

45.72

nmol/l

1.21

381

2873

Classical phenylketonuria

0.00

0.43

0.0

1.5

—

45.00

—

Familial hypercholesterolemia

144

1328

1.09

0.43

1.9

1.7

36.51

44.94

nmol/l

5.65

130

1264

Osteonecrosis due to drugs

0.65

0.43

2.3

1.8

43.83

42.44

nmol/l

—

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

0.65

0.43

1.5

1.8

44.00

42.94

nmol/l

—

Hydrocephalus

436

0.85

0.43

1.7

42.49

42.83

nmol/l

0.03

415

Mixed conductive and sensorineural hearing loss

818

0.89

0.42

1.7

1.8

44.63

42.40

nmol/l

0.34

790

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

378

2739

0.95

0.42

1.6

1.7

47.66

45.24

nmol/l

1.19

361

2624

Kidney transplant status

743

0.88

0.42

1.4

1.9

41.61

38.35

nmol/l

0.65

717

Osteolysis

0.00

0.42

0.0

1.6

—

40.20

—

Tuberculosis of other organs

0.63

0.42

1.3

1.6

34.83

42.13

nmol/l

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

0.42

0.0

1.7

—

43.00

—

Cystic fibrosis with intestinal manifestations

0.00

0.42

0.0

1.3

—

34.20

—

Other and unspecified disorders of pigmentation

1.39

0.42

1.5

1.7

43.38

38.31

nmol/l

—

Other nonautoimmune haemolytic anaemias

0.00

0.42

0.0

1.4

—

39.60

—

Chronic drug-induced interstitial lung disorders

0.00

0.42

0.0

1.4

—

47.75

—

Superficial injuries involving multiple body regions

283

0.81

0.42

1.5

1.7

44.43

38.09

nmol/l

0.46

273

Internuclear ophthalmoplegia

1.54

0.42

1.0

1.8

54.60

42.91

nmol/l

—

Hip and thigh

0.00

0.41

0.0

1.1

—

42.13

—

Lichenoid drug reaction

0.00

0.41

0.0

2.1

—

39.60

—

Cystic fibrosis, other manifestations/unspecified

0.00

0.41

0.0

1.2

—

42.65

—

Bleeding

1131

8453

0.97

0.41

1.7

42.44

40.75

nmol/l

1.48

1091

8235

Small kidney of unknown cause

0.00

0.41

0.0

1.8

—

37.59

—

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.3

—

45.00

—

Implicit bacterial Sepsis

371

3567

0.95

0.41

1.8

1.7

43.00

43.68

nmol/l

0.21

359

3430

Benign neoplasm: Other and unspecified parts of small intestine

1.40

0.41

1.5

1.7

39.64

43.05

nmol/l

0.16

Traumatic subcutaneous emphysema

0.00

0.41

0.0

1.4

—

39.50

—

Hypo-osmolality and hyponatraemia

130

1193

1.09

0.41

1.8

1.7

54.82

43.28

nmol/l

3.37

123

1152

Amoebiasis

1.35

0.41

1.8

1.7

29.88

40.23

nmol/l

—

Pityriasis lichenoides et varioliformis acuta

0.00

0.40

0.0

1.8

—

42.94

—

Leiomyoma of uterus

478

1.11

0.40

1.2

59.84

59.92

nmol/l

0.01

471

Other retinal disorders in diseases classified elsewhere

0.00

0.40

0.0

1.5

—

45.72

—

Erythema in diseases classified elsewhere

0.00

0.40

0.0

1.4

—

46.89

—

Other ulcerative colitis

772

0.89

0.40

1.9

1.8

38.46

38.30

nmol/l

0.02

751

Malignant neoplasm of accessory sinuses

0.00

0.40

0.0

1.4

—

38.72

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.40

0.0

1.6

—

32.56

—

Adenocarcinoma of small intestine

0.00

0.40

0.0

1.3

—

53.78

—

Familial hypercholesterolemia, with ischemic heart disease

720

1.11

0.40

1.7

1.8

36.42

45.91

nmol/l

3.74

686

104

0.67

0.40

2.9

1.6

38.57

38.53

nmol/l

—

Drug-induced cataract

214

1.22

0.40

1.7

36.23

40.32

nmol/l

0.51

207

Toxic effect of carbon monoxide

205

1.23

0.40

2.7

1.8

36.36

38.38

nmol/l

0.26

196

Benign neoplasm: Brain, supratentorial

142

1.28

0.39

2.1

1.9

36.33

38.21

nmol/l

0.15

136

Pacemaker

245

2249

1.06

0.38

1.6

1.7

46.60

45.29

nmol/l

0.36

231

2142

Benign neoplasm: Skin of scalp and neck

206

1.22

0.38

2.2

1.8

49.00

40.92

nmol/l

0.42

195

IBD patients in KELA-register

399

3821

1.05

0.38

1.7

1.8

39.18

39.00

nmol/l

0.05

391

3734

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

113

0.70

0.38

1.5

1.8

38.88

40.92

nmol/l

—

106

Respiratory tuberculosis, bacteriologically and histologically confirmed

136

0.73

0.38

1.3

1.8

52.10

43.16

nmol/l

—

129

Abnormal spermatozoa

166

1551

1.07

0.38

2.1

1.7

40.01

44.11

nmol/l

1.45

151

1479

Benign neoplasm: Tonsil

112

0.71

0.37

1.4

1.8

37.00

40.46

nmol/l

—

107

Autoimmune diseases excluding thyroid diseases, strict definition

1794

9790

1.02

0.37

1.7

43.36

40.19

nmol/l

4.93

1757

9568

Drug-induced hypoglycaemia without coma

169

0.76

0.37

1.5

1.8

34.92

41.30

nmol/l

0.82

161

Ulcerative colitis (strict definition, all Crohn cases excluded)

240

2271

1.06

0.37

1.7

1.8

38.11

38.89

nmol/l

0.21

235

2208

Type 1 diabetes

426

4430

0.96

0.37

1.7

1.8

50.41

39.79

nmol/l

8.70

419

4335

Protozoal diseases

235

1.20

0.36

1.6

1.8

45.14

39.72

nmol/l

0.47

226

Lesion of medial popliteal nerve

1.45

0.36

1.7

1.9

42.33

38.81

nmol/l

—

Endometriosis ASRM stages 3,4

516

1.12

0.36

1.2

63.95

57.31

nmol/l

0.62

510

Injuries involving multiple body regions

438

0.86

0.36

1.7

1.8

43.71

37.67

nmol/l

0.74

424

therapeutic use

171

1.23

0.36

1.7

41.87

42.95

nmol/l

0.08

161

Other injuries of upper limb, level unspecified

121

0.74

0.35

2.3

1.8

42.78

38.62

nmol/l

—

115

Carcinoma in situ of colon

108

1.31

0.35

1.4

1.9

46.79

42.82

nmol/l

0.25

100

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

122

0.73

0.35

1.2

1.8

40.44

42.11

nmol/l

—

117

Benign neoplasm of thyroid gland

153

1.25

0.35

1.6

41.63

43.82

nmol/l

0.16

146

Carcinoma in situ of skin of scalp and neck

108

1.30

0.35

1.4

1.8

60.64

47.45

nmol/l

0.75

Unspecified acute lower respiratory infection

247

2344

1.06

0.35

1.8

38.26

39.46

nmol/l

0.37

242

2285

Papillary adenocarcinoma of thyroid gland

301

1.17

0.35

2.0

1.6

39.74

40.55

nmol/l

0.08

291

Migraine, unspecified, drug-induced

1.37

0.34

1.8

1.6

33.50

36.20

nmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

303

2893

1.05

0.34

1.7

1.8

38.88

39.05

nmol/l

0.04

298

2820

Insulin, intermediate and long-acting

800

8067

0.97

0.34

1.7

1.8

43.82

40.83

nmol/l

2.10

774

7845

Transplanted organ and tissue status

142

1326

1.07

0.34

1.6

1.9

43.37

39.22

nmol/l

1.15

142

1292

Acute generalized exanthematous pustulosis

302

1.16

0.34

1.3

1.7

42.60

40.38

nmol/l

0.23

291

Focal epilepsy

234

2464

0.95

0.34

1.8

49.34

40.41

nmol/l

3.05

229

2394

Malignant neoplasm of other and unspecified parts of tongue

118

1.28

0.34

1.5

1.7

43.13

39.75

nmol/l

0.25

112

Exposure to ignition of highly flammable material

0.65

0.33

2.8

1.9

35.50

35.49

nmol/l

—

Habit and impulse disorders

303

1.16

0.33

1.9

1.7

37.86

38.12

nmol/l

0.02

297

Poor fetal growth

615

0.89

0.33

1.1

1.2

56.76

56.91

nmol/l

0.01

608

ILD-related respiratory insufficiency

191

1.21

0.33

1.4

1.8

43.39

43.29

nmol/l

0.01

178

Fracture of shoulder and upper arm

427

4108

1.04

0.33

1.7

1.8

41.76

39.82

nmol/l

0.93

417

4008

Diffuse large B-cell lymphoma

312

1.16

0.33

1.8

1.7

52.36

41.98

nmol/l

1.30

297

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

0.69

0.33

3.0

1.7

39.67

40.90

nmol/l

—

Pulmonary oedema

0.69

0.33

1.3

1.6

52.83

45.98

nmol/l

—

Other degenerative diseases of the basal ganglia

0.67

0.33

1.2

1.7

42.00

45.64

nmol/l

—

Malignant neoplasm of brain

381

0.86

0.33

1.5

1.8

38.76

38.92

nmol/l

0.02

366

Leiomyoma of uterus

512

1.09

0.32

1.2

60.55

60.19

nmol/l

0.03

505

Other and unspecified vasculitis limited to skin

176

0.79

0.32

2.2

1.8

34.14

39.17

nmol/l

0.47

166

Benign neoplasm: Other and unspecified parts of small intestine

1.33

0.32

1.5

1.9

39.64

43.09

nmol/l

0.16

Angina pectoris

713

4954

0.97

0.32

1.8

1.7

40.11

43.07

nmol/l

2.97

689

4797

Infective dermatitis

125

1166

1.07

0.31

1.7

1.8

39.49

41.27

nmol/l

0.42

120

1126

Ankylosing spondylitis, strict definition

772

1.09

0.31

1.6

1.9

34.33

36.55

nmol/l

0.61

754

Dermatitis due to substances taken internally

418

1.13

0.31

1.3

1.6

44.15

40.70

nmol/l

0.44

400

L04AC Interleukin inhibitors

705

1.10

0.31

1.7

1.8

37.77

37.90

nmol/l

0.02

688

Mixed connective tissue disease

305

1.15

0.30

2.1

1.7

49.60

42.71

nmol/l

0.47

291

Severe visual impairment, monocular

1.30

0.30

1.4

1.6

42.00

39.31

nmol/l

—

Basal cell carcinoma, including avohilmo

417

3166

1.04

0.30

1.6

1.7

48.10

45.74

nmol/l

1.20

397

3020

Contusion of other and unspecified parts of foot

610

1.10

0.30

1.8

38.92

38.68

nmol/l

0.02

596

Other/unspecified rheumatoid arthritis

610

0.90

0.30

2.0

1.7

44.27

42.94

nmol/l

0.16

583

Alcohol abuse counselling and surveillance

303

0.85

0.30

2.0

1.9

40.54

37.77

nmol/l

0.24

294

Secondary uncertain malignant neoplasm

1046

0.93

0.30

1.6

1.8

44.96

42.58

nmol/l

0.48

1002

Spinal enthesopathy

102

1.27

0.29

1.2

1.6

44.77

42.76

nmol/l

0.13

Disorders in reading

241

1.17

0.29

2.1

1.8

30.61

35.69

nmol/l

0.65

236

Benign neoplasm: Brain, supratentorial

148

1.22

0.29

2.1

1.8

36.33

38.36

nmol/l

0.16

142

Torticollis

206

0.82

0.29

1.8

1.7

39.00

37.04

nmol/l

0.15

199

Hypersensitivity pneumonitis due to organic dust

139

1.23

0.29

1.6

40.47

41.98

nmol/l

0.11

131

Ulcerative colitis (strict definition, require KELA)

281

2694

1.04

0.29

1.7

1.8

37.93

38.90

nmol/l

0.29

276

2624

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

440

0.88

0.29

1.6

1.8

57.03

43.59

nmol/l

1.88

416

Fracture of forearm

580

5275

1.03

0.29

1.7

41.28

40.43

nmol/l

0.33

568

5148

Malignant neoplasm of oropharynx

173

0.80

0.29

1.2

1.8

59.36

40.02

nmol/l

1.12

166

Benign neoplasm: Prostate

1.28

0.28

1.8

1.6

38.00

48.10

nmol/l

—

Crushing injury of wrist and hand

233

1.17

0.28

1.5

1.8

44.78

36.86

nmol/l

1.00

223

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1324

9666

0.98

0.28

1.9

1.7

42.78

41.56

nmol/l

0.86

1284

9433

Inflammatory bowel disease, strict (require KELA)

399

3857

1.04

0.28

1.7

1.8

39.18

39.10

nmol/l

0.02

391

3769

Other disorders of pigmentation

261

1.15

0.27

1.8

1.7

40.13

41.66

nmol/l

0.15

247

Mature T/NK-cell lymphomas, hilmo

117

0.76

0.27

1.2

1.7

40.44

43.52

nmol/l

—

111

Panniculitis, unspecified

1.26

0.27

2.5

1.6

46.00

40.53

nmol/l

—

Benign neoplasm: Bronchus and lung

120

0.75

0.27

1.9

1.8

42.33

40.62

nmol/l

—

115

Generalized skin eruption due to drugs and medicaments

252

1.15

0.27

1.2

1.7

44.38

40.50

nmol/l

0.39

243

Carcinoma in situ of colon

113

1.25

0.27

1.4

1.9

46.79

43.53

nmol/l

0.20

106

Rheumatic fever incl heart disease

204

0.83

0.27

1.6

1.8

45.71

39.76

nmol/l

0.29

192

Superficial injury of neck

289

0.86

0.27

2.2

1.8

40.92

39.35

nmol/l

0.11

282

Other conjunctival vascular disorders and cysts

150

1.20

0.26

1.6

1.8

55.44

40.69

nmol/l

0.76

143

Ankle and foot

1.20

0.26

1.5

1.7

46.88

41.59

nmol/l

—

In situ neoplasms

200

1819

1.05

0.26

1.5

1.6

49.27

48.82

nmol/l

0.08

192

1739

Pulmonary eosinophilia, not elsewhere classified

0.70

0.26

3.4

1.6

47.20

42.52

nmol/l

—

Pediculosis and phthiriasis

1.25

0.26

2.1

1.8

41.33

38.86

nmol/l

—

Otitis media, unspecified

143

1245

1.06

0.26

2.0

1.6

38.16

40.03

nmol/l

0.33

143

1222

Scar conditions and fibrosis of skin

282

1.14

0.25

1.4

1.7

43.97

40.23

nmol/l

0.27

271

Other superficial injuries of ankle and foot

1.23

0.25

1.1

1.7

39.22

40.22

nmol/l

—

Hypertensive Renal Disease

256

0.86

0.25

1.7

1.6

46.59

46.68

nmol/l

0.00

243

Complications of genitourinary prosthetic devices, implants and grafts

123

1.22

0.25

1.7

1.6

48.53

41.76

nmol/l

0.29

116

Burn and corrosion of shoulder and upper limb, except wrist and hand

266

0.86

0.25

1.2

1.7

34.13

37.70

nmol/l

0.33

257

Late syphilis

159

0.81

0.25

1.5

1.8

36.62

40.15

nmol/l

0.32

153

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

273

1.14

0.25

1.9

1.8

45.32

44.85

nmol/l

0.04

255

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

361

3045

0.97

0.25

1.6

1.5

47.84

49.95

nmol/l

0.57

344

2951

Perforation of tympanic membrane

102

956

1.07

0.25

1.8

39.08

40.25

nmol/l

0.23

927

Retinal vascular disorders

704

1.08

0.25

1.4

1.7

44.27

44.35

nmol/l

0.01

667

148

0.81

0.25

1.6

27.92

40.21

nmol/l

1.37

143

Use of galantamine

159

0.82

0.24

1.3

1.7

61.46

50.85

nmol/l

0.48

147

Personal history of allergy to drugs, medicaments and biological substances

1.27

0.24

1.3

1.7

58.55

39.20

nmol/l

0.73

Retinal haemorrhage

133

1.21

0.24

1.8

1.7

46.75

40.67

nmol/l

0.39

127

Malignant neoplasm of tonsil

158

0.82

0.24

1.2

1.8

58.85

40.60

nmol/l

0.93

151

Disease of hard tissues of teeth, NOS

115

1.23

0.24

2.1

1.7

42.93

37.77

nmol/l

0.28

115

Hereditary factor VIII deficiency

1.33

0.23

2.4

1.6

26.80

33.63

nmol/l

—

Vasculitis limited to skin, not elsewhere classified

190

0.84

0.23

2.1

1.8

34.62

38.98

nmol/l

0.46

179

Polyarthropathies

930

6319

0.98

0.23

1.8

1.7

40.45

41.94

nmol/l

0.98

901

6181

Other complications of labour and delivery, not elsewhere classified

690

1.08

0.23

1.1

1.2

61.45

54.67

nmol/l

0.60

685

Retinal vascular occlusion

698

1.08

0.23

1.5

1.7

44.42

44.19

nmol/l

0.03

661

Other/unspecified disorders of vestibular function

228

1.14

0.22

2.0

1.8

47.77

41.43

nmol/l

0.63

216

Follow-up examination after treatment for conditions other than malignant neoplasms

467

3143

0.97

0.22

1.7

1.6

45.13

42.37

nmol/l

1.29

450

3084

Other infiltrative disorders of skin and subcutaneous tissue

1.26

0.22

2.0

1.6

26.80

39.22

nmol/l

—

Other misadventures during surgical and medical care

153

1.18

0.22

2.6

1.7

45.11

41.06

nmol/l

0.26

144

Abscess of lung

178

0.84

0.22

1.3

1.7

43.13

38.77

nmol/l

0.48

171

Drowning and submersion in swimming-pool or bath

0.00

0.22

0.0

2.0

—

35.20

—

Pneumocystosis

135

0.81

0.22

1.9

1.7

45.36

40.46

nmol/l

0.18

128

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0.00

0.22

0.0

1.6

—

44.90

—

Cardiovascular devices associated with adverse incidents

0.00

0.22

0.0

1.4

—

39.90

—

Night blindness

0.00

0.22

0.0

1.4

—

33.18

—

Induced delusional disorder

0.00

0.22

0.0

2.5

—

36.45

—

Other eccrine sweat disorders

0.00

0.22

0.0

2.3

—

36.90

—

Crushing injuries involving multiple body regions

0.00

0.22

0.0

1.4

—

35.83

—

Unspecified nephritic syndrome

229

1.14

0.22

1.8

37.50

40.17

nmol/l

0.32

219

Extreme obesity with alveolar hypoventilation

305

1.12

0.22

2.1

1.8

30.12

40.61

nmol/l

2.97

293

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.22

0.0

1.2

—

39.83

—

Mucinosis of skin

0.00

0.22

0.0

1.6

—

44.91

—

Anaemia due to enzyme disorders

0.00

0.22

0.0

1.3

—

31.40

—

Benign neoplasm: Trachea

0.00

0.22

0.0

1.1

—

40.10

—

Other abnormalities of plasma proteins

107

1.22

0.21

1.7

1.9

46.15

40.19

nmol/l

0.69

100

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

0.00

0.21

0.0

1.3

—

31.95

—

Sweet's syndrome

0.00

0.21

0.0

1.5

—

33.73

—

Febrile neutrophilic dermatosis [Sweet]

0.00

0.21

0.0

1.5

—

33.73

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.21

0.0

1.2

—

47.36

—

Pustular psoriasis

286

1.12

0.21

1.6

1.7

48.09

39.79

nmol/l

0.59

275

Drug-induced autoimmune haemolytic anaemia

0.00

0.21

0.0

1.1

—

24.45

—

Iliac crest spur

0.00

0.21

0.0

1.1

—

44.92

—

Traumatic amputation of hip and thigh

0.00

0.21

0.0

1.5

—

39.30

—

Epidermolysis bullosa

0.00

0.21

0.0

1.5

—

34.20

—

Acquired coagulation factor deficiency

0.00

0.21

0.0

1.6

—

45.18

—

Drug-induced interstitial lung disorders, unspecified

0.00

0.21

0.0

1.3

—

36.18

—

Pityriasis alba

0.00

0.21

0.0

1.6

—

36.83

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.00

0.21

0.0

1.8

—

38.83

—

Other and unspecified atrophic disorders of skin

0.00

0.21

0.0

1.6

—

37.91

—

Other hypersecretion of intestinal hormones

0.00

0.21

0.0

1.1

—

44.31

—

Exposure to vibration

0.00

0.21

0.0

2.0

—

36.08

—

Benign neoplasm: Urethra

0.00

0.21

0.0

1.5

—

47.58

—

Benign neoplasm: Urethra

0.00

0.21

0.0

1.5

—

43.00

—

1186

10456

1.02

0.21

1.8

40.81

39.85

nmol/l

0.72

1149

10213

Abnormal findings on diagnostic imaging of breast

0.00

0.21

0.0

1.5

—

43.50

—

Nocardiosis

0.00

0.21

0.0

1.8

—

34.00

—

Other congenital malformations of the digestive system

399

1.10

0.21

1.5

1.8

40.43

39.27

nmol/l

0.13

386

Defect, injury or illness of chest

0.00

0.21

0.0

1.3

—

38.31

—

Hirsprung

0.00

0.21

0.0

1.2

—

31.81

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

1.24

0.21

1.2

1.7

38.73

39.40

nmol/l

0.06

Dislocations, sprains and strains involving multiple body regions

0.00

0.21

0.0

1.5

—

39.46

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.21

0.0

1.7

—

33.54

—

Unspecified severe protein-energy malnutrition

0.00

0.21

0.0

2.2

—

35.77

—

Burn and corrosion of hip and lower limb, except ankle and foot

287

1.12

0.21

1.7

44.31

38.50

nmol/l

0.43

278

Ototoxic hearing loss

0.00

0.21

0.0

1.2

—

35.77

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.21

0.0

1.4

—

31.77

—

SLE (Finngen)

173

1.16

0.21

1.8

1.6

35.55

42.91

nmol/l

1.09

168

Malignant neoplasm of pyriform sinus

0.00

0.21

0.0

1.9

—

41.36

—

Contusion of ankle

489

1.09

0.20

1.7

38.18

38.07

nmol/l

0.01

476

Leprosy [Hansen's disease]

0.00

0.20

0.0

2.1

—

44.29

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.20

0.0

1.4

—

41.71

—

Moyamoya

0.00

0.20

0.0

1.5

—

43.29

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.20

0.0

2.1

—

41.64

—

Other combined immunodeficiencies

0.00

0.20

0.0

2.0

—

37.86

—

Transepidermal elimination disorders

0.00

0.20

0.0

1.6

—

45.14

—

Other and unspecified thalassaemias

0.00

0.20

0.0

1.4

—

31.50

—

Polyp of middle ear

0.00

0.20

0.0

1.6

—

41.36

—

Haemophilus septicemia

0.00

0.20

0.0

1.5

—

33.36

—

Prolonged pregnancy

768

0.94

0.20

1.2

75.63

55.05

nmol/l

1.32

763

Radiodermatitis

0.00

0.20

0.0

1.7

—

48.29

—

Other or ill-defined heart diseases

683

1.07

0.20

2.0

1.8

38.62

38.67

nmol/l

0.01

662

Glomerular diseases

217

2250

0.96

0.20

1.7

1.8

44.50

40.65

nmol/l

0.78

212

2173

Other and unspecified disorders of psychological development

131

0.82

0.20

2.3

1.6

30.82

36.20

nmol/l

0.30

126

Congenital lens malformations

1.21

0.20

1.0

1.4

36.17

33.88

nmol/l

—

Inflammatory disorders of male genital organs, not elsewhere classified

212

1.14

0.20

1.6

1.8

45.33

37.46

nmol/l

0.82

203

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

110

1158

0.95

0.20

1.4

1.8

44.88

43.87

nmol/l

0.19

110

1104

Glucagon-like peptide-1 (GLP-1) analogues

592

4973

0.98

0.19

1.8

1.7

34.29

44.99

nmol/l

33.04

561

4825

Disorders of choroid and retina

993

7347

0.98

0.19

1.8

1.7

45.95

41.36

nmol/l

5.61

960

7139

Dissection of aorta

260

0.88

0.19

1.7

1.8

42.35

40.84

nmol/l

0.17

249

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

551

0.92

0.19

1.6

1.8

38.84

38.51

nmol/l

0.04

530

Peripheral retinal degeneration

222

1.13

0.19

2.0

1.7

56.88

40.77

nmol/l

1.06

214

Nephrotic syndrome

343

0.90

0.19

1.6

1.8

53.94

38.83

nmol/l

0.48

330

Malignant neoplasm of skin

474

3651

0.98

0.19

1.5

1.7

47.55

44.98

nmol/l

1.46

454

3489

Paranoid personality disorder

196

0.86

0.19

1.6

37.00

39.60

nmol/l

0.20

188

Disorders of globe

156

1.16

0.18

2.2

1.8

43.78

40.51

nmol/l

0.21

147

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

132

0.83

0.18

1.4

1.9

44.09

41.25

nmol/l

0.14

125

Diffuse large B-cell lymphoma, helper endpoint

328

1.10

0.18

1.8

1.7

52.36

42.77

nmol/l

1.17

308

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

328

1.10

0.18

1.8

1.7

52.36

42.77

nmol/l

1.17

308

Oral leukoplakia

128

1.18

0.18

1.5

1.9

37.93

41.48

nmol/l

0.31

123

Migraine with aura, drug-induced

1.19

0.18

3.4

1.8

24.29

36.58

nmol/l

—

Use of rivastigmine

372

0.91

0.18

1.5

51.68

50.81

nmol/l

0.07

348

Acute nephritic syndrome

237

0.88

0.18

1.7

1.8

33.14

40.37

nmol/l

1.20

229

Other secondary coxarthrosis

252

1.11

0.18

1.8

1.7

35.14

39.60

nmol/l

0.81

241

Foreign body on external eye

352

3434

1.03

0.17

1.7

1.8

38.11

38.09

nmol/l

0.01

340

3353

Communicating hydrocephalus

142

0.84

0.17

2.2

1.7

35.08

40.72

nmol/l

0.54

135

Glaucoma

441

3785

1.02

0.17

1.6

1.7

46.24

44.02

nmol/l

0.79

434

3628

Gout due to impairment of renal function

1.23

0.17

1.5

1.8

43.00

45.66

nmol/l

—

Dental caries 1 and operation codes, only avohilmo

401

2064

0.98

0.17

1.9

1.7

39.64

42.11

nmol/l

1.21

387

2019

Acute bronchiolitis

593

1.06

0.17

1.6

1.5

38.34

38.21

nmol/l

0.01

582

Postzoster neuralgia

1.16

0.16

2.5

1.6

35.63

44.60

nmol/l

—

Benign neoplasm: Prostate

1.13

0.16

1.8

1.7

38.00

45.32

nmol/l

—

Acute tubulo-interstitial nephritis

537

4851

0.98

0.16

1.7

1.6

43.69

45.97

nmol/l

0.96

523

4685

Condition for Implicit Sepsis (Organ dysfunction codes)

1214

8925

0.99

0.16

1.8

1.7

41.82

41.23

nmol/l

0.35

1169

8715

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

473

0.93

0.16

2.5

1.8

36.89

41.14

nmol/l

0.86

449

Spondylopathies in diseases classified elsewhere

1.10

0.16

2.8

1.6

31.13

43.25

nmol/l

—

Congenital malformations of cardiac chambers and connections

0.75

0.16

1.8

1.3

44.83

31.93

nmol/l

—

Tobacco use

604

1.06

0.15

2.0

1.8

47.08

39.54

nmol/l

0.86

585

ILD medications: immunosuppressive drugs

907

8579

1.01

0.15

1.6

1.7

41.68

40.64

nmol/l

0.56

890

8361

Malignant neoplasm of other connective and soft tissue

178

1.13

0.15

2.1

1.8

36.75

40.14

nmol/l

0.29

170

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

102

1.18

0.15

1.2

1.7

27.67

38.82

nmol/l

2.37

Corneal degeneration

1.10

0.15

2.0

1.7

35.33

43.31

nmol/l

—

Other anaemias

339

3200

1.02

0.14

1.7

48.91

44.56

nmol/l

1.52

327

3068

Alcohol abuse, main dg, excluding more controls

237

2432

0.97

0.14

1.7

39.14

39.54

nmol/l

0.11

232

2386

Keratoconus

392

1.07

0.14

2.5

1.8

33.81

36.77

nmol/l

0.40

382

Other bullous disorders

208

1.11

0.14

1.7

54.22

41.02

nmol/l

1.21

201

Other and unspecified anaemias

336

3182

1.02

0.14

1.8

1.7

48.70

44.59

nmol/l

1.38

324

3050

Erythema multiforme

189

1.11

0.14

2.4

1.7

38.43

39.21

nmol/l

0.06

178

Graves ophthalmopathy, strict

0.81

0.13

2.8

1.7

53.50

43.29

nmol/l

—

Abnormal findings on antenatal screening of mother

480

1.06

0.13

1.3

1.2

61.08

57.01

nmol/l

0.17

475

1108

10284

0.99

0.13

1.8

40.95

39.86

nmol/l

0.83

1076

10037

Superficial injury of head

280

2736

1.02

0.13

1.8

1.7

38.24

39.21

nmol/l

0.36

272

2672

107

985

0.96

0.13

1.7

1.6

50.52

49.22

nmol/l

0.20

923

Other melanin hyperpigmentation

1.17

0.13

1.8

1.7

39.27

42.57

nmol/l

0.23

Gout, FINNGEN

327

3204

1.02

0.13

1.9

1.7

36.62

44.26

nmol/l

8.42

312

3059

Malignant neoplasm of rectosigmoid junction

107

0.84

0.13

2.4

1.9

38.67

44.48

nmol/l

—

100

Disorders resulting from impaired renal tubular function

345

0.93

0.13

1.6

1.8

43.94

38.75

nmol/l

0.61

331

Ischaemic heart disease, wide definition

1076

6806

0.99

0.13

1.8

39.30

41.05

nmol/l

1.91

1043

6622

Gout, unspecified

222

2166

1.03

0.12

2.0

1.7

34.71

43.72

nmol/l

10.20

211

2063

Amyloidosis, other/unspecified

104

1.16

0.12

1.2

1.9

39.58

44.31

nmol/l

0.30

Chronic iridocyclitis

434

1.06

0.12

2.0

1.8

42.41

38.57

nmol/l

0.55

420

Myeloid leukaemia

191

1.10

0.12

2.9

1.8

44.43

41.31

nmol/l

0.15

181

Ulcer of lower limb, not elsewhere classified

117

1209

0.97

0.12

1.9

1.8

44.31

42.48

nmol/l

0.37

110

1157

Exposure to other and unspecified animate mechanical forces

298

1.08

0.11

1.9

1.7

38.28

39.39

nmol/l

0.13

292

Aphakia

126

0.87

0.11

1.5

1.8

53.55

38.34

nmol/l

0.92

121

Type 1 diabetes, wide definition, subgroup 1

377

3703

1.02

0.11

1.7

1.8

51.64

39.45

nmol/l

9.44

371

3622

Adenocarcinoma and Papillary adenocarcinoma of kidney

126

0.87

0.11

1.4

1.8

44.09

43.18

nmol/l

0.04

119

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

215

2128

0.98

0.11

1.7

1.8

39.60

39.51

nmol/l

0.02

210

2069

Complications of other internal prosthetic devices, implants and grafts

209

0.91

0.11

1.8

1.7

49.21

39.91

nmol/l

1.00

198

Sixth [abducent] nerve palsy

240

1.09

0.11

1.8

1.7

42.96

40.85

nmol/l

0.10

227

Cholangitis (primary sclerosing, PSC), with reimbursement 202

211

1.09

0.11

1.8

62.00

36.10

nmol/l

2.33

203

Other cataract

410

3124

1.02

0.11

1.8

1.7

47.77

43.25

nmol/l

2.05

398

3005

Gout, strict definition

182

1864

0.98

0.11

2.0

1.7

34.40

43.83

nmol/l

9.51

172

1778

Acquired haemolytic anaemia

167

0.90

0.10

1.7

55.87

41.48

nmol/l

0.97

160

Aneurysms, operations, SAH

130

1338

0.97

0.10

1.9

1.8

43.30

42.45

nmol/l

0.13

125

1287

Schizophrenia or delusion, excluding more controls

478

4808

0.99

0.10

1.8

1.7

39.23

38.70

nmol/l

0.15

465

4732

Viral pneumonia (known virus, not influenza)

208

0.91

0.10

1.8

1.7

41.47

38.77

nmol/l

0.18

196

Carcinoma in situ of other and unspecified digestive organs

173

1.10

0.10

1.5

1.8

43.21

42.83

nmol/l

0.02

163

Supplementary factors related to causes of morbidity and mortality classified elsewhere

430

4239

1.01

0.10

1.7

41.38

40.10

nmol/l

0.44

417

4140

Chorioretinal inflammation

259

0.92

0.10

2.0

1.8

40.46

39.25

nmol/l

0.11

249

Abnormal reflex

1.14

0.10

1.0

1.6

39.10

39.68

nmol/l

—

Oesophageal obstruction

261

1.07

0.10

1.3

1.7

45.86

41.72

nmol/l

0.47

248

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

269

0.93

0.10

1.5

1.8

40.60

40.41

nmol/l

0.02

257

Smoking dependency

961

0.97

0.10

1.9

1.8

43.07

39.72

nmol/l

0.56

926

Viral encephalitis, not elsewhere classified/unspecified

193

1.09

0.10

1.5

1.8

47.10

38.49

nmol/l

0.76

182

Schizoid personality disorder

279

0.93

0.10

2.1

1.7

41.15

38.49

nmol/l

0.16

271

Isolated proteinuria

320

0.94

0.10

1.9

1.8

38.97

38.42

nmol/l

0.04

306

Other intracranial haemorrhages

166

0.90

0.09

1.7

45.60

42.15

nmol/l

0.34

156

Idiopathic thrombocytopenic purpura

238

0.92

0.09

1.1

1.7

41.50

39.26

nmol/l

0.16

228

Frostbite involving multiple body regions and unspecified frostbite

1.07

0.09

2.4

1.7

28.40

38.23

nmol/l

—

Injury of muscle and tendon at wrist and hand level

235

2306

1.02

0.09

1.9

1.8

40.08

38.83

nmol/l

0.33

227

2245

Open wounds involving multiple body regions

1.07

0.09

1.4

1.9

42.40

35.45

nmol/l

—

Insulin, fast-acting or short human

553

5591

0.99

0.09

1.7

1.8

48.08

39.70

nmol/l

7.91

543

5430

Other disorders of fluid, electrolyte and acid-base balance

242

2377

0.98

0.09

1.8

1.7

49.69

43.78

nmol/l

2.22

233

2283

Amiodarone users

950

0.97

0.09

1.4

1.8

54.79

42.70

nmol/l

3.71

912

Aplastic and other anaemias

364

3501

0.99

0.09

1.7

48.48

44.23

nmol/l

1.58

351

3356

Contact with other hot metals

186

0.91

0.09

1.9

32.88

38.66

nmol/l

0.71

179

Other and unspecified hydrocephalus

124

0.89

0.09

1.3

1.7

40.82

40.85

nmol/l

0.00

119

Mental and behavioural disorders due to tobacco

959

0.97

0.09

1.9

1.8

43.07

39.41

nmol/l

0.63

926

Acute hepatitis A

1.14

0.09

1.8

44.00

36.51

nmol/l

—

Congenital malformations of great arteries

200

1.08

0.09

1.5

1.7

36.23

39.07

nmol/l

0.24

195

Hodgkin lymphoma, hilmo

341

1.06

0.08

1.5

1.8

42.75

38.11

nmol/l

0.72

326

Colitis due to radiation

1.07

0.08

2.0

1.5

44.17

45.04

nmol/l

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

136

1.11

0.08

2.5

1.5

44.47

37.91

nmol/l

0.36

131

Second line medication for Crohn's disease

719

7254

0.99

0.08

1.7

41.57

40.85

nmol/l

0.32

703

7064

Nondiabetic hypoglycaemic coma

0.81

0.08

1.4

1.7

51.40

33.67

nmol/l

—

Abscess of tendon sheath

0.83

0.08

1.2

1.4

45.40

41.45

nmol/l

—

Vitamin B12 deficiency anaemia

558

1.04

0.08

1.8

1.7

57.00

44.70

nmol/l

2.30

532

Focal epilepsy, strict definition

216

2197

0.98

0.08

1.7

1.8

48.26

40.51

nmol/l

2.52

211

2130

Hypothermia

195

0.92

0.08

1.7

1.8

45.72

39.90

nmol/l

0.52

186

Benign neoplasm: Pharynx, unspecified

1.06

0.08

3.4

1.8

26.71

36.75

nmol/l

—

Cystitis

775

4696

1.01

0.08

1.5

1.6

48.37

46.64

nmol/l

0.82

754

4545

6-mercaptopurine

419

0.95

0.08

1.6

1.7

36.03

38.15

nmol/l

0.34

407

severe traumatic brain injury, does not include concussion

236

2397

0.98

0.07

1.8

43.95

40.98

nmol/l

1.08

231

2308

Acute myringitis

0.82

0.07

1.5

31.83

39.89

nmol/l

—

Convulsions, not elsewhere classified

361

3606

0.99

0.07

1.9

1.7

44.76

40.25

nmol/l

1.91

352

3521

Carcinoma in situ, bladder

255

0.94

0.07

1.3

1.8

43.00

45.10

nmol/l

0.19

237

Chronic myeloproliferative disease

1.05

0.07

1.7

43.44

46.42

nmol/l

—

Other and unspecified degenerative diseases of nervous system

122

0.90

0.07

1.9

1.8

49.45

44.13

nmol/l

0.27

114

Liposarcoma, excluding all cancers (controls excluding all cancers)

0.86

0.07

2.3

1.7

39.13

43.43

nmol/l

—

Nystagmus and other irregular eye movements

128

1.10

0.06

2.1

1.8

51.14

35.41

nmol/l

1.18

122

Other diseases of pericardium

417

0.96

0.06

1.3

1.7

42.27

39.70

nmol/l

0.36

400

Adult respiratory distress syndrome

100

0.90

0.06

2.3

1.7

25.78

41.47

nmol/l

—

Ischemic heart diseases

1108

6897

1.01

0.06

1.8

39.45

41.00

nmol/l

1.62

1076

6710

Primary angle-closure glaucoma

193

0.93

0.06

1.2

1.8

51.83

41.93

nmol/l

0.64

182

Myeloid leukaemia

197

1.07

0.06

2.9

1.9

44.43

40.28

nmol/l

0.20

186

Pneumonia due to Streptococcus pneumoniae

477

0.96

0.06

2.0

1.8

37.52

39.01

nmol/l

0.24

459

Artificial opening status

446

0.96

0.06

1.6

1.8

37.30

41.12

nmol/l

1.08

433

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

324

0.96

0.05

2.1

1.8

37.10

40.53

nmol/l

0.45

309

Contusion of toe(s) without damage to nail

257

1.05

0.05

1.5

1.6

41.63

39.82

nmol/l

0.14

250

Alcohol use disorder, Swedish definition

1068

9961

0.99

0.05

1.9

1.8

41.34

39.79

nmol/l

1.33

1034

9722

Gout, idiopatic and unspecified

274

2711

1.01

0.05

1.9

1.7

35.07

43.66

nmol/l

11.13

261

2588

L04AX Other immunosuppressants

692

6960

0.99

0.05

1.7

41.85

40.94

nmol/l

0.42

677

6775

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

159

1.07

0.05

1.9

1.7

41.18

36.00

nmol/l

0.57

153

Atrial fibrillation and flutter with reimbursement

403

2562

1.01

0.05

1.7

40.17

42.72

nmol/l

1.51

383

2498

Carcinoma in situ, bladder

252

0.95

0.05

1.3

1.7

43.00

44.69

nmol/l

0.15

236

Background retinopathy and retinal vascular changes

181

0.94

0.05

1.4

1.8

38.82

40.02

nmol/l

0.10

176

Lung diseases due to external agents

114

1159

0.98

0.04

1.8

41.80

42.54

nmol/l

0.12

106

1115

Juvenile arthritis (FINNGEN)

476

1.03

0.04

1.8

1.7

44.53

39.91

nmol/l

0.28

469

Other lack of coordination

140

1.07

0.04

1.3

1.6

43.00

41.23

nmol/l

0.12

132

Other and unspecified injuries of abdomen, lower back and pelvis

160

1.06

0.04

2.3

1.8

40.53

38.90

nmol/l

0.15

155

Chronic kidney disease

264

2651

0.99

0.04

1.7

42.33

43.35

nmol/l

0.29

253

2541

Maternal care for other conditions predominantly related to pregnancy

833

1.02

0.04

1.3

1.1

64.08

57.65

nmol/l

0.52

826

Kela-code for severe mental illness

624

6208

1.01

0.04

1.9

1.8

37.65

38.91

nmol/l

0.63

605

6079

Rare circulating lymphoid malignancy

259

1.04

0.04

2.4

1.8

43.56

40.84

nmol/l

0.22

246

Graves ophthalmopathy

109

0.92

0.04

2.7

1.7

53.60

43.52

nmol/l

—

104

Motor neuron disease (with DMD)

111

1.08

0.04

1.5

50.58

40.39

nmol/l

0.63

106

Hypertensive Heart Disease

210

1734

0.99

0.04

1.6

1.7

40.58

48.00

nmol/l

4.79

199

1666

Malignant neoplasm of tongue

200

0.95

0.04

1.6

1.8

39.95

40.66

nmol/l

0.05

189

Burns and corrosions

220

2220

0.99

0.03

1.7

1.8

38.46

38.66

nmol/l

0.04

212

2163

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1331

9070

1.00

0.03

1.6

1.7

42.20

41.86

nmol/l

0.19

1270

8877

Glaucoma-related operations

250

1.04

0.03

1.8

1.7

41.54

43.46

nmol/l

0.23

235

Iridocyclitis in diseases classified elsewhere

169

0.95

0.03

2.0

1.7

35.37

39.41

nmol/l

0.46

163

Other diseases of peritoneum

209

0.96

0.03

1.7

1.8

41.45

41.17

nmol/l

0.02

200

260

1.04

0.02

1.5

1.6

43.74

40.87

nmol/l

0.16

250

Implicit Sepsis

964

7471

1.00

0.02

1.8

1.7

41.53

41.90

nmol/l

0.19

931

7273

Type 1 diabetes, wide definition

381

3823

1.00

0.02

1.7

1.8

51.54

39.49

nmol/l

9.39

375

3738

Hodgkin lymphoma

351

1.03

0.02

1.5

1.8

42.75

38.83

nmol/l

0.57

335

Carcinoma in situ of other and unspecified digestive organs

182

1.04

0.02

1.5

1.8

43.21

43.61

nmol/l

0.03

169

Chronic pancreatitis

174

1727

1.01

0.02

1.6

1.8

43.98

40.51

nmol/l

0.94

169

1669

Insulin, fast-acting

553

5544

1.00

0.02

1.7

1.8

48.08

39.86

nmol/l

7.63

543

5390

Carcinoma in situ of other and unspecified sites

268

0.97

0.02

1.2

1.8

43.00

45.45

nmol/l

0.24

249

Haemolytic anaemias

282

1.03

0.02

1.6

1.7

46.76

39.76

nmol/l

0.72

269

Disorders of lacrimal system and orbit in diseases classified elsewhere

107

0.93

0.02

2.7

1.7

53.60

43.75

nmol/l

—

102

Reimbursement for rheumatic diseases

608

6049

1.00

0.01

1.7

44.12

41.78

nmol/l

1.29

598

5875

Laparoscopic left hemicolectomy

137

0.95

0.01

1.5

1.8

39.00

41.88

nmol/l

0.23

131

Hypertrophic cardiomyopathy

392

1.02

0.01

1.6

1.8

35.80

39.18

nmol/l

0.65

377

Parapsoriasis

163

1.04

0.01

1.6

1.7

54.41

40.45

nmol/l

0.66

156

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

353

1.02

0.01

1.9

1.8

36.00

37.17

nmol/l

0.14

343

Motor neuron disease

104

1.06

0.01

1.5

52.45

40.81

nmol/l

0.69

Myasthenia gravis

126

0.95

0.00

1.6

33.42

41.36

nmol/l

1.12

118

Burns and corrosions of multiple body regions

144

1.04

0.00

1.7

41.33

38.94

nmol/l

0.18

139

Malignant neoplasm of mesothelium and soft tissue

284

1.02

0.00

2.3

1.7

36.72

41.88

nmol/l

0.71

268

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

264

1.02

0.00

2.4

1.9

43.56

41.40

nmol/l

0.17

250

Intestinal stricture

267

2663

1.00

0.00

1.9

1.7

43.16

42.72

nmol/l

0.12

259

2561

Pneumonitis due to solids and liquids

674

1.01

0.00

1.9

1.8

46.27

40.72

nmol/l

1.03

648

Contraceptive management

747

5256

1.00

0.00

1.8

38.70

38.06

nmol/l

0.31

733

5156

Persistent delusional disorders

864

1.01

0.00

1.9

37.26

37.27

nmol/l

0.00

840

Presence of other functional implants

475

3364

1.00

0.00

1.6

1.7

45.27

44.72

nmol/l

0.18

454

3244

Cellulitis of external ear

115

0.96

0.00

1.7

51.18

40.09

nmol/l

0.45

110

Other abnormal immunological findings in serum

145

1.04

0.00

1.9

1.8

50.73

38.64

nmol/l

0.60

139

Idiopathic gout

939

1.00

0.00

2.0

1.8

35.30

42.97

nmol/l

3.11

896

Other condition

182

1825

1.00

0.00

1.8

37.97

39.28

nmol/l

0.41

177

1772

Discitis, unspecified

124

0.97

0.00

2.3

1.6

46.42

40.44

nmol/l

0.48

118

Dermatitis herpetiformis

144

0.97

0.00

2.1

1.8

55.07

42.12

nmol/l

0.97

138

Diseases of spleen

154

0.97

0.00

1.8

1.7

43.67

40.34

nmol/l

0.16

148

Heart failure and hypertrophic cardiomyopathy

156

1.03

0.00

2.0

1.9

32.75

41.80

nmol/l

1.31

147

Other renal tubulo-interstitial diseases

125

0.96

0.00

1.7

24.92

43.32

nmol/l

4.70

120

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

127

1.02

0.00

2.4

1.9

50.62

42.28

nmol/l

0.64

120

Right hemicolectomy

356

1.01

0.00

1.4

1.8

35.50

41.72

nmol/l

0.99

336

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

102

0.98

0.00

1.8

1.9

44.50

42.64

nmol/l

—

Other and unspecified haemorrhagic conditions

112

0.98

0.00

1.1

1.8

44.18

40.19

nmol/l

0.30

107

Other retinal artery occlusion

142

0.99

0.00

1.2

1.7

41.50

42.39

nmol/l

0.05

135

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

198

1.01

0.00

1.5

1.8

39.60

40.76

nmol/l

0.10

188

Iron deficiency anaemia secondary to blood loss (chronic)

102

1022

1.00

0.00

2.3

1.7

43.12

42.18

nmol/l

0.14

982

Exposure to uncontrolled fire in building or structure

121

0.99

0.00

1.6

1.7

38.83

39.61

nmol/l

0.04

116

Mixed specific developmental disorders

223

1.00

0.00

1.7

1.6

29.38

35.82

nmol/l

1.16

217

SLE, ICD10

169

1.01

0.00

1.9

1.6

35.76

42.20

nmol/l

0.75

164

SLE, strict definition

169

1.01

0.00

1.9

1.6

35.76

42.20

nmol/l

0.75

164

Acute epiglottitis

179

1.01

0.00

1.6

33.83

39.95

nmol/l

0.90

169

Acute appendicitis, with complications

251

2506

1.00

0.00

1.9

1.8

38.23

40.41

nmol/l

0.71

245

2432

Lupus erythematosus

117

1.03

0.00

1.7

1.8

44.75

43.35

nmol/l

0.05

112

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

179

1.01

0.00

1.3

1.6

40.44

39.77

nmol/l

0.05

174

Carcinoma in situ of other and unspecified sites

265

0.98

0.00

1.2

1.8

43.00

44.47

nmol/l

0.13

248

Chronic Coagulation defects

165

0.97

0.00

2.7

1.5

39.69

40.26

nmol/l

0.04

160

Chronic nephritic syndrome

435

1.01

0.00

1.7

1.8

38.60

39.34

nmol/l

0.07

417

Contusion of toe(s) with damage to nail

134

0.97

0.00

2.6

1.7

41.00

38.63

nmol/l

0.13

129

Chagas' disease

0.00

0.0

1.0

—

56.40

—

Disorders of accommodation

0.00

0.0

1.4

—

28.60

—

GM2 gangliosidosis

0.00

0.0

1.2

—

59.00

—

Contact with other specified venomous plants

0.00

0.0

1.2

—

21.80

—

Miliaria crystallina

0.00

0.0

2.4

—

42.00

—

Assault by unspecified chemical or noxious substance

0.00

0.0

2.0

—

26.50

—

Cyst of iris, ciliary body and anterior chamber

0.00

0.0

1.7

—

48.00

—

Ophthalmic devices associated with adverse incidents

0.00

0.0

1.3

—

49.56

—

Bacterial agents resistant to antibiotics

0.00

0.0

1.4

—

38.75

—

Disorders of glycine metabolism

0.00

0.0

1.2

—

50.20

—

Traumatic shock

0.00

0.0

2.2

—

36.40

—

Scleritis and episcleritis (ICD-9) only

0.00

0.0

1.2

—

40.00

—

Disorders of urea cycle metabolism

0.00

0.0

1.2

—

30.33

—

Disorders of fatty-acid metabolism

0.00

0.0

1.5

—

33.33

—

Sequelae of other and unspecified effects of external causes

0.89

0.00

1.5

1.7

27.67

39.00

nmol/l

—

Duodenal ulcer - Acute without haemorrhage or perforation, drug-induced

0.00

0.0

1.6

—

40.22

—

Peutz-Jeghers syndrome

0.00

0.0

3.0

—

37.00

—

Intrauterine hypoxia

0.00

0.0

1.2

—

27.00

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.0

2.3

—

40.29

—

Crushing injury of neck

0.00

0.0

1.8

—

35.00

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.0

2.2

—

36.11

—

Malignant neoplasm of trachea, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

34.60

—

Noonan syndrome

0.00

0.0

1.4

—

28.89

—

Occupant of streetcar injured in transport accident

0.00

0.0

1.2

—

37.00

—

Carcinoma in situ of other/unspecified male genital organs

0.00

0.0

1.3

—

38.33

—

Androgen resistance syndrome

0.00

0.0

1.2

—

30.67

—

Flexion deformity

0.00

0.0

1.1

—

40.75

—

Ischaemic infarction of muscle

0.00

0.0

1.2

—

26.00

—

Other conditions of integument specific to fetus and newborn

0.00

0.0

1.5

—

26.50

—

Progressive external ophthalmoplegia

0.00

0.0

1.9

—

33.63

—

Non-neuropathic heredofamilial amyloidosis

0.00

0.0

1.7

—

41.33

—

Lethal midline granuloma

0.00

0.0

2.2

—

29.00

—

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

0.00

0.0

2.3

—

40.83

—

Malignant immunoproliferative diseases

0.93

0.00

2.0

1.7

35.29

45.56

nmol/l

—

Scleritis and episcleritis in diseases classified elsewhere

0.00

0.0

2.0

—

36.86

—

Carcinoma in situ, other and unspecified urinary organs

0.00

0.0

1.6

—

43.40

—

Arenaviral haemorrhagic fever

0.00

0.0

1.3

—

38.17

—

Toxic liver disease with cholestasis, drug-induced

0.00

0.0

1.7

—

47.57

—

Other inflammatory disorders of orbit (ICD-8 only)

0.00

0.0

1.3

—

26.83

—

Histoplasmosis

0.00

0.0

1.5

—

33.50

—

Total (external) ophthalmoplegia

0.00

0.0

2.3

—

36.00

—

Epiphyseal arrest

0.00

0.0

1.2

—

33.33

—

Melanoma in situ of ear and external auricular canal

0.00

0.0

1.6

—

36.11

—

Diphyllobothriasis and sparganosis

0.00

0.0

1.7

—

33.50

—

Hepatomegaly and splenomegaly, not elsewhere classified

0.91

0.00

2.0

1.6

32.11

39.34

nmol/l

—

Necrotizing fasciitis

0.91

0.00

1.0

1.5

55.80

40.73

nmol/l

—

Carcinoma in situ of other/unspecified male genital organs

0.00

0.0

1.4

—

37.00

—

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

0.0

2.0

—

39.40

—

Complications of anaesthesia during the puerperium

0.00

0.0

1.1

—

38.78

—

Traumatic anuria

0.00

0.0

1.2

—

33.80

—

Complicated migraine, drug-induced

0.00

0.0

1.8

—

35.00

—

Intracranial and intraspinal phlebitis and thrombophlebitis

0.00

0.0

1.6

—

37.40

—

Disorders of hypoglossal nerve

0.00

0.0

1.3

—

40.25

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

0.0

1.2

—

27.40

—

Disorders of olfactory nerve

0.00

0.0

1.2

—

43.40

—

Hypoplasia of dental enamel, prenatal

0.00

0.0

1.4

—

33.00

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

0.0

2.8

—

44.50

—

Blindness (ICD-9)

0.00

0.0

1.4

—

38.22

—

Hereditary factor XI deficiency

0.00

0.0

1.1

—

53.71

—

Trichomoniasis

0.00

0.0

1.2

—

41.11

—

Brucellosis

0.00

0.0

1.4

—

38.25

—

Wrist or foot drop (acquired)

0.00

0.0

1.0

—

46.00

—

Other diseases of arteries and capillaries

670

1.00

0.00

2.0

1.7

42.52

41.68

nmol/l

0.13

642

Iodine-deficiency-related goitre

0.00

0.0

1.4

—

55.60

—

Immunodeficiency following hereditary defective response to Epstein-Barr virus

0.00

0.0

1.4

—

39.40

—

Fetal alcohol syndrome (dysmorphic)

0.00

0.0

1.3

—

28.71

—

Plasmodium vivax malaria

0.00

0.0

2.0

—

39.14

—

Rat-bite fevers

0.00

0.0

1.2

—

38.20

—

Pseudomembranous colitis, drug-induced

0.00

0.0

2.2

—

34.40

—

Polydactyly

0.00

0.0

1.4

—

28.75

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

2.3

—

39.67

—

Hereditary erythropoietic porphyria

0.00

0.0

3.0

—

42.00

—

Disorders of oesophagus in diseases classified elsewhere

130

1.00

0.00

2.2

1.7

48.77

41.07

nmol/l

0.40

124

Disorder of amino-acid metabolism, other/unspecified

0.00

0.0

1.3

—

32.57

—

Use of benzatropine

0.00

0.0

1.0

—

47.86

—

Coccidioidomycosis

0.00

0.0

2.1

—

38.43

—

Other conditions originating in the perinatal period

0.00

0.0

2.2

—

40.40

—

Increased secretion of glucagon

0.00

0.0

1.1

—

27.22

—

Delta-beta thalassaemia

0.00

0.0

2.0

—

36.17

—

Bartonellosis

0.00

0.0

2.3

—

39.00

—

Forearm

0.00

0.0

1.4

—

33.22

—

Other chronic figurate erythema

0.00

0.0

1.0

—

55.00

—

Pemphigus foliaceus

0.00

0.0

1.7

—

49.78

—

Chronic bullous disease of childhood

0.00

0.0

1.5

—

36.17

—

Need for immunization against other single infectious diseases

0.00

0.0

1.5

—

26.83

—

Multiple sites

0.00

0.0

1.4

—

32.29

—

Eosinophilic cellulitis [Wells]

0.00

0.0

1.0

—

55.33

—

Other benign neoplasm of uterus: Corpus uteri

0.00

0.0

1.6

—

42.80

—

Lichen nitidus

0.00

0.0

1.3

—

36.33

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.2

—

40.00

—

Plasmodium malariae malaria

0.00

0.0

1.0

—

52.20

—

Myiasis

0.00

0.0

1.2

—

50.17

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

0.0

1.4

—

35.00

—

Benign neoplasm: Trachea

0.00

0.0

1.1

—

35.86

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.0

1.6

—

42.60

—

Merkel cell carcinoma of skin

0.00

0.0

1.3

—

47.87

—

Carcinoma in situ of breast, other/unspecified

0.00

0.0

1.6

—

59.00

—

Merkel cell carcinoma of skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

47.83

—

Strongyloidiasis

0.00

0.0

1.1

—

50.38

—

Other rickettsioses

0.00

0.0

2.2

—

40.00

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

1.01

0.00

1.3

1.8

39.78

43.65

nmol/l

—

Encephalocele

0.00

0.0

1.3

—

32.17

—

Enophthalmos

0.00

0.0

2.0

—

34.29

—

Malignant immunoproliferative diseases

0.94

0.00

2.0

35.29

45.12

nmol/l

—

Trichuriasis

0.00

0.0

1.4

—

32.40

—

Keratoderma in diseases classified elsewhere

0.00

0.0

1.0

—

52.20

—

Melanoma in situ of ear and external auricular canal

0.00

0.0

1.6

—

36.75

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

0.0

1.6

—

26.33

—

Agent resistant to multiple antibiotics

0.00

0.0

1.4

—

38.43

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.97

0.00

2.5

1.6

28.00

37.61

nmol/l

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.4

—

31.62

—

Postpolio syndrome

0.00

0.0

1.2

—

42.20

—

Vibratory urticaria

0.00

0.0

2.1

—

33.38

—

Traumatic amputation of forearm

0.00

0.0

1.2

—

29.20

—

Liposarcoma

1.01

0.00

2.3

1.6

39.14

45.91

nmol/l

—

Pemphigus erythematosus

0.00

0.0

1.3

—

37.50

—

Bladder disorders in in diseases classified elsewhere

0.00

0.0

1.1

—

54.67

—

Perioral dermatitis, drug-induced

0.00

0.0

2.0

—

29.40

—

Macular pucker, drug-induced

0.00

0.0

2.3

—

42.33

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

0.0

1.7

—

31.43

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.8

—

39.63

—

Leptospirosis

0.00

0.0

1.2

—

29.00

—

Biliary cirrhosis, secondary

0.00

0.0

1.3

—

52.86

—

Intracranial injury with prolonged coma

0.00

0.0

1.1

—

38.00

—

Ankylosing hyperostosis [Forestier]

120

1.00

0.00

2.2

1.6

35.75

40.91

nmol/l

0.82

115

Secondary lactase deficiency

0.00

0.0

1.2

—

46.89

—

Crushing injury of shoulder and upper arm

0.00

0.0

1.9

—

29.71

—

Mixed disorder of acid-base balance

0.00

0.0

1.0

—

30.00

—

Other migraine, drug-induced

0.00

0.0

2.1

—

35.43

—

R07AX Other respiratory system products

0.00

0.0

1.0

—

34.50

—

Congenital syphilis

0.00

0.0

1.0

—

49.43

—

Drug-induced tics and other tics of organic origin

0.00

-0.00

0.0

1.0

—

47.38

—

Birth injury to scalp

0.00

-0.00

0.0

1.0

—

35.50

—

Amputation of ankle

0.00

-0.00

0.0

1.7

—

41.11

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sex hormone binding globulin [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS